10-Q

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 1-8923

WELLTOWER INC.

(Exact name of registrant as specified in its charter) 

Delaware	34-1096634
(State or other jurisdiction of  incorporation or organization)	(I.R.S. Employer  Identification No.)
4500 Dorr Street, Toledo, Ohio	43615
(Address of principal executive offices)	(Zip Code)

(419) 247-2800

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☑  No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑  No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☑ Accelerated filer o Non-accelerated filer   o  (Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  ☑

As of April 28, 2017, the registrant had 366,166,605 shares of common stock outstanding.

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets — March 31, 2017 and December 31, 2016	3
Consolidated Statements of Comprehensive Income — Three months ended March 31, 2017 and 2016	4
Consolidated Statements of Equity — Three months ended March 31, 2017 and 2016	6
Consolidated Statements of Cash Flows — Three months ended March 31, 2017 and 2016	7
Notes to Unaudited Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3. Quantitative and Qualitative Disclosures About Market Risk	47
Item 4. Controls and Procedures	48
PART II. OTHER INFORMATION
Item 1. Legal Proceedings Item 1A. Risk Factors	48 49
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	49
Item 5. Other Information	49
Item 6. Exhibits	49
Signatures	50

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

CONSOLIDATED BALANCE SHEETS

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

				March 31, 2017		December 31, 2016
				(Unaudited)		(Note)
Assets:
Real estate investments:
	Real property owned:
		Land and land improvements		$	2,650,473	$	2,591,071
		Buildings and improvements			24,930,472		24,496,153
		Acquired lease intangibles			1,421,277		1,402,884
		Real property held for sale, net of accumulated depreciation			178,260		1,044,859
		Construction in progress			390,180		506,091
			Gross real property owned		29,570,662		30,041,058
		Less accumulated depreciation and amortization			(4,335,160)		(4,093,494)
			Net real property owned		25,235,502		25,947,564
	Real estate loans receivable				574,080		622,628
		Less allowance for losses on loans receivable			(6,196)		(6,563)
			Net real estate loans receivable		567,884		616,065
	Net real estate investments				25,803,386		26,563,629
Other assets:
		Investments in unconsolidated entities			416,110		457,138
		Goodwill			68,321		68,321
		Cash and cash equivalents			380,360		419,378
		Restricted cash			42,777		187,842
		Straight-line rent receivable			348,085		342,578
		Receivables and other assets			708,238		826,298
			Total other assets		1,963,891		2,301,555
Total assets				$	27,767,277	$	28,865,184
Liabilities and equity
Liabilities:
		Borrowings under primary unsecured credit facility		$	522,000	$	645,000
		Senior unsecured notes			8,188,928		8,161,619
		Secured debt			2,669,787		3,477,699
		Capital lease obligations			73,470		73,927
		Accrued expenses and other liabilities			817,411		827,034
Total liabilities					12,271,596		13,185,279
Redeemable noncontrolling interests					385,418		398,433
Equity:
		Preferred stock			718,750		1,006,250
		Common stock			365,187		363,071
		Capital in excess of par value			17,134,490		16,999,691
		Treasury stock			(62,306)		(54,741)
		Cumulative net income			5,130,593		4,803,575
		Cumulative dividends			(8,474,775)		(8,144,981)
		Accumulated other comprehensive income (loss)			(177,200)		(169,531)
		Other equity			1,464		3,059
			Total Welltower Inc. stockholders’ equity		14,636,203		14,806,393
		Noncontrolling interests			474,060		475,079
Total equity					15,110,263		15,281,472
Total liabilities and equity				$	27,767,277	$	28,865,184

NOTE: The consolidated balance sheet at December 31, 2016 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

See notes to unaudited consolidated financial statements

3

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands, except per share data)

			Three Months Ended
			March 31,
			2017		2016
Revenues:
	Rental income		$	367,141	$	415,663
	Resident fees and services			670,337		602,149
	Interest income			20,748		25,188
	Other income			4,072		4,050
		Total revenues		1,062,298		1,047,050
Expenses:
	Interest expense			118,597		132,960
	Property operating expenses			510,169		449,636
	Depreciation and amortization			228,276		228,696
	General and administrative			31,101		45,691
	Transaction costs			-		8,208
	Loss (gain) on derivatives, net			1,224		-
	Loss (gain) on extinguishment of debt, net			31,356		(24)
	Impairment of assets			11,031		14,314
	Other expenses			11,675		-
		Total expenses		943,429		879,481
Income (loss) from continuing operations before income taxes
	and income from unconsolidated entities			118,869		167,569
Income tax (expense) benefit				(2,245)		1,725
Income (loss) from unconsolidated entities				(23,106)		(3,820)
Income (loss) from continuing operations				93,518		165,474
Gain (loss) on real estate dispositions, net				244,092		-
Net income				337,610		165,474
Less:		Preferred stock dividends		14,379		16,352
Less:		Preferred stock redemption charge		9,769		-
Less:		Net income (loss) attributable to noncontrolling interests(1)		823		153
Net income (loss) attributable to common stockholders			$	312,639	$	148,969
Average number of common shares outstanding:
	Basic			362,534		355,076
	Diluted			364,652		356,051
Earnings per share:
	Basic:
	Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions		$	0.86	$	0.42
	Net income (loss) attributable to common stockholders*		$	0.86	$	0.42
	Diluted:
	Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions		$	0.86	$	0.42
	Net income (loss) attributable to common stockholders*		$	0.86	$	0.42
Dividends declared and paid per common share			$	0.87	$	0.86

* Amounts may not sum due to rounding

(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

4

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

		Three Months Ended March 31,
		2017		2016
Net income		$	337,610	$	165,474
Other comprehensive income (loss):
	Unrecognized gain (loss) on available for sale securities		(10,569)		(7,549)
	Unrealized gains (losses) on cash flow hedges		-		483
	Unrecognized actuarial gain (loss)		-		2
	Foreign currency translation gain (loss)		5,713		1,372
Total other comprehensive income (loss)			(4,856)		(5,692)
Total comprehensive income (loss)			332,754		159,782
Less: Total comprehensive income (loss) attributable to noncontrolling interests(1)			3,636		15,271
Total comprehensive income (loss) attributable to common stockholders		$	329,118	$	144,511
(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

5

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

		Three Months Ended March 31, 2017
														Accumulated
						Capital in								Other
		Preferred		Common		Excess of		Treasury		Cumulative		Cumulative		Comprehensive		Other		Noncontrolling
		Stock		Stock		Par Value		Stock		Net Income		Dividends		Income (Loss)		Equity		Interests		Total
Balances at beginning of period		$	1,006,250	$	363,071	$	16,999,691	$	(54,741)	$	4,803,575	$	(8,144,981)	$	(169,531)	$	3,059	$	475,079	$	15,281,472
Comprehensive income:
	Net income (loss)										336,787								1,780		338,567
	Other comprehensive income														(7,669)				2,813		(4,856)
Total comprehensive income																					333,711
Net change in noncontrolling interests							932												(5,612)		(4,680)
Amounts related to stock incentive plans, net of forfeitures					336		6,903		(7,565)								(1,605)				(1,931)
Proceeds from issuance of common stock					1,780		117,204														118,984
Redemption of preferred stock			(287,500)				9,760				(9,769)										(287,509)
Option compensation expense																	10				10
Dividends paid:
	Common stock dividends												(315,415)								(315,415)
	Preferred stock dividends												(14,379)								(14,379)
Balances at end of period		$	718,750	$	365,187	$	17,134,490	$	(62,306)	$	5,130,593	$	(8,474,775)	$	(177,200)	$	1,464	$	474,060	$	15,110,263
		Three Months Ended March 31, 2016
														Accumulated
						Capital in								Other
		Preferred		Common		Excess of		Treasury		Cumulative		Cumulative		Comprehensive		Other		Noncontrolling
		Stock		Stock		Par Value		Stock		Net Income		Dividends		Income (Loss)		Equity		Interests		Total
Balances at beginning of period		$	1,006,250	$	354,811	$	16,478,300	$	(44,372)	$	3,725,772	$	(6,846,056)	$	(88,243)	$	4,098	$	585,325	$	15,175,885
Comprehensive income:
	Net income (loss)										165,321								1,082		166,403
	Other comprehensive income														(20,810)				15,118		(5,692)
Total comprehensive income																					160,711
Net change in noncontrolling interests							(5,717)												(121,325)		(127,042)
Amounts related to stock incentive plans, net of forfeitures					637		25,555		(6,899)								(115)				19,178
Proceeds from issuance of common stock					1,505		91,600														93,105
Option compensation expense																	79				79
Dividends paid:
	Common stock dividends												(305,770)								(305,770)
	Preferred stock dividends												(16,352)								(16,352)
Balances at end of period		$	1,006,250		356,953		16,589,738		(51,271)		3,891,093		(7,168,178)		(109,053)		4,062		480,200	$	14,999,794

See notes to unaudited consolidated financial statements

6

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

			Three Months Ended
			March 31,
			2017		2016
Operating activities:
Net income			$	337,610	$	165,474
Adjustments to reconcile net income to
	net cash provided from (used in) operating activities:
		Depreciation and amortization		228,276		228,696
		Other amortization expenses		3,361		1,118
		Impairment of assets		11,031		14,314
		Stock-based compensation expense		4,906		8,186
		Loss (gain) on derivatives, net		1,224		-
		Loss (gain) on extinguishment of debt, net		31,356		(24)
		Loss (income) from unconsolidated entities		23,106		3,820
		Rental income in excess of cash received		(18,141)		(29,669)
		Amortization related to above (below) market leases, net		8		230
		Loss (gain) on sales of properties, net		(244,092)		-
		Distributions by unconsolidated entities		474		174
		Increase (decrease) in accrued expenses and other liabilities		19,478		(13,526)
		Decrease (increase) in receivables and other assets		(13,071)		1,816
Net cash provided from (used in) operating activities				385,526		380,609
Investing activities:
	Cash disbursed for acquisitions			(102,356)		(171,482)
	Cash disbursed for capital improvements to existing properties			(42,115)		(35,025)
	Cash disbursed for construction in progress			(69,334)		(66,739)
	Capitalized interest			(4,129)		(3,037)
	Investment in real estate loans receivable			(25,375)		(27,251)
	Other investments, net of payments			48,311		(30,773)
	Principal collected on real estate loans receivable			8,792		93,774
	Contributions to unconsolidated entities			(13,073)		(12,784)
	Distributions by unconsolidated entities			24,161		11,747
	Proceeds from (payments on) derivatives			8,218		-
	Decrease (increase) in restricted cash			145,065		(394)
	Proceeds from sales of real property			1,087,074		-
Net cash provided from (used in) investing activities				1,065,239		(241,964)
Financing activities:
	Net increase (decrease) under unsecured credit facilities			(123,000)		(190,000)
	Proceeds from issuance of senior unsecured notes			-		688,560
	Payments to extinguish senior unsecured notes			-		(400,000)
	Net proceeds from the issuance of secured debt			12,536		75,136
	Payments on secured debt			(822,438)		(130,343)
	Net proceeds from the issuance of common stock			119,651		93,433
	Redemption of preferred stock			(287,500)		-
	Payments for deferred financing costs and prepayment penalties			(36,674)		(1,217)
	Contributions by noncontrolling interests(1)			2,667		126,142
	Distributions to noncontrolling interests(1)			(20,014)		(76,222)
	Acquisitions of noncontrolling interests			(38)		-
	Cash distributions to stockholders			(329,794)		(322,122)
	Other financing activities			(8,022)		(7,294)
Net cash provided from (used in) financing activities				(1,492,626)		(143,927)
Effect of foreign currency translation on cash and cash equivalents				2,843		323
Increase (decrease) in cash and cash equivalents				(39,018)		(4,959)
Cash and cash equivalents at beginning of period				419,378		360,908
Cash and cash equivalents at end of period			$	380,360	$	355,949
Supplemental cash flow information:
	Interest paid		$	109,438	$	134,872
	Income taxes paid			3,349		2,431
(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

7

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business

     Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.  Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.  Founded in 1970, we were the first real estate investment trust to invest exclusively in health care facilities.

2. Accounting Policies and Related Matters

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily an indication of the results that may be expected for the year ending December 31, 2017. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.

New Accounting Standards

     In May 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services.  ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted beginning after December 15, 2016.  A reporting entity may apply the new standard using either a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or a full retrospective approach.  We are currently evaluating the impact that the adoption of the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the new standard.  A significant source of our revenue is generated through leasing arrangements, which are specifically excluded from the new standard.  We expect that the new standard will affect our accounting policies related to non-lease revenue, including certain fees in our RIDEA joint ventures, common area maintenance in our outpatient medical properties and real estate sales.  Under ASU 2014-09, revenue recognition for real estate sales is mainly based on the transfer of control versus current guidance of continuing involvement.  We expect that the new guidance will result in more transactions qualifying as sales of real estate and being recognized at an earlier date than under the current guidance.

     In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which will require entities to measure their investments at fair value and recognize any changes in fair value in net income unless the investments qualify for the new practicability exception.  The practicability exception will be available for equity investments that do not have readily determinable fair values. ASU 2016-01 is effective for fiscal years and interim periods within those years, beginning after December 15, 2017.  We are currently evaluating the impact that the standard will have on our consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” which requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term.  It will also require disclosures designed to give financial statement users information regarding amount, timing, and uncertainty of cash flows arising from leases.  ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted.  Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements.  We are currently evaluating the impact of this standard on our consolidated financial statements.  We believe that the adoption of this standard will likely have a material impact to our consolidated balance sheet for the recognition of certain operating leases as right-of-use assets and lease liabilities.  We are in the process of analyzing our lease portfolio and evaluating systems to comply with the standard’s retrospective adoption requirements. 

In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting”.  ASU 2016-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted.  We adopted ASU 2016-09 on January 1, 2017.  The standard allows companies to make a policy election as to whether

8

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

they will include an estimate of awards expected to be forfeited or whether they will account for forfeitures as they occur.  We have elected to account for forfeitures as they occur. This election had an immaterial impact on our consolidated financial statements.  The standard also requires an employer to classify as a financing activity in the statement of cash flow the cash paid to a tax authority when shares are withheld to satisfy the employer’s statutory income tax withholding obligation.  This standard is required to be applied on a retrospective basis and resulted in an increase in net cash provided by operating activities and a decrease in net cash used in financing activities of $6,897,000 for the three months ended March 31, 2016.  Upon adoption, no other provisions of ASU 2016-09 had an effect on our unaudited consolidated financial statements or related footnote disclosures.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments”.  This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments.  ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018.  We are currently evaluating the impact that the standard will have on our consolidated financial statements. 

     In January 2017, the FASB issued ASU No. 2017-01, “Clarifying the Definition of a Business”.  This standard changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business.  ASU 2017-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted.  A reporting entity must apply ASU 2017-01 using a prospective approach.  We adopted ASU 2017-01 on January 1, 2017 and as a result, have classified our real estate acquisitions completed during the three months ended March 31, 2017 as asset acquisitions rather than business combinations due to the fact that substantially all of the fair value of the gross assets acquired were concentrated in a single asset or group of similar identifiable assets. We have recorded identifiable assets acquired, liabilities assumed and any noncontrolling interests associated with any asset acquisitions at cost on a relative fair value basis and have capitalized transaction costs incurred.

3. Real Property Acquisitions and Development

     The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their relative fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments.  Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs.  Effective January 1, 2017, with our adoption of ASU 2017-01, transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in “Other Expenses” on our Consolidated Statements of Comprehensive Income. Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. See Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for information regarding our foreign currency policies.

    Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,017		$	15,331
Buildings and improvements				37,241			114,235
Acquired lease intangibles				-			1,623
	Total assets acquired			41,258			131,189
Accrued expenses and other liabilities				-			(809)
	Total liabilities assumed			-			(809)
Non-cash acquisition related activity(1)				-			(28,621)
	Cash disbursed for acquisitions			41,258			101,759
Construction in progress additions				46,754			43,835
Less:	Capitalized interest			(2,028)			(1,684)
	Foreign currency translation			(164)			(583)
Cash disbursed for construction in progress				44,562			41,568
Capital improvements to existing properties				10,495			7,438
	Total cash invested in real property, net of cash acquired		$	96,315		$	150,765
(1) Includes $25,691,000 related to the acquisition of assets previously financed as real estate loans receivable and $2,871,000 related to the acquisition of assets previously financed as an investment in an unconsolidated entity.

9

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Seniors Housing Operating Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,304		$	3,440
Building and improvements				44,075			48,218
Acquired lease intangibles				1,741			1,942
Receivables and other assets				74			36
	Total assets acquired(1)			50,194			53,636
Accrued expenses and other liabilities				(2,755)			(11)
	Total liabilities assumed			(2,755)			(11)
Noncontrolling interests				(647)			(549)
Non-cash acquisition related activity(2)				(14,148)			-
	Cash disbursed for acquisitions			32,644			53,076
Construction in progress additions				8,062			4,033
Less:	Capitalized interest			(1,707)			(565)
	Foreign currency translation			691			(1,107)
Cash disbursed for construction in progress				7,046			2,361
Capital improvements to existing properties				24,254			16,808
	Total cash invested in real property, net of cash acquired		$	63,944		$	72,245
(1) Excludes $400,000 and $113,000 of cash acquired during the three months ended March 31, 2017 and 2016, respectively.
(2) Includes $6,349,000 related to the acquisition of assets previously financed as real estate loans receivable and $7,799,000 previously financed as an investment in an unconsolidated entity.

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	2,895	$	-
Buildings and improvements				23,310		17,637
Acquired lease intangibles				3,496		-
Receivables and other assets				3		-
	Total assets acquired			29,704		17,637
Accrued expenses and other liabilities				(1,250)		(990)
	Total liabilities assumed			(1,250)		(990)
	Cash disbursed for acquisitions			28,454		16,647
Construction in progress additions				14,921		28,934
Less:	Capitalized interest			(717)		(788)
	Accruals(1)			3,522		(5,336)
Cash disbursed for construction in progress				17,726		22,810
Capital improvements to existing properties				7,366		10,779
	Total cash invested in real property		$	53,546	$	50,236
(1) Represents the change in non-cash consideration accruals for amounts to be paid in periods other than the period in which the construction projects converted to operations.

10

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Construction Activity

     The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

			Three Months Ended
			March 31, 2017			March 31, 2016
	Development projects:
		Triple-net		$	157,460		$	-
		Seniors housing operating			3,634			-
		Outpatient medical			25,910			35,363
	Total development projects				187,004			35,363
Total construction in progress conversions				$	187,004		$	35,363

4. Real Estate Intangibles

     The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

		March 31, 2017		December 31, 2016
Assets:
	In place lease intangibles	$	1,267,280	$	1,252,143
	Above market tenant leases		63,184		61,700
	Below market ground leases		62,224		61,628
	Lease commissions		28,589		27,413
	Gross historical cost		1,421,277		1,402,884
	Accumulated amortization		(1,010,364)		(966,714)
	Net book value	$	410,913	$	436,170
	Weighted-average amortization period in years		14.4		13.7
Liabilities:
	Below market tenant leases	$	90,745	$	89,468
	Above market ground leases		8,107		8,107
	Gross historical cost		98,852		97,575
	Accumulated amortization		(54,354)		(52,134)
	Net book value	$	44,498	$	45,441
	Weighted-average amortization period in years		15.1		15.2

     The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended
	March 31,
	2017		2016
Rental income related to above/below market tenant leases, net	$	304	$	81
Property operating expenses related to above/below market ground leases, net		(312)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(39,302)		(34,454)

11

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

     The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

		Assets		Liabilities
2017	$	105,454	$	4,959
2018		77,561		6,106
2019		37,948		5,685
2020		24,169		5,208
2021		20,191		4,720
Thereafter		145,590		17,820
Total	$	410,913	$	44,498

5. Dispositions, Assets Held for Sale and Discontinued Operations

We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (e.g., property type, operator or geography). During the three months ended March 31, 2017 and 2016, we recorded impairment charges on certain held-for-sale seniors housing operating and outpatient medical properties as the fair values less estimated costs to sell exceeded our carrying values. The following is a summary of our real property disposition activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2017			March 31, 2016
Real estate dispositions:
	Triple-net		$	808,204		$	-
	Seniors housing operating			13,845			-
	Total dispositions			822,049			-
Gain (loss) on real estate dispositions, net				244,092			-
	Net other assets/liabilities disposed			20,933			-
Proceeds from real estate dispositions			$	1,087,074		$	-

Dispositions and Assets Held for Sale

     Pursuant to our adoption of ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”, operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income.  The following represents the activity related to these properties for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2017		2016
Revenues:
	Rental income	$	16,734	$	5,477
Expenses:
	Interest expense		1,301		851
	Property operating expenses		1,855		1,362
	Provision for depreciation		245		820
	Total expenses		3,401		3,033
Income (loss) from real estate dispositions, net		$	13,333	$	2,444

12

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

6. Real Estate Loans Receivable

     Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for discussion of our accounting policies for real estate loans receivable and related interest income. 

     The following is a summary of our real estate loan activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2017						March 31, 2016
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	7,828	$	-	$	7,828	$	8,013	$	-	$	8,013
	Draws on existing loans		17,547		-		17,547		19,206		32		19,238
	Net cash advances on real estate loans		25,375		-		25,375		27,219		32		27,251
Receipts on real estate loans receivable:
	Loan payoffs		14,474		60,500		74,974		104,068		12,290		116,358
	Principal payments on loans		667		-		667		3,107		-		3,107
	Sub-total		15,141		60,500		75,641		107,175		12,290		119,465
	Less: Non-cash activity(1)(2)		(6,349)		(60,500)		(66,849)		(25,691)		-		(25,691)
	Net cash receipts on real estate loans		8,792		-		8,792		81,484		12,290		93,774
Net cash advances (receipts) on real estate loans			16,583		-		16,583		(54,265)		(12,258)		(66,523)
Change in balance due to foreign currency translation			1,718		-		1,718		(1,987)		-		(1,987)
Net change in real estate loans receivable		$	11,952	$	(60,500)	$	(48,548)	$	(81,943)	$	(12,258)	$	(94,201)
(1) Triple-net represents acquisitions of assets previously financed as real estate loans.  Please see Note 3 for additional information.
(2) Outpatient medical represents a deed in lieu of foreclosure on a previously financed first mortgage property.

In 2016, we restructured two existing real estate loans in the triple-net segment with Genesis Healthcare.  The two existing loans, with a combined principal balance of $317,000,000, were scheduled to mature in 2017 and 2018.  These loans were restructured into four separate loans effective October 1, 2016.  Each loan has a five-year term, a 10% interest rate and 25 basis point annual escalator.  In 2016, we recorded a loan loss charge in the amount of $6,935,000 on one of the loans as the present value of expected future cash flows was less than the carrying value of the loan.  We expect to collect all principal amounts due under the loans and, due to the passage of time, at March 31, 2017, the allowance for loan losses related to these loans is $6,196,000.  At March 31, 2017, we had no real estate loans with outstanding balances on non-accrual status and recorded no provision for loan losses during the three months ended March 31, 2017.

		Three Months Ended
	March 31, 2017		March 31, 2016
Balance of impaired loans at end of period	$	317,049	$	-
Allowance for loan losses		6,196		-
Balance of impaired loans not reserved	$	310,853	$	-
Average impaired loans for the period	$	340,920	$	-
Interest recognized on impaired loans(1)		8,243		-
(1) Represents interest recognized in period since loans were identified as impaired.

13

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

7. Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate.  The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities.  The following is a summary of our investments in unconsolidated entities (dollars in thousands):

	Percentage Ownership(1)	March 31, 2017		December 31, 2016
Triple-net	10% to 49%	$	23,108	$	27,005
Seniors housing operating	10% to 50%		360,260		407,172
Outpatient medical	43%		32,742		22,961
Total		$	416,110	$	457,138
(1) Excludes ownership of in-substance real estate.

     At March 31, 2017, the aggregate unamortized basis difference of our joint venture investments of $211,268,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the entity.  This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.

8. Credit Concentration

     We use net operating income from continuing operations (“NOICO”) as our credit concentration metric.  See Note 17 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the three months ended March 31, 2017, excluding our share of NOICO in unconsolidated entities (dollars in thousands):

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOICO		NOICO(2)
	Genesis Healthcare	86	$	49,048	9%
	Sunrise Senior Living(3)	153		74,893	14%
	Brookdale Senior Living	137		38,372	7%
	Revera(3)	98		37,802	7%
	Benchmark Senior Living	48		22,614	4%
	Remaining portfolio	755		329,400	59%
	Totals	1,277	$	552,129	100%
(1) Genesis Healthcare is in our triple-net segment.  Sunrise Senior Living and Revera are in our seniors housing operating segment.  Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.
(2) NOICO with our top five relationships comprised 45% of total NOICO for the year ending December 31, 2016.
(3) Revera owns a controlling interest in Sunrise Senior Living.

9. Borrowings Under Credit Facilities and Related Items

At March 31, 2017, we had a primary unsecured credit facility with a consortium of 29 banks that includes a $3,000,000,000 unsecured revolving credit facility, a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility.  We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000.  The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at March 31, 2017).  Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate (1.88% at March 31, 2017). The applicable margin is based on certain of our debt ratings and was 0.90% at March 31, 2017.  In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount.  The facility fee depends on certain of our debt ratings and was 0.15% at March 31, 2017.  The term credit facilities mature on May 13, 2021. The revolving credit facility is scheduled to mature on May 13, 2020 and can be extended for two successive terms of six months each at our option.

14

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

     The following information relates to aggregate borrowings under the primary unsecured revolving credit facility for the periods presented (dollars in thousands):

		Three Months Ended March 31,
		2017		2016
Balance outstanding at quarter end(1)		$	522,000	$	645,000
Maximum amount outstanding at any month end		$	1,010,000	$	945,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	796,356	$	671,044
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.81%		1.29%
(1) As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

10. Senior Unsecured Notes and Secured Debt

     We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms.   The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions.   Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.At March 31, 2017, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2017	$	-	$	284,879	$	284,879
2018		450,000		421,751		871,751
2019		605,000		499,895		1,104,895
2020(4)		675,208		149,888		825,096
2021(5,6)		1,137,674		228,993		1,366,667
Thereafter(7,8,9,10)		5,416,385		1,080,071		6,496,456
Totals	$	8,284,267	$	2,665,477	$	10,949,744
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.6% to 6.5%.
(3) Annual interest rates range from 1.32% to 7.93%.  Carrying value of the properties securing the debt totaled $4,947,646,000 at March 31, 2017.
(4) In November 2015, one of our wholly-owned subsidiaries issued and we guaranteed $300,000,000 of Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $225,208,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017).
(5) On May 13, 2016, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $187,674,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017).  The loan matures on May 13, 2021 and bears interest at the Canadian Dealer Offered Rate plus 95 basis points (1.84% at March 31, 2017).
(6) On May 13, 2016, we refinanced the funding on a $500,000,000 unsecured term credit facility.  The loan matures on May 13, 2021 and bears interest at LIBOR plus 95 basis points (1.83% at March 31, 2017).
(7) On November 20, 2013, we completed the sale of £550,000,000 (approximately $689,535,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.8% senior unsecured notes due 2028.
(8) On November 25, 2014, we completed the sale of £500,000,000 (approximately $626,850,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.5% senior unsecured notes due 2034.
(9) In May 2015, we issued $750,000,000 of 4.0% senior unsecured notes due 2025.  In October 2015, we issued an additional $500,000,000 of these notes under a re-opening of the offer.
(10) In March 2016, we issued $700,000,000 of 4.25% senior unsecured notes due 2026.

15

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Three Months Ended
	March 31, 2017			March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	8,260,038	4.245%	$	8,645,758	4.237%
Debt issued		-	0.000%		700,000	4.250%
Debt extinguished		-	0.000%		(400,000)	3.625%
Foreign currency		24,229	4.391%		(11,665)	3.943%
Ending balance	$	8,284,267	4.262%	$	8,934,093	4.266%

         The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands):

	Three Months Ended
		March 31, 2017		March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	3,465,066	4.094%	$	3,478,207	4.440%
Debt issued		12,536	2.340%		75,136	3.060%
Debt extinguished		(806,189)	5.580%		(111,701)	4.450%
Principal payments		(16,249)	4.469%		(18,642)	4.539%
Foreign currency		10,313	3.262%		65,488	3.669%
Ending balance	$	2,665,477	3.744%	$	3,488,488	4.400%

     Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2017, we were in compliance with all of the covenants under our debt agreements.

11. Derivative Instruments

     We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates.  We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to manage the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates.  In addition, non-U.S. investments expose us to the potential losses associated with adverse changes in foreign currency to U.S. Dollar exchange rates.  We may elect to manage this risk through the use of forward contracts and issuing debt in foreign currencies.

 Interest Rate Swap Contracts and Foreign Currency Forward Contracts Designated as Cash Flow Hedges

     For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”), and reclassified into earnings in the same period or periods, during which the hedged transaction affects earnings.  Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings.  Approximately $3,395,000 of gains, which are included in accumulated other comprehensive income (“AOCI”), are expected to be reclassified into earnings in the next 12 months.

Foreign Currency Hedges

     For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.  During the three months ended March 31, 2017 and 2016, we settled certain net investment hedges generating cash proceeds of $8,218,000 and $0, respectively.  The balance of the cumulative translation adjustment will be reclassified to earnings when the hedged investment is sold or substantially liquidated. 

16

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

     The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands):

		March 31, 2017		December 31, 2016
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	875,000	$	900,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars	$	-	$	57,000
Denominated in Canadian Dollars	$	72,000	$	54,000
Denominated in Pounds Sterling	£	69,000	£	48,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	37,000	$	37,000

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended
		March 31,
	Location		2017		2016
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense	$	-	$	(483)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,457		(1,327)
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		(44,341)		(2,739)

12. Commitments and Contingencies

     At March 31, 2017, we had 14 outstanding letter of credit obligations totaling $169,961,000 and expiring between 2017 and 2024.  At March 31, 2017, we had outstanding construction in progress of $390,180,000 and were committed to providing additional funds of approximately $466,031,000 to complete construction.  At March 31, 2017, we had contingent purchase obligations totaling $17,058,000.  These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property. 

     We evaluate our leases for operating versus capital lease treatment in accordance with ASC Topic 840 “Leases.”  A lease is classified as a capital lease if it provides for transfer of ownership of the leased asset at the end of the lease term, contains a bargain purchase option, has a lease term greater than 75% of the economic life of the leased asset, or if the net present value of the future minimum lease payments are in excess of 90% of the fair value of the leased asset. Certain leases contain bargain purchase options and have been classified as capital leases.  At March 31, 2017, we had operating lease obligations of $1,092,169,000 relating to certain ground leases and company office space and capital lease obligations of $93,697,000 relating primarily to certain investment properties. Regarding ground leases, we have sublease agreements with certain of our operators that require the operators to reimburse us for our monthly operating lease obligations.  At March 31, 2017, aggregate future minimum rentals to be received under these noncancelable subleases totaled $73,840,000.

17

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

13. Stockholders’ Equity

     The following is a summary of our stockholders’ equity capital accounts as of the dates indicated:

	March 31, 2017	December 31, 2016
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	14,375,000	25,875,000
Outstanding shares	14,375,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	365,651,576	363,576,924
Outstanding shares	364,563,653	362,602,173

Preferred Stock. The following is a summary of our preferred stock activity during the periods indicated:

	Three Months Ended
	March 31, 2017		March 31, 2016
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	25,875,000	6.500%
Shares redeemed	(11,500,000)	6.500%	-	0.000%
Ending balance	14,375,000	6.500%	25,875,000	6.500%

     During the three months ended March 31, 2017, we recognized a charge of $9,769,000 in connection with the redemption of the Series J preferred stock.

Common Stock. The following is a summary of our common stock issuances during the three months ended March 31, 2017 and 2016 (dollars in thousands, except per share amounts):

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2016 Dividend reinvestment plan issuances	1,058,085	$	60.00	$	63,484	$	63,484
2016 Option exercises	9,864		21.29		210		210
2016 Equity shelf program issuances	443,096		67.12		30,192		29,739
2016 Stock incentive plans, net of forfeitures	484,005				-		-
2016 Totals	1,995,050			$	93,886	$	93,433
2017 Dividend reinvestment plan issuances	1,284,719	$	68.33	$	87,985	$	87,784
2017 Option exercises	156,675		52.71		8,258		8,258
2017 Equity shelf program issuances	338,486		69.75		23,776		23,609
2017 Stock incentive plans, net of forfeitures	181,600				-		-
2017 Totals	1,961,480			$	120,019	$	119,651

Dividends.  The increase in dividends is primarily attributable to increases in our common shares outstanding as described above and an increase in common dividends per share.  The following is a summary of our dividend payments (in thousands, except per share amounts):

18

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Three Months Ended
	March 31, 2017				March 31, 2016
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8700	$	315,415	$	0.8600	$	305,770
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.2347		2,699		0.4064		4,672
Totals			$	329,794			$	322,122

     Accumulated Other Comprehensive Income.  The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2016	$	(173,496)	$	5,120	$	(1,153)	$	(2)	$	(169,531)
Other comprehensive income before reclassification adjustments		2,900		(10,569)		-		-		(7,669)
Net current-period other comprehensive income		2,900		(10,569)		-		-		(7,669)
Balance at March 31, 2017	$	(170,596)	$	(5,449)	$	(1,153)	$	(2)	$	(177,200)
Balance at December 31, 2015	$	(85,484)	$	-	$	(1,343)	$	(1,416)	$	(88,243)
Other comprehensive income before reclassification adjustments		(13,746)		(7,549)		2		-		(21,293)
Reclassification amount to net income		-		-		-		483 (1)		483
Net current-period other comprehensive income		(13,746)		(7,549)		2		483		(20,810)
Balance at March 31, 2016	$	(99,230)	$	(7,549)	$	(1,341)	$	(933)	$	(109,053)
(1) Please see Note 11 for additional information.

14. Stock Incentive Plans

     Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant.  Stock-based compensation expense totaled $4,906,000 for the three months ended March 31, 2017 and $8,186,000 for the same period in 2016.

19

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

15. Earnings Per Share

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

		Three Months Ended
		March 31,
		2017		2016
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	312,639	$	148,969
Denominator for basic earnings per
	share - weighted average shares		362,534		355,076
Effect of dilutive securities:
	Employee stock options		70		101
	Non-vested restricted shares		397		253
	Redeemable shares		1,651		621
Dilutive potential common shares			2,118		975
Denominator for diluted earnings per
	share - adjusted weighted average shares		364,652		356,051
Basic earnings per share		$	0.86	$	0.42
Diluted earnings per share		$	0.86	$	0.42

The Series I Cumulative Convertible Perpetual Preferred Stock was not included in the calculations as the effect of conversions into common stock was anti-dilutive.

16. Disclosure about Fair Value of Financial Instruments

U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities.  The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for additional information.  The guidance describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

     The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. 

Cash and Cash Equivalents — The carrying amount approximates fair value.

20

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Available-for-sale Equity Investments — Available-for-sale equity investments are recorded at their fair value based on Level 1 publicly available trading prices.

Borrowings Under Primary Unsecured Credit Facility — The carrying amount of the primary unsecured credit facility approximates fair value because the borrowings are interest rate adjustable.

Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable.

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities.  The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable.

Foreign Currency Forward Contracts — Foreign currency forward contracts are recorded in other assets or other liabilities on the balance sheet at fair market value.  Fair market value is determined using Level 2 inputs by estimating the future value of the currency pair based on existing exchange rates, comprised of current spot and traded forward points, and calculating a present value of the net amount using a discount factor based on observable traded interest rates.

Redeemable OP Unitholder Interests — Our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs.  The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances.

     The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

		March 31, 2017				December 31, 2016
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	430,607	$	465,548	$	485,735	$	521,773
	Other real estate loans receivable		143,473		149,151		136,893		138,050
	Available-for-sale equity investments		17,330		17,330		27,899		27,899
	Cash and cash equivalents		380,360		380,360		419,378		419,378
	Foreign currency forward contracts		110,439		110,439		135,561		135,561
Financial liabilities:
	Borrowings under unsecured credit facilities	$	522,000	$	522,000	$	645,000	$	645,000
	Senior unsecured notes		8,188,928		8,965,318		8,161,619		8,879,176
	Secured debt		2,669,787		2,728,171		3,477,699		3,558,378
	Foreign currency forward contracts		9,840		9,840		4,342		4,342
Redeemable OP unitholder interests		$	116,917	$	116,917	$	110,502	$	110,502

Items Measured at Fair Value on a Recurring Basis

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis.  The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

21

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Fair Value Measurements as of March 31, 2017
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	17,330	$	17,330	$	-	$	-
Foreign currency forward contracts, net(2)		100,599		-		100,599		-
Redeemable OP unitholder interests		116,917		-		116,917		-
Totals	$	234,846	$	17,330	$	217,516	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis.  As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 6 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates.  We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value.  We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above.  We estimate the fair value of secured debt assumed in business combinations using current interest rates at which similar borrowings could be obtained on the transaction date.

17. Segment Reporting

We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: triple-net, seniors housing operating and outpatient medical.  During the three months ended December 31, 2016, we reclassified interest expense on our foreign-denominated senior notes from the seniors housing operating segment to non-segment.  Accordingly, the segment information provided in this Note has been reclassified to conform to the current presentation for all periods presented.

     Our triple-net properties include long-term/post-acute care facilities, assisted living facilities, independent living/continuing care retirement communities, care homes (United Kingdom), independent support living facilities (Canada), care homes with nursing (United Kingdom) and combinations thereof. Under the triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our seniors housing operating properties include the seniors housing communities referenced above that are owned and/or operated through RIDEA structures (see Notes 3 and 18). Our outpatient medical properties are typically leased to multiple tenants and generally require a certain level of property management.

     We evaluate performance based upon net operating income from continuing operations (“NOICO”) of each segment. We define NOICO as total revenues, including tenant reimbursements, less property operating expenses. We believe NOICO provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOICO to make decisions about resource allocations and to assess the property level performance of our properties.    

     Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOICO. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments.  There are no intersegment sales or transfers. Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands):

22

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Three Months Ended March 31, 2017:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	227,290	$	-	$	139,851	$	-	$	367,141
Resident fees and services		-		670,337		-		-		670,337
Interest income		20,679		69		-		-		20,748
Other income		1,766		1,461		612		233		4,072
Total revenues		249,735		671,867		140,463		233		1,062,298
Property operating expenses		-		462,425		47,744		-		510,169
Net operating income from continuing operations		249,735		209,442		92,719		233		552,129
Interest expense		5,511		15,816		2,291		94,979		118,597
Loss (gain) on derivatives, net		1,224		-		-		-		1,224
Depreciation and amortization		59,608		119,737		48,931		-		228,276
General and administrative		-		-		-		31,101		31,101
Loss (gain) on extinguishment of debt, net		29,084		890		1,382		-		31,356
Impairment of assets		-		5,406		5,625		-		11,031
Other expenses		5,010		1,778		360		4,527		11,675
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		149,298		65,815		34,130		(130,374)		118,869
Income tax (expense) benefit		(800)		(1,087)		(335)		(23)		(2,245)
Income (loss) from unconsolidated entities		5,638		(29,191)(1)		447		-		(23,106)
Income (loss) from continuing operations		154,136		35,537		34,242		(130,397)		93,518
Gain (loss) on real estate dispositions, net		231,081		13,011		-		-		244,092
Net income (loss)	$	385,217	$	48,548	$	34,242	$	(130,397)	$	337,610
Total assets	$	9,906,585	$	12,646,321	$	4,947,544	$	266,827	$	27,767,277
(1) Primarily due to the recognition of goodwill and intangible asset impairments, as well as non-recurring income tax expense.

Three Months Ended March 31, 2016:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	283,825	$	-	$	131,838	$	-	$	415,663
Resident fees and services		-		602,149		-		-		602,149
Interest income		22,853		1,031		1,304		-		25,188
Other income		1,490		2,189		313		58		4,050
Total revenues		308,168		605,369		133,455		58		1,047,050
Property operating expenses		-		408,894		40,742		-		449,636
Net operating income from continuing operations		308,168		196,475		92,713		58		597,414
Interest expense		6,364		20,523		5,744		100,329		132,960
Depreciation and amortization		79,800		101,832		47,064		-		228,696
General and administrative		-		-		-		45,691		45,691
Transaction costs		2,852		3,933		1,423		-		8,208
Loss (gain) on extinguishment of debt, net		(24)		-		-		-		(24)
Impairment of assets		14,314		-		-		-		14,314
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		204,862		70,187		38,482		(145,962)		167,569
Income tax (expense) benefit		(317)		2,767		(228)		(497)		1,725
Income (loss) from unconsolidated entities		3,081		(6,935)		34		-		(3,820)
Income (loss) from continuing operations		207,626		66,019		38,288		(146,459)		165,474
Net income (loss)	$	207,626	$	66,019	$	38,288	$	(146,459)	$	165,474

23

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

     Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada.  Revenues and assets are attributed to the country in which the property is physically located.  The following is a summary of geographic information for the periods presented (dollars in thousands):

		Three Months Ended
		March 31, 2017			March 31, 2016
Revenues:		Amount	%		Amount	%
United States	$	858,668	80.9%	$	842,357	80.5%
United Kingdom		93,843	8.8%		100,555	9.6%
Canada		109,787	10.3%		104,138	9.9%
Total	$	1,062,298	100.0%	$	1,047,050	100.0%
		As of
		March 31, 2017			December 31, 2016
Assets:		Amount	%		Amount	%
United States	$	22,425,964	80.8%	$	23,572,459	81.7%
United Kingdom		2,835,782	10.2%		2,782,489	9.6%
Canada		2,505,531	9.0%		2,510,236	8.7%
Total	$	27,767,277	100.0%	$	28,865,184	100.0%

18. Income Taxes and Distributions

We elected to be taxed as a REIT commencing with our first taxable year.  To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes.

Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.”  A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years.

     Income taxes reflected in the financial statements primarily represents U.S. federal and state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S.  The provision for income taxes for the three months ended March 31, 2017 and 2016, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities.  In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure.  The structure includes a property holding company that is tax resident in the United Kingdom.  No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and all of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes.  The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service (“IRS”) for the year ended December 31, 2013 and subsequent years and by state taxing authorities for the year ended December 31, 2012 and subsequent

24

WELLTOWER INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

years.  The company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada in May 2012, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom in August 2012 and by Luxembourg taxing authorities generally for periods subsequent to our establishment of certain Luxembourg-based subsidiaries during 2014.

19. Variable Interest Entities

     We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be variable interest entities (“VIE”).   We have concluded that we are the primary beneficiary of these VIE’s based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIE’s in the aggregate (in thousands):

		March 31, 2017		December 31, 2016
Assets
	Net real property owned	$	980,570	$	989,596
	Cash and cash equivalents		7,390		10,501
	Receivables and other assets		16,530		12,102
	Total assets(1)	$	1,004,490	$	1,012,199
Liabilities and equity
	Secured debt	$	449,163	$	450,255
	Accrued expenses and other liabilities		13,880		13,803
	Redeemable noncontrolling interests		72,957		185,556
	Total equity		468,490		362,585
	Total liabilities and equity	$	1,004,490	$	1,012,199
(1) Note that assets of the consolidated variable interest entities can only be used to settle obligations relating to such variable interest entities.  Liabilities of the consolidated variable interest entities represent claims against the specific assets of the variable interest entities.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

EXECUTIVE SUMMARY
Company Overview      Business Strategy      Key Transactions in 2017      Key Performance Indicators, Trends and Uncertainties      Corporate Governance	27 27 28 29 31
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Cash      Off-Balance Sheet Arrangements      Contractual Obligations      Capital Structure	31 32 33 33
RESULTS OF OPERATIONS
Summary      Triple-net      Seniors Housing Operating      Outpatient Medical      Non-Segment/Corporate	34 34 36 38 41
OTHER
Cautionary Statement Regarding Forward-Looking Statements	47

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following discussion and analysis is based primarily on the unaudited consolidated financial statements of Welltower Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2016, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”  References herein to “we,” “us,” “our,” or the “company” refer to Welltower Inc. and its subsidiaries unless specifically noted otherwise.

Executive Summary

Company Overview

Welltower Inc. (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.  Welltower™, a real estate investment trust (“REIT”), owns properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. Our capital programs, when combined with comprehensive planning, development and property management services, make us a single-source solution for acquiring, planning, developing, managing, repositioning and monetizing real estate assets. 

     The following table summarizes our consolidated portfolio for the three months ended March 31, 2017 (dollars in thousands):

			Percentage of	Number of
Type of Property	NOICO(1)		NOICO	Properties
Triple-net	$	249,735	45.3%	592
Seniors housing operating		209,442	37.9%	421
Outpatient medical		92,719	16.8%	264
Totals	$	551,896	100.0%	1,277
(1) Represents net operating income from continuing operations per Note 17 of our unaudited consolidated financial statements. Excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.

Business Strategy

     Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in net operating income from continuing operations and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.

     Substantially all of our revenues are derived from operating lease rentals, resident fees and services, and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our customers/partners experience operating difficulties and become unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our proactive and comprehensive asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections, and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division actively manages and monitors the outpatient medical portfolio with a comprehensive process including tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs, and market conditions among other things. In monitoring our portfolio, our personnel use a proprietary database to collect and analyze property-specific data. Additionally, we conduct extensive research to ascertain industry trends.  We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility.  When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we are generally able to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.

     In addition to our asset management and research efforts, we also structure our investments to help mitigate payment risk. Operating leases and loans are normally credit enhanced by guaranties and/or letters of credit. In addition, operating leases are

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.

     For the three months ended March 31, 2017, rental income and resident fees and services represented 35% and 63%, respectively, of total revenues.  Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.

     Our primary sources of cash include rent and interest receipts, resident fees and services, borrowings under our primary unsecured credit facility, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses.  Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.

     We also continuously evaluate opportunities to finance future investments.  New investments are generally funded from temporary borrowings under our primary unsecured credit facility, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from net operating income from continuing operations and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our primary unsecured credit facility, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.

     Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also possible that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our primary unsecured credit facility. At March 31, 2017, we had $380,360,000 of cash and cash equivalents, $42,777,000 of restricted cash and $2,445,544,000 of available borrowing capacity under our primary unsecured credit facility.

Key Transactions in 2017

Capital.   During the three months ended March 31, 2017, we extinguished $806,189,000 of secured debt at a blended average interest rate of 5.6%.  In addition, we redeemed all 11,500,000 shares of our 6.5% Series J Cumulative Redeemable Preferred Stock.  During the three months ended March 31, 2017, we raised $111,761,000 through our dividend reinvestment program and our Equity Shelf Program (as defined below).

Investments.  The following summarizes our acquisitions and joint venture investments completed during the three months ended March 31, 2017 (dollars in thousands):

	Properties		Investment Amount(1)	Capitalization Rates(2)		Book Amount(3)
Triple-net	3	$	41,301	6.7%	$	41,258
Seniors housing operating	1		34,200	6.1%		50,194
Outpatient medical	2		28,995	6.5%		29,704
Totals	6	$	104,496	6.4%	$	121,156
(1) Represents stated pro rata purchase price including cash and any assumed debt but excludes fair value adjustments pursuant to U.S. GAAP.
(2) Represents annualized contractual or projected income to be received in cash divided by investment amounts.
(3) Represents amounts recorded on our books including fair value adjustments pursuant to U.S. GAAP.  See Notes 3 and 7 to our unaudited consolidated financial statements for additional information.

Dispositions.  The following summarizes property dispositions made during the three months ended March 31, 2017 (dollars in thousands):

28

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Properties		Proceeds(1)	Capitalization Rates(2)		Book Amount(3)
Triple-net	43	$	1,027,951	6.5%	$	808,204
Seniors housing operating	1		27,519	4.8%		13,845
Totals	44	$	1,055,470	6.5%	$	822,049
(1) Represents pro rata proceeds received upon disposition including any seller financing.
(2) Represents annualized contractual income that was being received in cash at date of disposition divided by disposition proceeds.
(3) Represents carrying value of assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.

Dividends. Our Board of Directors increased the annual cash dividend to $3.48 per common share ($0.87 per share quarterly), as compared to $3.44 per common share for 2016, beginning in February 2017.  The dividend declared for the quarter ended March 31, 2017 represents the 184^th consecutive quarterly dividend payment.

Key Performance Indicators, Trends and Uncertainties

     We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.

Operating Performance. We believe that net income attributable to common stockholders (“NICS”) per the Statement of Comprehensive Income and net operating income from continuing operations (“NOICO”) per Note 17 to the Consolidated Financial Statements are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”) and same store NOI (“SSNOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations of FFO and SSNOI. These earnings measures (and FFO per share amounts) are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands, except per share amounts):

			Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
		2016		2016		2016		2016			2017
Net income (loss) attributable to common stockholders		$	148,969	$	195,474	$	334,910	$	333,042	$	312,639
Funds from operations attributable to common stockholders			391,264		416,974		401,870		372,829		306,231
Net operating income from continuing operations			597,414		617,825		605,453		583,486		552,128
Same store net operating income			469,784		485,091		472,347		469,928		468,590
Per share data (fully diluted):
	Net income (loss) attributable to common stockholders	$	0.42	$	0.54	$	0.93	$	0.91	$	0.86
	Funds from operations attributable to common stockholders		1.10		1.16		1.11		1.02		0.84

     Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and IRC section 1031 deposits. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented:

29

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

		Three Months Ended
		March, 31	June 30,	September 30,	December 31,	March 31,
		2016	2016	2016	2016	2017
Net debt to book capitalization ratio		45%	45%	45%	43%	42%
Net debt to undepreciated book
	capitalization ratio	40%	39%	39%	37%	36%
Net debt to market capitalization ratio		32%	30%	31%	31%	29%
Interest coverage ratio		3.85x	4.21x	5.24x	5.26x	5.67x
Fixed charge coverage ratio		3.06x	3.34x	4.17x	4.15x	4.53x

Concentration Risk. We evaluate our concentration risk in terms of NOICO by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOICO could be at risk if certain sectors were to experience downturns.  Property mix measures the portion of our NOICO that relates to our various property types. Relationship mix measures the portion of our NOICO that relates to our top five relationships. Geographic mix measures the portion of our NOICO that relates to our top five states (or international equivalents). The following table reflects our recent historical trends of concentration risk by NOICO for the periods indicated below:

		Three Months Ended
		March 31,	June 30,	September 30,	December 31,	March 31,
		2016	2016	2016	2016	2017
Property mix:(1)
	Triple-net	52%	50%	51%	48%	45%
	Seniors housing operating	32%	34%	33%	36%	38%
	Outpatient medical	16%	16%	16%	16%	17%
Relationship mix:(1)
	Sunrise Senior Living(2)	13%	14%	12%	13%	14%
	Genesis Healthcare	17%	16%	16%	13%	9%
	Brookdale Senior Living	7%	7%	7%	7%	7%
	Revera(2)	6%	6%	6%	7%	7%
	Benchmark Senior Living	4%	4%	4%	4%	4%
	Remaining relationships	53%	53%	55%	56%	59%
Geographic mix:(1)
	California	10%	10%	10%	12%	13%
	United Kingdom	8%	8%	7%	7%	9%
	Canada	7%	7%	7%	8%	8%
	New Jersey	8%	8%	8%	8%	7%
	Texas	6%	6%	7%	7%	7%
	Remaining geographic areas	61%	61%	61%	58%	56%
(1) Excludes our share of investments in unconsolidated entities.  Entities in which the company has a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) Revera owns a controlling interest in Sunrise Senior Living.

     Lease Expirations. The following table sets forth information regarding lease expirations for certain portions of our portfolio as of March 31, 2017 (dollars in thousands):

30

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

			Expiration Year
			2017		2018		2019		2020		2021		2022		2023		2024		2025		2026		Thereafter
Triple-net:
	Properties		-		51		-		14		12		8		4		5		61		32		406
	Base rent(1)	$	-	$	37,120	$	-	$	17,740	$	25,239	$	8,784	$	4,175	$	11,076	$	73,478	$	64,327	$	701,046
	% of base rent		0.0%		3.9%		0.0%		1.9%		2.7%		0.9%		0.4%		1.2%		7.8%		6.8%		74.3%
	Units/beds		-		3,151		-		1,225		2,289		810		317		762		4,538		3,724		41,529
	% of Units/beds		0.0%		5.4%		0.0%		2.1%		3.9%		1.4%		0.5%		1.3%		7.8%		6.4%		71.2%
Outpatient medical:
	Square feet		899,397		999,677		1,189,481		1,205,331		1,465,953		2,381,966		1,197,716		1,392,959		690,769		1,063,903		3,979,627
	Base rent(1)	$	22,866	$	25,911	$	31,568	$	31,876	$	39,422	$	51,176	$	30,197	$	38,992	$	19,586	$	27,377	$	90,952
	% of base rent		5.6%		6.3%		7.7%		7.8%		9.6%		12.5%		7.4%		9.5%		4.8%		6.7%		22.1%
	Leases		242		275		305		276		264		252		177		109		96		118		151
	% of Leases		10.7%		12.1%		13.5%		12.2%		11.7%		11.1%		7.8%		4.8%		4.2%		5.2%		6.7%
(1) The most recent monthly base rent including straight line for leases with fixed escalators or annual cash rents for leases with contingent escalators.  Base rent does not include tenant recoveries or amortization of above and below market lease intangibles.

     We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2016, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.

Corporate Governance

     Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance.  The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.

Liquidity and Capital Resources

Sources and Uses of Cash

     Our primary sources of cash include rent and interest receipts, resident fees and services, borrowings under our primary unsecured credit facility, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below.  The following is a summary of our sources and uses of cash flows (dollars in thousands):

31

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Three Months Ended				Change
	March 31, 2017		March 31, 2016		$		%
Cash and cash equivalents at beginning of period	$	419,378	$	360,908	$	58,470	16%
Cash provided from (used in) operating activities		385,526		380,609		4,917	1%
Cash provided from (used in) investing activities		1,065,239		(241,964)		1,307,203	n/a
Cash provided from (used in) financing activities		(1,492,626)		(143,927)		(1,348,699)	937%
Effect of foreign currency translation		2,843		323		2,520	780%
Cash and cash equivalents at end of period	$	380,360	$	355,949	$	24,411	7%

Operating Activities. The change in net cash provided from operating activities was immaterial.  Please see “Results of Operations” for discussion of net income fluctuations. For the three months ended March 31, 2017 and 2016, cash flow provided from operations exceeded cash distributions to stockholders.

Investing Activities.  The changes in net cash used in investing activities are primarily attributable to an increase in dispositions, which are summarized above in “Key Transactions in 2017” and Notes 5 and 6 of our unaudited consolidated financial statements. The following is a summary of cash used in non-acquisition capital improvement activities (dollars in thousands):

	Three Months Ended				Change
	March 31,		March 31,
	2017		2016		$		%
New development	$	69,334	$	66,739	$	2,595	4%
Recurring capital expenditures, tenant improvements and lease commissions		13,834		12,265		1,569	13%
Renovations, redevelopments and other capital improvements		28,281		22,760		5,521	24%
Total	$	111,449	$	101,764	$	9,685	10%

    The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods.  Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization.  Generally, these expenditures have increased as a result of acquisitions, primarily in our seniors housing operating segment.

      Financing Activities.  The changes in net cash provided from financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuance/redemption of common and preferred stock and dividend payments. Please refer to Notes 9, 10 and 13 of our unaudited consolidated financial statements for additional information.

Off-Balance Sheet Arrangements

     At March 31, 2017, we had investments in unconsolidated entities with our ownership ranging from 10% to 50%. Please see Note 7 to our unaudited consolidated financial statements for additional information.  We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. Please see Note 11 to our unaudited consolidated financial statements for additional information.  At March 31, 2017, we had 14 outstanding letter of credit obligations. Please see Note 12 to our unaudited consolidated financial statements for additional information.

32

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Contractual Obligations

     The following table summarizes our payment requirements under contractual obligations as of March 31, 2017 (in thousands):

	Payments Due by Period
Contractual Obligations	Total		2017		2018-2019		2020-2021		Thereafter
Unsecured revolving credit facility(1)	$	522,000	$	-	$	-	$	522,000	$	-
Senior unsecured notes and term credit facilities:(2)
U.S. Dollar senior unsecured notes		6,050,000		-		1,050,000		900,000		4,100,000
Canadian Dollar senior unsecured notes(3)		225,208		-		-		225,208		-
Pounds Sterling senior unsecured notes(3)		1,316,385		-		-		-		1,316,385
U.S. Dollar term credit facility		505,000		-		5,000		500,000		-
Canadian Dollar term credit facility(3)		187,674		-		-		187,674		-
Secured debt:(2,3)
Consolidated		2,665,477		284,879		921,646		378,881		1,080,071
Unconsolidated		683,574		21,195		156,839		45,426		460,114
Contractual interest obligations:(4)
Unsecured revolving credit facility		49,683		7,845		20,919		20,919		-
Senior unsecured notes and term loans(3)		3,330,186		281,365		689,321		580,751		1,778,749
Consolidated secured debt(3)		526,087		73,890		159,552		110,453		182,192
Unconsolidated secured debt(3)		161,651		19,443		50,734		34,700		56,774
Capital lease obligations(5)		93,697		4,592		9,012		8,346		71,747
Operating lease obligations(5)		1,092,169		12,818		34,485		33,629		1,011,237
Purchase obligations(5)		483,089		360,773		122,316		-		-
Other long-term liabilities(6)		3,810		1,106		2,704		-		-
Total contractual obligations	$	17,895,690	$	1,067,906	$	3,222,528	$	3,547,987	$	10,057,269
(1) Relates to unsecured revolving credit facility with an aggregate commitment of $3,000,000,000. See Note 9 to our unaudited consolidated financial statements for additional information.
(2) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(3) Based on foreign currency exchange rates in effect as of balance sheet date.
(4) Based on variable interest rates in effect as of balance sheet date.
(5) See Note 12 to our unaudited consolidated financial statements for additional information.
(6) Primarily relates to payments to be made under our Supplemental Executive Retirement Plan.

Capital Structure

     Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends.  Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2017, we were in compliance with all of the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged.  We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.

     On May 1, 2015, we filed with the Securities and Exchange Commission (1) an open-ended automatic or “universal” shelf registration statement covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units and (2) a registration statement in connection with our enhanced dividend reinvestment plan (“DRIP”) under which we may issue up to 15,000,000 shares of common stock. As of April 28, 2017, 5,893,662 shares of common stock remained available for issuance under the DRIP registration statement. We have entered into separate Equity Distribution Agreements with each of Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Goldman, Sachs & Co., UBS Securities LLC and Wells Fargo Securities, LLC relating to the offer and sale from time to time of up to $1,000,000,000 aggregate amount of our common stock (“Equity Shelf Program”). As of April 28, 2017, we had $903,411,000 of remaining capacity

33

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

under the Equity Shelf Program. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our primary unsecured credit facility.

Results of Operations

Summary

Our primary sources of revenue include rent and resident fees and services. Our primary expenses include interest expense, depreciation and amortization, property operating expenses, and general and administrative expenses. We evaluate our business and make resource allocations on our three business segments: triple-net, seniors housing operating and outpatient medical. The primary performance measures for our properties are NOICO and SSNOI, which are discussed below.  Please see Note 17 to our unaudited consolidated financial statements for additional information. The following is a summary of our results of operations (dollars in thousands, except per share amounts):

	Three Months Ended				Change
	March 31,		March 31,
	2017		2016		Amount		%
Net income (loss) attributable to common stockholders	$	312,639	$	148,969	$	163,670	110%
Funds from operations attributable to common stockholders		306,231		391,264		(85,033)	-22%
EBITDA		686,728		525,405		161,323	31%
Net operating income from continuing operations (NOICO)		552,129		597,414		(45,285)	-8%
Same store NOI		468,590		469,784		(1,194)	0%
Per share data (fully diluted):
Net income (loss) attributable to common stockholders	$	0.86	$	0.42	$	0.44	105%
Funds from operations attributable to common stockholders	$	0.84	$	1.10	$	(0.26)	-24%
Interest coverage ratio		5.67x		3.85x		1.82x	47%
Fixed charge coverage ratio		4.53x		3.06x		1.47x	48%

Triple-net

          The following is a summary of our NOICO and SSNOI for the triple-net segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2017		2016		$		%
NOICO		$	249,735	$	308,168	$	(58,433)	-19%
Non SSNOI attributable to same store properties			(13,253)		(16,181)		2,928	-18%
NOICO attributable to non same store properties(1)			(46,995)		(105,327)		58,332	-55%
SSNOI(2)		$	189,487	$	186,660	$	2,827	2%
(1) Change is primarily due to the acquisition of 14 properties and the conversion of 23 construction projects into revenue-generating properties subsequent to January 1, 2016 and 211 properties disposed or held for sale.
(2) Relates to 538 same store properties.

34

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following is a summary of our results of operations for the triple-net segment (dollars in thousands):

			Three Months Ended				Change
			March 31,		March 31,
			2017		2016		$		%
Revenues:
	Rental income		$	227,290	$	283,825	$	(56,535)	-20%
	Interest income			20,679		22,853		(2,174)	-10%
	Other income			1,766		1,490		276	19%
		Total revenues		249,735		308,168		(58,433)	-19%
		Net operating income from continuing operations (NOICO)(1)		249,735		308,168		(58,433)	-19%
Other expenses:
	Interest expense			5,511		6,364		(853)	-13%
	Loss (gain) on derivatives, net			1,224		-		1,224	n/a
	Depreciation and amortization			59,608		79,800		(20,192)	-25%
	Transaction costs(2)			-		2,852		(2,852)	-100%
	Loss (gain) on extinguishment of debt, net			29,084		(24)		29,108	n/a
	Impairment of assets			-		14,314		(14,314)	-100%
	Other expenses(2)			5,010		-		5,010	n/a
		Total other expenses		100,437		103,306		(2,869)	-3%
Income from continuing operations before income taxes and income (loss) from unconsolidated entities				149,298		204,862		(55,564)	-27%
Income tax benefit (expense)				(800)		(317)		(483)	152%
Income (loss) from unconsolidated entities				5,638		3,081		2,557	83%
Income from continuing operations				154,136		207,626		(53,490)	-26%
Gain (loss) on real estate dispositions, net(3)				231,081		-		231,081	n/a
Net income				385,217		207,626		177,591	86%
Less: Net income (loss) attributable to noncontrolling interests				603		(342)		945	n/a
Net income attributable to common stockholders			$	384,614	$	207,968	$	176,646	85%
(1) See Note 17 to our unaudited consolidated financial statements.
(2) See Note 2 to our unaudited consolidated financial statements.
(3) See Note 5 to our unaudited consolidated financial statements.

     The decrease in rental income is attributable to the disposition of properties exceeding new acquisitions.  Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties.  These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period.  If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase  For the three months ended March 31, 2017, we had one lease renewal and 25 leases with rental rate increasers ranging from 0.13% to 0.41% in our triple-net portfolio. The decrease in interest income is directly related to the volume of loan payoffs during 2016 and 2017.

     Depreciation and amortization decreased as a result of the disposition of triple-net properties. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.

During the three months ended March 31, 2016, we recorded impairment charges on certain held-for-sale triple-net properties as the fair values less estimated costs to sell exceeded our carrying values.  Changes in the gain on sales of properties are related to the volume of property sales and the sales prices.

    During the three months ended March 31, 2017, we completed five triple-net construction projects totaling $157,460,000 or $257,290 per bed/unit.  The following is a summary of triple-net construction projects pending as of March 31, 2017 (dollars in thousands):

35

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Location	Units/Beds		Commitment		Balance	Est. Completion
Raleigh, NC	60	$	23,925	$	16,415	2Q17
Livingston, NJ	120		53,440		46,048	2Q17
Piscataway, NJ	124		40,800		38,190	2Q17
Bracknell, UK	64		15,825		12,213	2Q17
Alexandria, VA	116		60,156		23,549	2Q18
Exton, PA	120		34,175		5,939	2Q18
	604	$	228,321	$	142,354

     Interest expense for the three months ended March 31, 2017 and 2016 represents secured debt interest expense and related fees.  The change in interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The fluctuation in losses/gains on debt extinguishment is attributable to the large volume of extinguishments in the first quarter of 2017.  The following is a summary of our triple-net secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2017			March 31, 2016
			Wtd. Avg.			Wtd. Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	594,199	4.580%	$	554,014	5.488%
Debt extinguished		(255,553)	5.923%		(33,919)	5.895%
Foreign currency		3,155	2.751%		5,291	5.315%
Principal payments		(2,531)	5.790%		(2,987)	5.587%
Ending balance	$	339,270	3.549%	$	522,399	5.467%
Monthly averages	$	531,647	4.441%	$	540,554	5.482%

A portion of our triple-net properties were formed through partnerships.  Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner.  Net income attributable to noncontrolling interest represents our partners’ share of net income relating to those partnerships where we are the controlling partner.

Seniors Housing Operating

     The following is a summary of our NOICO and SSNOI for the seniors housing operating segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2017		2016		$		%
NOICO		$	209,442	$	196,475	$	12,967	7%
Non SSNOI attributable to same store properties			231		248		(17)	-7%
NOICO attributable to non same store properties(1)			(17,109)		99		(17,208)	-17382%
SSNOI(2)		$	192,564	$	196,822	$	(4,258)	-2%
(1) Change is primarily due to the acquisition of 41 properties subsequent to January 1, 2016.
(2) Relates to 376 same store properties.

     The following is a summary of our seniors housing operating results of operations (dollars in thousands):

36

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

			Three Months Ended				Change
			March 31,		March 31,
			2017		2016		$		%
Revenues:
	Resident fees and services		$	670,337	$	602,149	$	68,188	11%
	Interest income			69		1,031		(962)	-93%
	Other income			1,461		2,189		(728)	-33%
		Total revenues		671,867		605,369		66,498	11%
Property operating expenses				462,425		408,894		53,531	13%
	Net operating income from continuing operations (NOICO)(1)			209,442		196,475		12,967	7%
Other expenses:
	Interest expense			15,816		20,523		(4,707)	-23%
	Depreciation and amortization			119,737		101,832		17,905	18%
	Transaction costs(2)			-		3,933		(3,933)	-100%
	Loss (gain) on extinguishment of debt, net			890		-		890	n/a
	Impairment of assets			5,406		-		5,406	n/a
	Other expenses(2)			1,778		-		1,778	n/a
		Total other expenses		143,627		126,288		17,339	14%
Income (loss) from continuing operations before income taxes and income (loss) from unconsolidated entities				65,815		70,187		(4,372)	-6%
Income tax benefit (expense)				(1,087)		2,767		(3,854)	n/a
Income (loss) from unconsolidated entities				(29,191)		(6,935)		(22,256)	321%
Income from continuing operations				35,537		66,019		(30,482)	-46%
Gain (loss) on real estate dispositions, net(3)				13,011		-		13,011	n/a
Net income (loss)				48,548		66,019		(17,471)	-26%
Less: Net income (loss) attributable to noncontrolling interests				(590)		360		(950)	n/a
Net income (loss) attributable to common stockholders			$	49,138	$	65,659	$	(16,521)	-25%
(1) See Note 17 to our unaudited consolidated financial statements.
(2) See Note 2 to our unaudited consolidated financial statements.
(3) See Note 5 to our unaudited consolidated financial statements.

     Fluctuations in revenues and property operating expenses are primarily a result of acquisitions and the movement of U.S. and foreign currency exchange rates. The fluctuations in depreciation and amortization are due to acquisitions and variations in amortization of short-lived intangible assets. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 

     During the three month period ended March 31, 2017, we recorded an impairment charge related to one held-for-sale property for which the fair value less costs to sell exceeded our carrying value.  During the three month period ended March 31, 2017, we recorded a gain on sale related to the sale of one property previously classified as held-for-sale.

     During the three month period ended March 31, 2017, we completed one seniors housing construction project representing $3,634,000 or $302,833 per unit.  The following is a summary of our seniors housing operating construction projects, excluding expansions, pending as of March 31, 2017 (dollars in thousands):

37

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Location	Units		Commitment		Balance	Est. Completion
Chertsey, UK	94	$	39,115	$	22,504	1Q18
Bushey, UK	95		51,088		19,851	2Q18
	189	$	90,203		42,355
New York, NY	Project in planning stage				129,327
Total				$	171,682

Interest expense represents secured debt interest expense.  The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations.  The following is a summary of our seniors housing operating property secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2017			March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	2,463,249	3.936%	$	2,290,552	3.958%
Debt issued		12,536	2.340%		75,136	3.063%
Debt extinguished		(438,532)	5.301%		(58,533)	3.037%
Foreign currency		7,158	3.488%		60,197	3.524%
Principal payments		(11,259)	3.733%		(12,170)	3.959%
Ending balance	$	2,033,152	3.663%	$	2,355,182	3.980%
Monthly averages	$	2,162,185	3.729%	$	2,306,203	3.976%

The majority of our seniors housing operating properties are formed through partnership interests.  Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures. The fluctuations in income (loss) from unconsolidated entities is primarily due to the recognition of goodwill and intangible asset impairments as well as non-recurring income tax expense adjustments related to our investments in unconsolidated entities during the three month period ended March 31, 2017.

Outpatient Medical

     The following is a summary of our NOICO and SSNOI for the outpatient medical segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2017		2016		$		%
NOICO		$	92,719	$	92,713	$	6	0%
Non SSNOI on same store properties			(2,214)		(2,373)		159	-7%
NOICO attributable to non same store properties(1)			(3,966)		(4,038)		72	-2%
SSNOI(2)		$	86,539	$	86,302	$	237	0%
(1) Change is primarily due to acquisitions of five properties and conversions of construction projects into seven revenue-generating properties subsequent to January 1, 2016.
(2) Relates to 235 same store properties.

38

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following is a summary of our results of operations for the outpatient medical segment (dollars in thousands):

			Three Months Ended				Change
			March 31,		March 31,
			2017		2016		$		%
Revenues:
	Rental income		$	139,851	$	131,838	$	8,013	6%
	Interest income			-		1,304		(1,304)	-100%
	Other income			612		313		299	96%
		Total revenues		140,463		133,455		7,008	5%
Property operating expenses				47,744		40,742		7,002	17%
	Net operating income from continuing operations (NOICO)(1)			92,719		92,713		6	0%
Other expenses:
	Interest expense			2,291		5,744		(3,453)	-60%
	Depreciation and amortization			48,931		47,064		1,867	4%
	Transaction costs(2)			-		1,423		(1,423)	-100%
	Impairment of assets			5,625		-		5,625	n/a
	Loss (gain) on extinguishment of debt, net			1,382		-		1,382	n/a
	Other expenses(2)			360		-		360	n/a
		Total other expenses		58,589		54,231		4,358	8%
Income from continuing operations before income taxes and income from unconsolidated entities				34,130		38,482		(4,352)	-11%
Income tax (expense) benefit				(335)		(228)		(107)	47%
Income from unconsolidated entities				447		34		413	1215%
Net income (loss)				34,242		38,288		(4,046)	-11%
Less: Net income (loss) attributable to noncontrolling interests				810		135		675	500%
Net income (loss) attributable to common stockholders			$	33,432	$	38,153	$	(4,721)	-12%
(1) See Note 17 to our unaudited consolidated financial statements.
(2) See Note 2 to our unaudited consolidated financial statements.

     The increase in rental income is primarily attributable to the acquisitions of new properties and the conversion of newly constructed outpatient medical properties from which we receive rent. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income.  For the three months ended March 31, 2017, our consolidated outpatient medical portfolio signed 93,623 square feet of new leases and 163,472 square feet of renewals.  The weighted-average term of these leases was six years, with a rate of $36.86 per square foot and tenant improvement and lease commission costs of $21.36 per square foot. Substantially all of these leases during the referenced quarter contain an annual fixed or contingent escalation rent structure ranging from 0% to 5%. 

     The fluctuation in property operating expenses is primarily attributable to acquisitions and construction conversions of new outpatient medical facilities for which we incur certain property operating expenses.The fluctuations in depreciation and amortization are due to acquisitions and variations in amortization of short-lived intangible assets. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 

     During the three months ended March 31, 2017, we recorded impairment charges related to certain held-for-sale properties for which the fair values less estimated costs to sell exceeded our carrying values. 

39

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    During the three months ended March 31, 2017, we completed two outpatient medical construction projects representing $25,910,000 or $259 per square foot. The following is a summary of the outpatient medical construction projects, excluding expansions, pending as of March 31, 2017 (dollars in thousands):

Location	Square Feet		Commitment		Balance	Est. Completion
Timmonium, MD	46,000		20,996		13,118	3Q17
Howell, MI	56,211		15,509		10,827	3Q17
Brooklyn, NY	140,955		103,624		43,236	2Q18
Total	243,166	$	140,129	$	67,181

     Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The fluctuation in losses/gains on debt extinguishment is attributable to the large volume of extinguishments in the first quarter of 2017.  The following is a summary of our outpatient medical secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2017			March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	404,079	4.846%	$	627,689	5.177%
Debt extinguished		(112,104)	5.889%		(19,187)	6.196%
Principal payments		(2,151)	6.491%		(3,142)	5.671%
Ending balance	$	289,824	4.509%	$	605,360	5.218%
Monthly averages	$	332,085	4.664%	$	619,350	5.237%

         A portion of our outpatient medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses related to certain unconsolidated property investments. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner.

40

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Non-Segment/Corporate

     The following is a summary of our results of operations for the non-segment/corporate activities (dollars in thousands):

		Three Months Ended				Change
		March 31,		March 31,
		2017		2016		$		%
Revenues:
	Other income	$	233	$	58	$	175	302%
Expenses:
	Interest expense		94,979		100,329		(5,350)	-5%
	General and administrative		31,101		45,691		(14,590)	-32%
	Other expenses		4,527		-		4,527	n/a
	Total expenses		130,607		146,020		(15,413)	-11%
Loss from continuing operations before income taxes			(130,374)		(145,962)		15,588	-11%
Income tax (expense) benefit			(23)		(497)		474	-95%
Loss from continuing operations			(130,397)		(146,459)		16,062	-11%
Less: Preferred stock dividends			14,379		16,352		(1,973)	-12%
Less: Preferred stock redemption charge			9,769		-		9,769	n/a
Net loss attributable to common stockholders		$	(154,545)	$	(162,811)	$	8,266	-5%

     The following is a summary of our non-segment/corporate interest expense (dollars in thousands):

	Three Months Ended				Change
	March 31,		March 31,
	2017		2016		$		%
Senior unsecured notes	$	86,591	$	93,534	$	(6,943)	-7%
Secured debt		60		97		(37)	-38%
Primary unsecured credit facility		5,037		3,709		1,328	36%
Loan expense		3,291		2,989		302	10%
Totals	$	94,979	$	100,329	$	(5,350)	-5%

The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments.  The decrease in interest expense is attributed primarily to the $450,000,000 of 4.70% senior unsecured notes extinguished in December 2016.  Please refer to Note 10 to our unaudited consolidated financial statements for additional information.  Loan expense represents the amortization of deferred loan costs incurred in connection with the issuance and amendments of debt. Loan expense changes are due to amortization of charges for costs incurred in connection with senior unsecured note issuances.  The change in interest expense on the primary unsecured credit facility is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes.  Please refer to Note 9 of our unaudited consolidated financial statements for additional information regarding our primary unsecured credit facility.

     General and administrative expenses as a percentage of consolidated revenues for the three months ended March 31, 2017 and 2016 were 2.93% and 4.36%, respectively.  The decrease in general and administrative expenses for the three months ended March 31, 2017 is primarily related to a reduction in professional service fees for tax and legal consulting and compensation costs as a result of execution of our strategic initiatives. Other expenses for the three months ended March 31, 2017 included costs associated with the departure of certain executive officers and key employees.

41

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Other

Non-GAAP Financial Measures

     We believe that net operating income from continuing operations (“NOICO”), net income and net income attributable to common stockholders (“NICS”), as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.

     As discussed in Note 17 to our unaudited consolidated financial statements, NOICO is used to evaluate the operating performance of our properties. We define NOICO as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our seniors housing operating and medical facility properties.  These expenses include, but are not limited to, property-related payroll and benefits, property management fees, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance.  General and administrative expenses represent costs unrelated to property operations or transaction costs.  These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets.  Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties under a consistent population which eliminates changes in the composition of our portfolio.  As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the reporting period subsequent to January 1, 2016.  Land parcels, loans and sub-leases as well as any properties acquired, developed/redeveloped, transitioned, sold or classified as held for sale during that period are excluded from the same store amounts.  We believe NOICO and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOICO and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.

     EBITDA stands for earnings (net income) before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. We primarily utilize EBITDA to measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends. Covenants in our senior unsecured notes contain a financial ratios based on a definition of EBITDA that is specific to those agreements. Failure to satisfy these covenants could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of these debt agreements and the financial covenants, we have disclosed Adjusted EBITDA, which represents EBITDA as defined above excluding unconsolidated entities and adjusted for items per our covenant. We use Adjusted EBITDA to measure our adjusted fixed charge coverage ratio, which represents Adjusted EBITDA divided by fixed charges on a trailing twelve months basis. Fixed charges include total interest (excluding capitalized interest and non-cash interest expenses), secured debt principal amortization and preferred dividends. Our covenant requires an adjusted fixed charge coverage ratio of at least 1.50 times.

     Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.

42

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following table reflects the reconciliation of SSNOI to NOICO, the most directly comparable U.S. GAAP measure, for the periods presented.  Dollars are in thousands.

					Three Months Ended
					March 31,		June 30,		September 30,		December 31,		March 31,
SSNOI Reconciliations:					2016		2016		2016		2016		2017
NOICO:
	Triple-net				$	308,168	$	310,311	$	310,864	$	279,516	$	249,735
	Seniors housing operating					196,475		207,255		199,495		210,895		209,442
	Outpatient medical					92,713		99,805		94,905		92,841		92,719
			Total			597,356		617,371		605,264		583,252		551,896
Adjustments:
	Triple-net:
		Non SSNOI on same store properties				(16,181)		(14,399)		(14,251)		(14,138)		(13,253)
		NOICO attributable to non same store properties				(105,327)		(106,242)		(107,491)		(76,528)		(46,995)
			Subtotal			(121,508)		(120,641)		(121,742)		(90,666)		(60,248)
	Seniors housing operating:
		Non SSNOI on same store properties				248		242		1,269		231		231
		NOICO attributable to non same store properties				99		71		(4,532)		(17,908)		(17,109)
			Subtotal			347		313		(3,263)		(17,677)		(16,878)
	Outpatient medical:
		Non SSNOI on same store properties				(2,373)		(2,611)		(2,636)		(1,974)		(2,214)
		NOICO attributable to non same store properties				(4,038)		(9,341)		(5,276)		(3,007)		(3,966)
			Subtotal			(6,411)		(11,952)		(7,912)		(4,981)		(6,180)
SSNOI:				Properties
	Triple-net			538		186,660		189,670		189,122		188,850		189,487
	Seniors housing operating			376		196,822		207,568		196,232		193,218		192,564
	Outpatient medical			235		86,302		87,853		86,993		87,860		86,539
			Total	1,149	$	469,784	$	485,091	$	472,347	$	469,928	$	468,590
SSNOI Property Reconciliation:
	Total properties			1,277
	Acquisitions			(60)
	Developments			(34)
	Held-for-sale			(24)
	Segment transitions			(2)
	Other(1)			(8)
		Same store properties		1,149
(1) Includes eight land parcels.

43

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization.  Amounts are in thousands except for per share data.

		Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
FFO Reconciliations:		2016		2016		2016		2016		2017
NICS		$	148,969	$	195,474	$	334,910	$	333,042	$	312,639
Depreciation and amortization			228,696		226,569		218,061		227,916		228,276
Impairment of assets			14,314		-		9,705		13,187		11,031
Loss (gain) on sales of properties, net			-		(1,530)		(162,351)		(200,165)		(244,092)
Noncontrolling interests			(17,319)		(20,616)		(15,695)		(17,897)		(18,107)
Unconsolidated entities			16,604		17,077		17,240		16,746		16,484
FFO		$	391,264	$	416,974	$	401,870	$	372,829	$	306,231
Average common shares outstanding:
	Basic		355,076		356,646		358,932		362,088		362,534
	Diluted		356,051		358,891		361,237		364,369		364,652
Per share data:
NICS
	Basic	$	0.42	$	0.55	$	0.93	$	0.92	$	0.86
	Diluted		0.42		0.54		0.93		0.91		0.86
FFO
	Basic	$	1.10	$	1.17	$	1.12	$	1.03	$	0.84
	Diluted		1.10		1.16		1.11		1.02		0.84

     The table below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.

		Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
EBITDA Reconciliations:		2016		2016		2016		2016		2017
Net income		$	165,474	$	210,749	$	354,741	$	351,108	$	337,610
Interest expense			132,960		132,326		129,699		126,360		118,597
Income tax expense (benefit)			(1,725)		(513)		(305)		(16,585)		2,245
Depreciation and amortization			228,696		226,569		218,061		227,916		228,276
EBITDA		$	525,405	$	569,131	$	702,196	$	688,799	$	686,728
Interest Coverage Ratio:
Interest expense		$	132,960	$	132,326	$	129,699	$	126,360	$	118,597
Non-cash interest expense			599		(1,519)		(543)		(216)		(1,679)
Capitalized interest			3,037		4,306		4,766		4,834		4,129
	Total interest		136,596		135,113		133,922		130,978		121,047
EBITDA		$	525,405	$	569,131	$	702,196	$	688,799	$	686,728
	Interest coverage ratio		3.85x		4.21x		5.24x		5.26x		5.67x
Fixed Charge Coverage Ratio:
Total interest		$	136,596	$	135,113	$	133,922	$	130,978	$	121,047
Secured debt principal payments			18,642		19,096		18,151		18,577		16,249
Preferred dividends			16,352		16,352		16,352		16,352		14,379
	Total fixed charges		171,590		170,561		168,425		165,907		151,675
EBITDA		$	525,405	$	569,131	$	702,196	$	688,799	$	686,728
	Fixed charge coverage ratio		3.06x		3.34x		4.17x		4.15x		4.53x

44

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.

		Twelve Months Ended
Adjusted EBITDA		March 31,		June 30,		September 30,		December 31,		March 31,
Reconciliations:		2016		2016		2016		2016		2017
Net income		$	844,606	$	724,894	$	880,380	$	1,082,070	$	1,254,208
Interest expense			504,048		517,512		526,082		521,345		506,982
Income tax expense (benefit)			5,030		(2,899)		139		(19,128)		(15,158)
Depreciation and amortization			866,106		883,873		896,135		901,242		900,822
	EBITDA		2,219,790		2,123,380		2,302,736		2,485,529		2,646,854
Loss (income) from unconsolidated entities			12,676		11,682		10,801		10,357		29,643
Transaction costs			70,579		63,245		73,754		42,910		34,702
Stock-based compensation expense			29,976		25,883		25,807		28,869		25,588
Loss (gain) on extinguishment of debt, net			19,252		398		(186)		17,214		48,593
Losses/impairments (gain) on sale of properties, net			(209,228)		(20,647)		(171,246)		(326,839)		(574,216)
Provision for loan losses			-		-		-		10,215		10,215
Loss (gain) on derivatives, net			-		-		(2,516)		(2,448)		(1,225)
Other expenses			40,636		37,386		37,386		7,721		19,396
Additional other income			(2,144)		(13,955)		(11,811)		(16,664)		(16,664)
Adjusted EBITDA		$	2,181,537	$	2,227,372	$	2,264,725	$	2,256,864	$	2,222,886
Adjusted Fixed Charge Coverage Ratio:
Interest expense		$	504,048	$	517,512	$	526,082	$	521,345	$	506,982
Capitalized interest			9,320		11,566		14,467		16,943		18,035
Non-cash interest expense			(1,868)		(7,589)		(4,341)		(1,681)		(3,958)
	Total interest		511,500		521,489		536,208		536,607		521,059
Adjusted EBITDA		$	2,181,537	$	2,227,372	$	2,264,725	$	2,256,864	$	2,222,886
	Adjusted interest coverage ratio		4.26x		4.27x		4.22x		4.21x		4.27x
Total interest		$	511,500	$	521,489	$	536,208	$	536,607	$	521,059
Secured debt principal payments			70,076		71,836		74,170		74,466		72,073
Preferred dividends			65,408		65,408		65,407		65,406		63,434
	Total fixed charges		646,984		658,733		675,785		676,479		656,566
Adjusted EBITDA		$	2,181,537	$	2,227,372	$	2,264,725	$	2,256,864	$	2,222,886
	Adjusted fixed charge coverage ratio		3.37x		3.38x		3.35x		3.34x		3.39x

     Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and any IRC section 1031 deposits), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization. The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Dollars are in thousands.

45

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

			As of
		March 31,		June 30,		September 30,		December 31,		March 31,
			2016		2016		2016		2016		2017
Book capitalization:
Borrowings under primary unsecured credit facility		$	645,000	$	745,000	$	1,350,000	$	645,000	$	522,000
Long-term debt obligations(1)			12,418,198		12,228,727		12,080,888		11,713,245		10,932,185
Cash & cash equivalents(2)			(355,949)		(466,585)		(456,420)		(557,659)		(380,360)
Total net debt			12,707,249		12,507,142		12,974,468		11,800,586		11,073,825
Total equity			14,999,794		14,868,568		15,264,238		15,281,472		15,110,263
Redeemable noncontrolling interest			359,656		394,126		393,530		398,433		385,418
Book capitalization		$	28,066,699	$	27,769,836	$	28,632,236	$	27,480,491	$	26,569,506
	Net debt to book capitalization ratio		45%		45%		45%		43%		42%
Undepreciated book capitalization:
Total net debt		$	12,707,249	$	12,507,142	$	12,974,468	$	11,800,586	$	11,073,825
Accumulated depreciation and amortization			4,032,726		4,109,585		4,243,038		4,093,494		4,335,160
Total equity			14,999,794		14,868,568		15,264,238		15,281,472		15,110,263
Redeemable noncontrolling interest			359,656		394,126		393,530		398,433		385,418
Undepreciated book capitalization		$	32,099,425	$	31,879,421	$	32,875,274	$	31,573,985	$	30,904,666
	Net debt to undepreciated book capitalization ratio		40%		39%		39%		37%		36%
Market capitalization:
Total net debt		$	12,707,249	$	12,507,142	$	12,974,468	$	11,800,586	$	11,073,825
Common shares outstanding			356,773		357,690		362,425		362,602		364,564
Period end share price		$	69.34	$	76.17	$	74.77	$	66.93	$	70.82
Common equity market capitalization			24,738,620		27,245,247		27,098,517		24,268,952		25,818,422
Noncontrolling interests			839,856		869,320		867,923		873,512		859,478
Preferred stock			1,006,250		1,006,250		1,006,250		1,006,250		718,750
Enterprise value		$	39,291,975	$	41,627,959	$	41,947,158	$	37,949,300	$	38,470,475
	Net debt to market capitalization ratio		32%		30%		31%		31%		29%
(1) Amounts include senior unsecured notes, secured debt and capital lease obligations as reflected on our consolidated balance sheet.
(2) Inclusive of IRC section 1031 deposits, if any.

Critical Accounting Policies

Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions.  Management considers an accounting estimate or assumption critical if:

·the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and

·the impact of the estimates and assumptions on financial condition or operating performance is material.

Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors.  Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future.  However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change.  If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition.  Please refer to Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for further information regarding significant accounting policies that impact us.  There have been no material changes to these policies in 2017.

46

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Statements

    This Quarterly Report on Form 10-Q may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to the company’s opportunities to acquire, develop or sell properties; the company’s ability to close its anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of the company’s operators/tenants and properties; the company’s expected occupancy rates; the company’s ability to declare and to make distributions to shareholders; the company’s investment and financing opportunities and plans; the company’s continued qualification as a real estate investment trust (“REIT”); the company’s ability to access capital markets or other sources of funds; and the company’s ability to meet its earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the company’s actual results to differ materially from the company’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting the company’s properties; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting the company’s properties; changes in rules or practices governing the company’s financial reporting; the movement of U.S. and foreign currency exchange rates; the company’s ability to maintain its qualification as a REIT; and key management personnel recruitment and retention.  Other important factors are identified in the company’s Annual Report on Form 10-K for the year ended December 31, 2016, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures.  We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.

      We historically borrow on our primary unsecured credit facility to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our primary unsecured credit facility.  We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

      A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the

47

analysis performed as of the dates indicated (in thousands):

	March 31, 2017				December 31, 2016
	Principal		Change in		Principal		Change in
	balance		fair value		balance		fair value
Senior unsecured notes	$	7,591,593	$	(517,480)	$	7,568,832	$	(521,203)
Secured debt		1,731,448		(60,509)		2,489,276		(73,944)
Totals	$	9,323,041	$	(577,989)	$	10,058,108	$	(595,147)

     Our variable rate debt, including our primary unsecured credit facility, is reflected at fair value. At March 31, 2017, we had $2,148,703,000 outstanding related to our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $21,487,000.  At December 31, 2016, we had $2,311,996,000 outstanding under our variable rate debt.  Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $23,120,000.

We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended March 31, 2017, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our net income from these investments would increase or decrease, as applicable, by less than $1,500,000.  We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts.  If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value.  The following table summarizes the results of the analysis performed, excluding cross currency hedging activity (dollars in thousands):

	March 31, 2017				December 31, 2016
	Carrying		Change in		Carrying		Change in
	Value		fair value		Value		fair value
Foreign currency forward contracts(1)	$	101,116	$	14,491	$	87,962	$	722
Debt designated as hedges		1,504,059		15,041		1,481,591		13,000
Totals	$	1,605,175	$	29,532	$	1,569,553	$	13,722
(1) Amounts exclude cross currency hedge activity.

     For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 11 and 16 to our unaudited consolidated financial statements.

Item 4. Controls and Procedures

     Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

     From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. 

48

Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition.  Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters.  Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.

     From time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers, are contractually obligated to indemnify, defend and hold us harmless.  In some of these matters, the indemnitors have insurance for the potential damages.  In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us.  The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition.  It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect.

Item 1A. Risk Factors

     There have been no material changes from the risk factors identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased(1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1, 2017 through January 31, 2017	101,340	$	66.51
February 1, 2017 through February 28, 2017	11,222		70.38
March 1 2017 through March 31, 2017	610		69.14
Totals	113,172	$	66.90
(1) During the three months ended March 31, 2017, the company acquired shares of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.
(2) No shares were purchased as part of publicly announced plans or programs.

Item 5. Other Information

None.

Item 6. Exhibits

10.1            Amended and Restated Employment Agreement, dated January 3, 2017, between the company and Thomas J. DeRosa (filed with the Securities and Exchange Commission as Exhibit 10.4(a) to the company’s Form 10-K filed February 22, 2017 (File No. 001-08923), and incorporated herein by reference thereto).*

10.2            Executive Retirement Agreement, dated as of February 10, 2017, by and between Jeffrey H. Miller and the company (filed with the Securities and Exchange Commission as Exhibit 10.8 to the company’s Form 10-K filed February 22, 2017 (File No. 001-08923), and incorporated herein by reference thereto).*

10.3            Separation Agreement, dated as of February 6, 2017, by and between Scott M. Brinker and the company (filed with the Securities and Exchange Commission as Exhibit 10.10 to the company’s Form 10-K filed February 22, 2017 (File No. 001-08923), and incorporated herein by reference thereto).*

10.4            Welltower Inc. 2017-2019 Long-Term Incentive Program.*

12               Statement Regarding Computation of Ratio of Earnings to Fixed Charges and Ratio of Earnings to Combined Fixed Charges and Preferred Stock Dividends (Unaudited).

49

31.1            Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.

31.2            Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.

32.1            Certification pursuant to 18 U.S.C. Section 1350 by Chief Executive Officer.

32.2            Certification pursuant to 18 U.S.C. Section 1350 by Chief Financial Officer.

101.INS     XBRL Instance Document**

101.SCH   XBRL Taxonomy Extension Schema Document**

101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document**

101.LAB   XBRL Taxonomy Extension Label Linkbase Document**

101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document**

101.DEF    XBRL Taxonomy Extension Definition Linkbase Document**

* ** Management Contract or Compensatory Plan or Arrangement Attached as Exhibit 101 to this Quarterly Report on Form 10-Q are the following materials, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets at March 31, 2017 and December 31, 2016, (ii) the Consolidated Statements of Comprehensive Income for the three months ended March 31, 2017 and 2016, (iii) the Consolidated Statements of Equity for the three months ended March 31, 2017 and 2016, (iv) the Consolidated Statements of Cash Flows for the three months ended March 31, 2017 and 2016 and (v) the Notes to Unaudited Consolidated Financial Statements.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	WELLTOWER INC.
Date: May 5, 2017	By:	/s/ THOMAS J. DEROSA
	Thomas J. DeRosa,
	Chief Executive Officer  (Principal Executive Officer)
Date: May 5, 2017	By:	/s/ SCOTT A. ESTES
	Scott A. Estes,
	Executive Vice President - Chief Financial Officer  (Principal Financial Officer)
Date: May 5, 2017	By:	/s/ PAUL D. NUNGESTER, JR.
	Paul D. Nungester, Jr.,
	Senior Vice President & Controller  (Principal Accounting Officer)

50

EX-10.4

 

EXHIBIT 10.4

welltower INC.

2017-2019 LONG-TERM INCENTIVE PROGRAM

1.Purpose.  This 2017-2019 Long-Term Incentive Program (the “Program”) is adopted pursuant to the Welltower Inc. 2016 Long-Term Incentive Plan (the “Equity Plan”) and any successor equity plan and is intended to provide an incentive for superior work and to motivate executives and employees of Welltower Inc. (the “Company”) toward even higher achievement and business results, to tie their goals and interests to those of the Company and its stockholders and to enable the Company to attract and retain highly qualified executives and employees.  The Program is for the benefit of Participants (as defined below). 

2.Definitions.  Capitalized terms used herein without definitions shall have the meanings given to those terms in the Equity Plan.  In addition, as used herein:

“All REIT Index” means the MSCI US REIT Index

“Annualized TSR Percentage” means (1*(1 + Cumulative TSR))^(1/3) - 1.

“Award” means a grant to a Participant hereunder.

“Award Notice” means the restricted stock unit award agreement with a Participant that sets forth the terms, conditions and limitations of the Participant’s participation in this Program, including, without limitation, the Participant’s Target Award and the Participant’s threshold, target, and high payout multiples.

“Cause” for termination of the Participant’s employment for purposes of Section 7 means (a) if the Participant is a party to an employment agreement with the Company immediately prior to such termination, and “Cause” is defined therein, then “Cause” shall have the meaning set forth in such employment agreement, or (b) if the Participant is not party to an employment agreement with the Company immediately prior to such termination or the Participant’s employment agreement does not define “Cause,” then “Cause” shall mean: (i) negligence or willful misconduct by the Participant in connection with the performance of his or her material duties as an employee of the Company or any Subsidiary; (ii) a breach by the Participant of any of his or her material duties as an employee of the Company or any Subsidiary, including but not limited to the provisions of Section 4 herein; (iii) conduct by the Participant against the material best interests of the Company or any Subsidiary, including but not limited to embezzlement or misappropriation of corporate assets, or a material act of statutory or common law fraud against the Company, any Subsidiary or the employees of either the Company or any Subsidiary; (iv) conviction for or plea of nolo contendere to any crime that is a felony, involves moral turpitude, or was committed in connection with the performance of Participant’s job responsibilities for the Company; (v) indictment of the Participant of a felony or a misdemeanor involving moral turpitude and such indictment has a material adverse effect on the interests or reputation of the Company or any Subsidiary; (vi) the intentional and willful failure by Participant to substantially perform his or her job responsibilities to the Company (other than any such failure resulting from Participant’s incapacity due to physical or mental disability) after a demand for substantial performance is made by the Company; (vii) the failure by Participant to satisfactorily perform his or her job responsibilities to the Company (other than any such failure resulting from Participant’s incapacity due to physical or mental disability); or (viii) a breach by Participant of any of the Company’s policies and procedures, including but not limited to the Company’s Code of Business Conduct & Ethics. 

“Change in Corporate Control” shall have the same meaning as set forth in Section 10.1(a) of the Equity Plan and Section 10.1(c) of the Equity Plan.  In addition, in order to qualify as a “Change in Corporate Control”, an event must also meet the requirements for a “change in the ownership or effective control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation” with the meaning of Treas. Reg. §1.409A-3(i)(5).

“Code” means the Internal Revenue Code of 1986, as amended.

“Common Stock” means the Company’s common stock, par value $1.00 per share, either currently existing or authorized hereafter.

“Common Stock Price” means, as of a particular date, the average of the Fair Market Value of one share of Common Stock over the 20 consecutive trading days ending on, and including such date (or if such date is not a trading day, the most recent trading day immediately preceding such date); provided that, if such date is the date upon which a Change in Corporate Control occurs, the

Common Stock Price as of such date shall be equal to the fair value, as determined by the Committee, of the total consideration paid or payable in the transaction resulting in the Change in Corporate Control for one share of Common Stock.

“Cumulative TSR” means ((1*(1 + TSR Year 1)*(1 + TSR Year 2)*(1 + TSR Year 3)) ‑ 1.

“Debt + Preferred” means the sum of the Company’s secured debt, unsecured debt and the total amount of preferred stock for the designated period.

“Disability” for termination of the Participant’s employment for purposes of Section 7 means (a) if the Participant is a party to an employment agreement with the Company immediately prior to such termination, and “Disability” is defined therein, then “Disability” shall have the meaning set forth in such employment agreement, or (b) if the Participant is not party to an employment agreement with the Company that defines “Disability,” then “Disability” shall have the same meaning as defined in the Equity Plan.

“Dividend Value” means the aggregate amount of dividends and other distributions paid on one Share for which the record date occurred on or after the first day of the Performance Period and prior to the final settlement date at which shares of Common Stock are issued to a Participant (excluding dividends and distributions paid in the form of additional Shares).

“Earned Award” means, with respect to a Participant, the actual number of shares of Common Stock that were earned by such Participant pursuant to this Program at the end of the Performance Period based on the achievement of the performance goals set forth in Section 5.

“EBITDA” means the Company’s earnings before interest, taxes, depreciation and amortization, as determined in accordance with Generally Accepted Accounting Principles, for the designated period.

“Equity Plan” means the Welltower Inc. 2016 Long-Term Incentive Plan, as amended from time to time.

“Fair Market Value” means, as of any given date, the fair market value of a security which shall be the closing sale price reported for such security on the principal stock exchange or, if applicable, any other national exchange on which the security is traded or admitted to trading on such date on which a sale was reported.  If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which  there are market quotations.

“Good Reason” for termination of the Participant’s employment for purposes of Section 7 means (a) if the Participant is a party to an employment agreement with the Company immediately prior to such termination, and “good reason” is defined therein, then “Good Reason” shall have the meaning set forth in such employment agreement, or (b) if the Participant is not party to an employment agreement with the Company immediately prior to such termination and/or the Participant’s employment agreement does not define “Good Reason”:  (i) a substantial adverse change, not consented to by the Participant, in the nature or scope of the Participant’s responsibilities, authorities, powers, functions, or duties; or (ii) a breach by the Company of any of its material obligations hereunder.  Unless otherwise provided in an employment agreement to which the Participant is a party immediately prior to such termination, to constitute “good reason termination,” the Participant must:  (1) provide written notice to the Company within 90 days of the initial existence of the event constituting “Good Reason;” (2) may not terminate his or her employment unless the Company fails to substantially remedy the event constituting “Good Reason” within 30 days after such notice has been given; and (3) the Participant must terminate employment with the Company no later than 30 days after the end of the 30-day period in which the Company fails to substantially remedy the event constituting “Good Reason.”

“Health Care REIT Index” means the NAREIT Health Care REIT Index (or a successor index including a comparable universe of publicly traded U.S. real estate investment trusts), in each case adjusted and reweighted to exclude the Company from the index.   As of the beginning of the Performance Period, the NAREIT Health Care REIT Index was comprised of Ventas, Inc, HCP, Inc., Omega Healthcare Investors, Senior Housing Properties Trust, Healthcare Trust of America, Inc., Healthcare Realty Trust, National Health Investors, Medical Properties Trust, Community Healthcare Trust, Inc., Care Capital Properties, Sabra Health Care REIT, LTC Properties, New Senior Investment Group, Physicians Realty Trust, Universal Health Realty Income, Care Trust REIT, Quality Care Properties, Inc., MedEquities Realty Trust, Inc., and Global Medical REIT.  Any health care REIT organization that is not in existence for the entire Performance Period shall be omitted from this index.

“Index Return” means, with respect to the Performance Period, the compounded annualized return of either the Health Care REIT Index, or the All REIT Index, as applicable, over the Performance Period expressed as a percentage.  For the avoidance of doubt, the intent of the Committee is that Index Return over the Performance Period be calculated in a manner designed to produce a fair comparison between the Company’s Annualized TSR Percentage and the Index Return for the purpose of determining Relative Performance.  In the case of the Health Care REIT Index, the Index Return shall be computed as the sum of each component

company’s weighted TSR with each component company’s weight as the average of its relative market capitalization on dates that correspond to the beginning of each year of the Performance Period.

“Participant” means an executive or employee of the Company or any Subsidiary selected by the Compensation Committee to participate in the Program.

“Performance Period” means the period commencing on January 1, 2017 and concluding on the earlier of (i) December 31, 2019, or (ii) a Change in Corporate Control.

“Program” means this Welltower Inc. 2017-2019 Long-Term Incentive Program, as amended from time to time.

“Qualified Termination” means termination of a Participant’s employment for Good Reason, by reason of the Participant’s death, Disability, by the Company without Cause, Retirement and in the case of a Participant who is party to an employment agreement with the Company, a non‑renewal by the Company of the term of such agreement.

“Relative Performance” means the Annualized TSR Percentage relative to the applicable Index Return.

“Retirement” means the voluntary termination of employment by a Participant after attaining age 55 and completing ten consecutive full years of service; provided, however, that the sum of the Participant’s age and consecutive full years of service to the Company shall be equal to 70 or more; and provided further that the Participant (a) delivers to the Company, so that the Company receives or is deemed to have received in accordance with Section 12(i) at least six months prior to the date of his or her retirement, written notice specifying such retirement date, (b) remains in the continuous service of the Company from the date the written notice is received until his or her retirement date, and (c) enters into a retirement agreement with the Company  in such form as shall be determined by the Company from time to time that includes both (i) a customary release of claims covering the Company and its affiliates, and (ii) an affirmation of continued compliance with the non-competition, non-solicitation, non-disparagement and non-disclosure covenants in favor of the Company and related persons as set forth in Section 4.

“Target Award” means a Participant’s target award, expressed as a number of restricted stock units, for the Performance Period, as set forth in the Participant’s Award Notice.

“Total Shareholder Return” or “TSR” means the compounded annual growth rate, expressed as a percentage (rounded to the nearest tenth of a percent (0.1%)) in the value per share of Common Stock during the Performance Period due to the appreciation in the price per share of Common Stock and dividends paid during the Performance Period, assuming dividends are reinvested.  Total Shareholder Return or TSR for any 12-month period shall be calculated as follows:  (i) the Common Stock Price at the end of the period plus dividends paid during the 12-month period divided by (ii) the Fair Market Value of the Common Stock at the beginning of the period, minus (iii) 1.  As set forth in, and pursuant to, Section 9 of this Agreement, appropriate adjustments to the Total Shareholder Return shall be made to take into account all stock dividends, stock splits, reverse stock splits and the other events set forth in Section 9 that occur during the Performance Period.

3.Administration 

(a)The Program shall be administered by the Compensation Committee in accordance with the Equity Plan.  The Compensation Committee shall have the discretionary authority to make all determinations (including, without limitation, the interpretation and construction of the Program and the determination of relevant facts) regarding the entitlement to any Award hereunder and the amount of any Award to be paid under the Program (including the number of shares of Common Stock issuable to any Participant), provided such determinations are not made in bad faith and are not inconsistent with the terms, purpose and intent of the Program.  The Compensation Committee may delegate to one or more officers or employees of the Company some or all of its authority to administer the Program as described in this Section 3, and in the event of such delegation, references to the Compensation Committee in this Section 3 shall apply in the same manner to such delegate or delegates to the extent of such delegated authority.  In particular, but without limitation and subject to the foregoing, the Compensation Committee shall have the authority:

(i)to select Participants under the Program in its sole discretion;

(ii)to determine the Target Award and any formula or criteria for the determination of the Target Award for each Participant and to determine the Earned Award;

(iii)to determine the terms and conditions, consistent with the terms of this Program, which shall govern Award Notices and all other written instruments evidencing an Award hereunder, including the waiver or modification of any such conditions;

(iv)to adopt, alter and repeal such administrative rules, guidelines and practices governing the Program as it shall from time to time deem advisable; and

(v)to interpret the terms and provisions of the Program and any Award granted under the Program (and any Award Notices or other agreements relating thereto) and to otherwise supervise the administration of the Program.

(b)Subject to the terms hereof, all decisions made by the Compensation Committee in good faith pursuant to the Program shall be final, conclusive and binding on all persons, including the Company and the Participants.  No member of the Compensation Committee, and no officer or employee of the Company acting on behalf of the Compensation Committee, shall be personally liable for any action, determination, or interpretation taken or made in good faith with respect to this Program, and all members of the Compensation Committee and each and any officer or employee of the Company acting on their behalf shall, to the fullest extent not prohibited by law, be fully indemnified and protected by the Company in respect of any such action, determination or interpretation.

4.Conditions of Participation

As a condition of entitlement to participate in the Program, whether or not the Participant receives any payment or other benefit under the Program, each Participant shall comply with the following restrictive covenants.

(a)Protection of Confidential Information.         Participant, both during employment with the Company and thereafter, shall not, directly or indirectly, disclose or make available to any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Information (as defined below) except as may be required for Participant to perform in good faith his or her job responsibilities to the Company while employed by the Company.  Upon Participant’s termination of employment, Participant shall return to the Company all Confidential Information and shall not retain any Confidential Information in Participant’s possession that is in written or other tangible form and shall not furnish any such Confidential Information to any third party, except as provided herein.  Notwithstanding the foregoing, this Section 4(a) shall not apply to Confidential Information that (i) was publicly known at the time of disclosure to Participant, (ii) becomes publicly known or available thereafter other than by any means in violation of this Section 4 or any other duty owed to the Company by Participant, (iii) is lawfully disclosed to Participant by a third party, or (iv) is required to be disclosed by law or by any court, arbitrator or administrative or legislative body with actual or apparent jurisdiction to order Participant to disclose or make accessible any information or is voluntarily disclosed by Participant to law enforcement or other governmental authorities.  Furthermore, in accordance with the Defend Trade Secrets Act of 2016, Participant will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (x) is made (i) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (y) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. As used in this Program, Confidential Information means, without limitation, any non-public confidential or proprietary information disclosed to Participant or known by Participant as a consequence of or through Participant’s relationship with the Company, in any form, including electronic media.  Confidential Information also includes, but is not limited to the Company’s business plans and financial information, marketing plans, and business opportunities. Nothing herein shall limit in any way any obligation Participant may have relating to Confidential Information under any other agreement, promise or duty to the Company.

(b)           Non-Competition.               In the course of the performance of Participant’s job responsibilities for the Company, Participant has obtained extensive and valuable knowledge and information concerning the Company’s business (including confidential information relating to the Company and its operations, intellectual property, assets, contracts, customers, personnel, plans, marketing plans, research and development plans and prospects).  Accordingly, during employment with the Company and for [one year]^[1] following Participant’s termination of employment, Participant will not engage in any business activities on behalf of any enterprise which competes with the Company or any of its affiliates in the business of (i) ownership or operation of Health Care Facilities (defined below); (ii) investment in or lending to health care related enterprises (including, without limitation, owners or developers of Health Care Facilities); (iii) management of Health Care Facilities; or (iv) provision of any planning or development services for Health Care Facilities. “Health Care Facilities” means any senior housing facilities or facilities used or intended primarily for the delivery of health care services, including, without limitation, any active adult communities, independent living facilities,

[1]               One year will be the duration of the non-competition period for SVPs and above.  For employees holding the title of Director, Assistant Vice President and Vice President, the duration will be six months.  For all other employees (i.e., Managers and below), the duration will be three months.

assisted living facilities, skilled nursing facilities, inpatient rehabilitation facilities, ambulatory surgery centers, medical office buildings, hospitals of any kind, or any similar types of facilities or projects.  Participant will be deemed to be engaged in such competitive business activities if Participant participates in such a business enterprise as an employee, officer, director, consultant, agent, partner, proprietor, or other participant; provided that the ownership of no more than two percent (2%) of the stock of a publicly traded corporation engaged in a competitive business shall not be deemed to be engaging in competitive business activities.

(c)           Non-Solicitation.  During employment with the Company and for one year following the end of Participant’s employment with the Company, Participant, to the fullest extent not prohibited by applicable law, directly or indirectly, individually or on behalf of any other person or entity, including Participant, will not encourage, induce, attempt to induce, recruit, attempt to recruit, solicit or attempt to solicit or participate in any way in hiring or retaining for employment, contractor or consulting opportunities anyone who is employed or providing full-time services as a consultant at that time by the Company or any subsidiary or affiliate of the Company.

(d)           Non-Disparagement.           At all times during and following Participant’s employment with the Company, Participant will not make or direct anyone else to make on Participant’s behalf any disparaging or untruthful remarks or statements, whether oral or written, about the Company, its operations or its products, services, affiliates, officers, directors, employees, or agents, or issue any communication that reflects adversely on or encourages any adverse action against the Company.  Participant will not make any direct or indirect written or oral statements to the press, television, radio, on social media or to, on or through other media or other external persons or entities concerning any matters pertaining to the business and affairs of the Company, its affiliates or any of its officers or directors.  The restrictions described in this paragraph shall not apply to any truthful statements made in response to a subpoena or other compulsory legal process or to law enforcement or other governmental authorities.

(e)           Remedies.             For the avoidance of doubt, any breach of any of the provisions in this Section 4 shall constitute a material breach by Participant.  Notwithstanding any other provision of this Program, by becoming entitled to receive any payments or other benefits under this Program, Participant is deemed to have agreed that damages would be an inadequate remedy for the Company in the event of a breach or threatened breach by Participant of any of Sections 4(a) through 4(d), inclusive.  In the event of any such breach or threatened breach, and without relinquishing any other rights or remedies that the Company may have, including but not limited to the forfeiture or repayment by Participant of any payments or benefits otherwise payable or paid to Participant under this Program, the Company may, either with or without pursuing any potential damage remedies and without being required to post a bond, obtain from a court of competent jurisdiction, and enforce, an injunction prohibiting Participant from violating this Section 4 and requiring Participant to comply with its provisions.  The Company may present this Section 4 to any third party with which Participant may have accepted employment, or otherwise entered into a business relationship, that the Company contends violates this Section 4, if the Company has reason to believe Participant has or may have breached a provision of this Section 4.

5.Determination of Awards

(a)Each Participant’s Award Notice shall specify such Participant’s Target Award and threshold, target, and high payout multiples.

(b)The percentage of a Participant’s Target Award that may be earned for the Performance Period shall be determined as follows:  25 percent of the Target Award shall be earned based on the Company’s Relative Performance to the Health Care REIT Index; 15 percent of the Target Award shall be earned based on the Company’s Relative Performance to the All REIT Index; 10 percent of the Target Award shall be earned based on the Company’s Annualized TSR Percentage; 20 percent of the Target Award shall be earned based on the Company’s (Debt + Preferred) / EBITDA ratio; 15% shall be earned based on the establishment of Academic Medical Centers and Super-Regional Health Systems Relationships; and 15 percent of the Target Award shall be earned based on the Effectiveness of  Management and Progression on Corporate Initiatives; all as further set forth on Exhibit A.

(c)Depending on the score for each of the performance goals as determined pursuant to Exhibit A, the Earned Award for the Performance Period shall be determined based on the Participant’s individual threshold, target and high payout multiples described in the Participant’s Award Notice. 

For performance between two different tiers, the percentage payable shall be calculated using interpolation between tiers. The level of achievement for each listed performance goal shall be determined independently.

Except as otherwise provided herein, the Earned Award shall be settled in shares of Common Stock upon satisfaction of the vesting requirements as set forth in Section 8.

6.Change in Corporate Control.  In the event that prior to December 31, 2019, a Change in Corporate Control occurs, then each outstanding Award will be deemed earned as of the date of such Change in Corporate Control in accordance with the computation described in Section 5(b) as if the Performance Period ended on the day prior to the consummation of the Change in Corporate Control, except that corporate metrics not tied to TSR shall be calculated based on the results through the most recent completed fiscal quarter, but each Award shall further be multiplied by a fraction, the numerator of which shall be the number of full and partial months from the beginning of the Performance Period through the Change in Corporate Control and the denominator of which shall be 36.  Notwithstanding Sections 4 and 8(b), any shares of Common Stock issued to satisfy such outstanding Earned Awards shall be fully vested and nonforfeitable.

7.Termination of Participant’s Employment.

(a)If a Participant’s employment with the Company terminates, the provisions of this Section 7 shall govern the treatment of the Participant’s Award exclusively, regardless of the provisions of any employment, change in control or other agreement or arrangement to which the Participant is a party, or any termination or severance policies of the Company then in effect, which shall be superseded by this Program.

(b)In the event of termination of a Participant’s employment by reason of a Qualified Termination prior to the end of the Performance Period, then the Compensation Committee shall determine the Participant’s Earned Award in accordance with the computation described in Section 5(b) as if the Performance Period ended on the calendar quarter end immediately preceding the date of the Participant’s Qualified Termination; provided, however, that the Earned Award of such terminated Participant for the Performance Period shall be multiplied by a fraction, the numerator of which shall be the number of days in which the Participant an employee of the Company during the Performance Period and the denominator of which shall be the total number of days in the Performance Period.  The pro-rated Earned Award shall be paid out in shares of Common Stock that are fully vested.

(c)In the event of termination of a Participant’s employment by reason of a Qualified Termination after the end of the Performance Period, any portion of the Participant’s Earned Award that has not yet been settled shall become fully vested and shall be paid out in shares of Common Stock.

(d)As a condition of receiving any payments or benefits under this Program on account of Participant’s Qualified Termination, the Company may require Participant to deliver an irrevocable, effective release of claims in the form determined by the Company and/or an affirmation of continued compliance with the non-competition, non-solicitation, non-disparagement and non-disclosure covenants in favor of the Company and related persons as set forth in Section 4.

(e)In the event of a termination of a Participant’s employment for any reason other than a Qualified Termination prior to the end of the Performance Period, except as otherwise set forth in the Participant’s Award Notice, the Award held by the Participant for the Performance Period shall, without payment of any consideration by the Company, automatically and without notice terminate, be forfeited and be and become null and void, and neither the Participant nor any of his or her successors, heirs, assigns, or personal representatives will thereafter have any further rights or interests in such Award.  In the event of a termination of a Participant’s employment for any reason other than a Qualified Termination after the end of the Performance Period, any portion of the Earned Award that has not yet been settled in shares of Common Stock shall be forfeited.

8.Payment of Awards.

(a)As soon as practicable following the end of the Performance Period , the Compensation Committee shall determine the size of each Participant’s Earned Award, if any, with respect to the Performance Period (with the date of such determination being referred to as the “Issuance Date”).  In no event shall the Issuance Date with respect to the Performance Period be later than 74 days after the end of the Performance Period; provided that (i) in the case of the Performance Period that ends upon a Change in Corporate Control, the Issuance Date shall be no later than immediately prior to the consummation of the Change in Corporate Control, and (ii) in the case of a determination required by Section 7(b), the Issuance Date shall be no later than 74 days after the date of the Participant’s Qualified Termination.

(b)Except as otherwise provided in Sections 6 and 7, on each vesting date described below, the Company shall issue to each Participant (or such Participant’s estate or beneficiary, if applicable) a number of shares of Common Stock equal to the vested portion of the Earned Award.  Subject to a Participant’s continued employment with the Company or a subsidiary and continued compliance with the restrictive covenants set forth in Section 4 through such date, one-third of the shares subject to a Participant’s Earned Award shall be vested as of the Issuance Date, one-third of such shares shall become fully vested on December 31, 2020, and one-third of such shares shall become fully vested on December 31, 2021.  In addition, on each such vesting date, as applicable (or on the Issuance Date with regard to an Earned Award settled in accordance with Section 6 or 7), the Company shall pay

in cash to each Participant (or such Participant’s estate or beneficiary, if applicable) an amount equal to the Dividend Value multiplied by the number of shares issued pursuant to Section 6, Section 7 or this Section 8(b) on such date.

9.Adjustments.  Without duplication with the provisions of Sections 3 and 11 of the Equity Plan, if (i) the Company shall at any time be involved in a merger, consolidation, dissolution, liquidation, reorganization, exchange of Shares, sale of all or substantially all of the assets or Shares of the Company or a transaction similar thereto, (ii) any stock dividend, stock split, reverse stock split, stock combination, reclassification, recapitalization, or other similar change in the capital structure of the Company, or any distribution to holders of Shares other than ordinary cash dividends, shall occur or (iii) any other event shall occur which in the judgment of the Compensation Committee necessitates action by way of adjusting the terms of the Program, then and in that event, the Compensation Committee shall take such action as shall be necessary to maintain the Participants’ rights hereunder so that they are substantially the same rights existing under this Program prior to such event.

10.Restrictions and Conditions.  Subject to the provisions of the Equity Plan and this Program, except as may otherwise be permitted by the Compensation Committee, a Participant shall not be permitted voluntarily or involuntarily to sell, assign, transfer, or otherwise encumber or dispose of the restricted stock units or an Award; provided that the foregoing restriction shall not apply to Shares actually issued to a Participant.

11.Withholding of Tax.  Each Participant shall, not later than the date as of which vesting or payment in respect of an Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Company for payment of any Federal, state and local taxes required by law to be withheld on account of such taxable event.  The Company shall have the authority to cause the required minimum tax withholding obligation to be satisfied by withholding a number of Shares to be issued to a Participant with an aggregate Fair Market Value that would satisfy the withholding amount due.  The Company’s obligation to deliver stock certificates (or evidence of book entry) to any Participant is subject to and conditioned on tax withholding obligations being satisfied by such Participant or through the Company’s exercise of its authority.

12.Miscellaneous. 

(a)Amendment and Termination.  The Company reserves the right to amend or terminate the Program at any time in its discretion without the consent of any Participant, but no such amendment shall adversely affect the rights of the Participants with regard to outstanding Awards in any material respect.

(b)No Contract for Continuing Services.  This Program shall not be construed as creating any contract for continued services between the Company or any of its Subsidiaries and any Participant and nothing herein contained shall give any Participant the right to be retained as an employee or consultant of the Company or any of its Subsidiaries.

(c)Governing Law.  The Program and each Award Notice awarded under the Program shall be construed in accordance with and governed the laws of the State of Ohio, without regard to principles of conflict of laws of such state.

(d)Arbitration.            Subject to Section 4(e) hereof, all claims, disputes, questions, or controversies arising out of or relating to this Program, will be resolved exclusively in final and binding arbitration held under the auspices of Judicial Arbitration & Mediation Services, Inc. (“JAMS”) in accordance with JAMS then current Employment Arbitration Rules and Procedures, or successor rules then in effect. The arbitration will be held in New York, New York, and will be conducted and administered by JAMS or, in the event JAMS does not then conduct arbitration proceedings, a similarly reputable arbitration administrator. Participant and the Company will select a mutually acceptable, neutral arbitrator from among the JAMS panel of arbitrators.  Except as provided by this Program, the Federal Arbitration Act will govern the administration of the arbitration proceedings. The arbitrator will apply the substantive law (and the law of remedies, if applicable) of the State of Ohio, or federal law, if Ohio law is preempted, and the arbitrator is without jurisdiction to apply any different substantive law. Participant and the Company will each be allowed to engage in adequate discovery, the scope of which will be determined by the arbitrator consistent with the nature of the claim(s) in dispute. The arbitrator will have the authority to entertain a motion to dismiss and/or a motion for summary judgment by any party and will apply the standards governing such motions under the Federal Rules of Civil Procedure. The arbitrator will render a written award and supporting opinion that will set forth the arbitrator’s findings of fact and conclusions of law. Judgment upon the award may be entered in any court of competent jurisdiction. The Company will pay the arbitrator’s fees, as well as all administrative fees, associated with the arbitration. Each party will be responsible for paying its own attorneys’ fees and costs (including expert witness fees and costs, if any), provided, however, that the arbitrator may award attorney’s fees and costs to the prevailing party, except as prohibited by law.  If the Company is the prevailing party, the arbitration may award some or all of the costs for the arbitrator’s fees and/or other administrative fees to the fullest extent not prohibited by law.  The existence and subject matter of all arbitration proceedings, including, any settlements or awards thereunder, shall remain confidential.

(e)Construction.  Wherever appropriate, the use of the masculine gender shall be extended to include the feminine and/or neuter or vice versa; and the singular form of words shall be extended to include the plural; and the plural shall be restricted to mean the singular.

(f)Headings.  The Section headings and Section numbers are included solely for ease of reference.  If there is any conflict between such headings or numbers and the text of this Program, the text shall control.

(g)Effect on Other Plans.  Nothing in this Program shall be construed to limit the rights of Participants under the Company’s or its Subsidiaries’ benefit plans, programs or policies.

(h)Clawback Policy.  All Awards granted under this Program shall be subject to forfeiture (as determined by the Compensation Committee) in accordance with the terms of the Company’s clawback or recoupment policy (as in effect from time to time).  Furthermore, prior to the occurrence of a Change in Corporate Control, an Award (including an Earned Award) granted under this Program and shares of Common Stock issued under this Program to a Participant shall be subject to forfeiture (as determined by the Compensation Committee) in the event that a Participant breaches any provision of Section 4 herein.

(i)Notices.  Any notice provided for under this Program shall be in writing and may be delivered in person or sent by overnight courier, certified mail, or registered mail (return receipt requested), postage prepaid, addressed as follows (or to such other address as such party may designate in writing from time to time):

If to the Company:  Welltower Inc., 4500 Dorr Street, Toledo, OH  43615

Attention:  Legal Department

If to a Participant, at the address on file with the Company’s Human Resources Department.

The actual date of mailing, as shown by a mailing receipt therefor, shall determine the time at which notice was given.  Any Participant may change the address at which notice shall be given by notifying the Company in the manner set forth in this Section 12(i).  The Company may change the address at which notice shall be given by notifying each Participant in the manner set forth in this Section 12(i).

(j)Section 409A.

(1)This Program is intended to comply with Section 409A of the Code (“Code Section 409A”) and will be interpreted in a manner intended to comply with Code Section 409A.  Any provision that would cause this Program or any payment hereunder to fail to satisfy Code Section 409A of the Code shall have no force or effect until amended to the minimum extent required to comply with Code Section 409A, which amendment may be retroactive to the extent permitted by Code Section 409A.  A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts or benefits that may be considered “deferred compensation” under Code Section 409A (after taking into account all exclusions applicable to such payments or benefits under Code Section 409A) upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Program, references to a “retirement,” “termination,” “termination of employment” or like terms shall mean separation from service. 

(2)Any payment scheduled to be made under this Program that may be considered “deferred compensation” under Code Section 409A (after taking into account all exclusions applicable to such payments or benefits under Code Section 409A), that are otherwise due on or within the six-month period following termination of employment will accrue during such six-month period and will instead become payable in a lump sum payment on the first business day period following such six-month period.  Furthermore, if any other payments of money or other benefits due to a Participant under this Agreement could cause the application of an accelerated or additional tax under Code Section 409A, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Code Section 409A, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that does not cause such an accelerated or additional tax.  

(3)Notwithstanding any contrary provision herein, a Participant’s right to any payment (including each installment payment) under this Program shall be treated as a “separate payment” within the meaning of Code Section 409A.

END OF PROGRAM DOCUMENT

EX-12

 

EXHIBIT 12
STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDENDS (UNAUDITED)
	Year Ended December 31,										Three Months Ended March 31,
(dollars in thousands)	2012		2013		2014		2015		2016		2016		2017
Earnings:
Pretax income from continuing operations before adjustment for income or loss from equity investees(1)	$	185,912	$	102,245	$	384,213	$	636,117	$	709,253	$	167,569	$	118,869
Fixed charges		359,947		460,918		485,762		498,253		536,607		136,596		121,047
Capitalized interest		(9,777)		(6,700)		(7,150)		(8,670)		(16,943)		(3,037)		(4,129)
Amortized premiums, discounts and capitalized expenses related to indebtedness		11,395		4,142		2,427		2,586		1,681		(599)		1,679
Noncontrolling interest in pre-tax income of subsidiaries that have not incurred fixed charges		2,415		6,770		(147)		(4,799)		(4,267)		(153)		(823)
Earnings	$	549,892	$	567,375	$	865,105	$	1,123,487	$	1,226,331	$	300,376	$	236,643
Fixed charges:
Interest expense(1)	$	361,565	$	458,360	$	481,039	$	492,169	$	521,345	$	132,960	$	118,597
Capitalized interest		9,777		6,700		7,150		8,670		16,943		3,037		4,129
Amortized premiums, discounts and capitalized expenses related to indebtedness		(11,395)		(4,142)		(2,427)		(2,586)		(1,681)		599		(1,679)
Fixed charges	$	359,947	$	460,918	$	485,762	$	498,253	$	536,607	$	136,596	$	121,047
Consolidated ratio of earnings to fixed charges		1.53		1.23		1.78		2.25		2.29		2.20		1.95
Earnings:
Pretax income from continuing operations before adjustment for income or loss from equity investees(1)	$	185,912	$	102,245	$	384,213	$	636,117	$	709,253	$	167,569	$	118,869
Fixed charges		359,947		460,918		485,762		498,253		536,607		136,596		121,047
Capitalized interest		(9,777)		(6,700)		(7,150)		(8,670)		(16,943)		(3,037)		(4,129)
Amortized premiums, discounts and capitalized expenses related to indebtedness		11,395		4,142		2,427		2,586		1,681		(599)		1,679
Noncontrolling interest in pre-tax income of subsidiaries that have not incurred fixed charges		2,415		6,770		(147)		(4,799)		(4,267)		(153)		(823)
Earnings	$	549,892	$	567,375	$	865,105	$	1,123,487	$	1,226,331	$	300,376	$	236,643
Fixed charges:
Interest expense(1)	$	361,565	$	458,360	$	481,039	$	492,169	$	521,345	$	132,960	$	118,597
Capitalized interest		9,777		6,700		7,150		8,670		16,943		3,037		4,129
Amortized premiums, discounts and capitalized expenses related to indebtedness		(11,395)		(4,142)		(2,427)		(2,586)		(1,681)		599		(1,679)
Fixed charges		359,947		460,918		485,762		498,253		536,607		136,596		121,047
Preferred stock dividends		69,129		66,336		65,408		65,406		65,406		16,352		14,379
Combined fixed charges and preferred stock dividends	$	429,076	$	527,254	$	551,170	$	563,659	$	602,013	$	152,948	$	135,426
Consolidated ratio of earnings to combined fixed charges and preferred stock dividends		1.28		1.08		1.57		1.99		2.04		1.96		1.75
(1) We have reclassified the income and expenses attributable to the properties sold prior to or held for sale at January 1, 2014 to discontinued operations.

EX-31.1

 

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Thomas J. DeRosa, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welltower Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2017

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chief Executive Officer 

EX-31.2

 

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Scott A. Estes, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welltower Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2017

/s/ SCOTT A. ESTES

Scott A. Estes, 

Chief Financial Officer 

EX-32.1

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, Thomas J. DeRosa, the Chief Executive Officer of Welltower Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2017 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chief Executive Officer

 Date: May 5, 2017

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

 

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, Scott A. Estes, the Chief Financial Officer of Welltower Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2017 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ SCOTT A. ESTES

Scott A. Estes, 

Chief Financial Officer

 Date: May 5, 2017 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - USD ($)	3 Months Ended
	Mar. 31, 2017	Apr. 28, 2017	Jun. 30, 2016
Document And Entity Information [Abstract]
Entity Registrant Name	WELLTOWER INC. /DE/
Entity Central Index Key	0000766704
Document Type	10-Q
Document Period End date	Mar. 31, 2017
Amendment Flag	false
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 27,176,263,145
Entity Common Stock Shares Outstanding		366,166,605

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2017		Dec. 31, 2016
Real property owned:
Land and land improvements	$ 2,650,473		$ 2,591,071
Buildings and improvements	24,930,472		24,496,153
Acquired lease intangibles	1,421,277		1,402,884
Real property held for sale, net of accumulated depreciation	178,260		1,044,859
Construction in progress	390,180		506,091
Gross real property owned	29,570,662		30,041,058
Less accumulated depreciation and amortization	(4,335,160)		(4,093,494)
Net real property owned	25,235,502		25,947,564
Real estate loans receivable:
Real estate loans receivable	574,080		622,628
Allowance for losses on loans receivable	(6,196)		(6,563)
Net real estate loans receivable	567,884		616,065
Net real estate investments	25,803,386		26,563,629
Other assets:
Investments in unconsolidated entities	416,110		457,138
Goodwill	68,321		68,321
Cash and cash equivalents	380,360		419,378
Restricted cash	42,777		187,842
Straight-line rent receivable	348,085		342,578
Receivables and other assets	708,238		826,298
Total other assets	1,963,891		2,301,555
Total assets	27,767,277		28,865,184
Liabilities:
Borrowings under primary unsecured credit facilities, Carrying Value	522,000	[1]	645,000
Senior unsecured notes	8,188,928		8,161,619
Secured debt	2,669,787		3,477,699
Capital lease obligations	73,470		73,927
Accrued expenses and other liabilities	817,411		827,034
Total liabilities	12,271,596		13,185,279
Redeemable noncontrolling interests	385,418		398,433
Equity:
Preferred stock	718,750		1,006,250
Common stock	365,187		363,071
Capital in excess of par value	17,134,490		16,999,691
Treasury stock	(62,306)		(54,741)
Cumulative net income	5,130,593		4,803,575
Cumulative dividends	(8,474,775)		(8,144,981)
Accumulated other comprehensive income (loss)	(177,200)		(169,531)
Other equity	1,464		3,059
Total Welltower Inc. stockholders' equity	14,636,203		14,806,393
Noncontrolling interests	474,060		475,079
Total equity	15,110,263		15,281,472
Total liabilities and equity	$ 27,767,277		$ 28,865,184

[1] As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues:
Rental income	$ 367,141	$ 415,663
Resident fees and services	670,337	602,149
Interest income	20,748	25,188
Other income	4,072	4,050
Total revenues	1,062,298	1,047,050
Expenses:
Interest expense	118,597	132,960
Property operating expenses	510,169	449,636
Depreciation and amortization	228,276	228,696
General and administrative	31,101	45,691
Transaction costs	0	8,208
Loss (gain) on derivatives, net	1,224	0
Loss (gain) on extinguishment of debt, net	31,356	(24)
Impairment of Asset	11,031	14,314
Other expenses	11,675	0
Total expenses	943,429	879,481
Income (loss) from continuing operations before income taxes and income from unconsolidated entities, total	118,869	167,569
Income tax expense	(2,245)	1,725
(Loss) income from unconsolidated entities	(23,106)	(3,820)
Income from continuing operations	93,518	165,474
Gain (loss) on real estate dispositions, net	244,092	0
Net income	337,610	165,474
Less: Preferred stock dividends	14,379	16,352
Preferred stock redemption charge	9,769	0
Less: Net income (loss) attributable to noncontrolling interests	823	153
Net income (loss) attributable to common stockholders	$ 312,639	$ 148,969
Average number of common shares outstanding:
Basic	362,534	355,076
Diluted	364,652	356,051
Basic:
Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions	$ 0.86	$ 0.42
Net income (loss) attributable to common stockholders, total	0.86	0.42
Diluted:
Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions	0.86	0.42
Net income (loss) attributable to common stockholders, total	0.86	0.42
Dividends declared and paid per common share	$ 0.87	$ 0.86

XML

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income		$ 337,610	$ 165,474
Other comprehensive income (loss):
Unrecognized gain (loss) on equity investments		(10,569)	(7,549)
Unrecognized gain (loss) on cash flow hedges		0	483
Unrecognized actuarial gain/(loss)		0	2
Unrecognized gain (loss) on foreign currency translation		5,713	1,372
Total other comprehensive income (loss)		(4,856)	(5,692)
Total comprehensive income (loss), total		332,754	159,782
Total comprehensive income (loss) attributable to noncontrolling interests	[1]	3,636	15,271
Comprehensive income (loss) attributable to controlling interests		$ 329,118	$ 144,511

[1] Includes amounts attributable to redeemable noncontrolling interests.

XML

Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital in Excess of Par Value	Treasury Stock	Cumulative Net Income	Cumulative Dividends	Accumulated Other Comprehensive Income (Loss)	Other Equity	Noncontrolling Interests
Balances at beginning of period at Dec. 31, 2015	$ 15,175,885	$ 1,006,250	$ 354,811	$ 16,478,300	$ (44,372)	$ 3,725,772	$ (6,846,056)	$ (88,243)	$ 4,098	$ 585,325
Comprehensive income:
Net income (loss)	166,403					165,321				1,082
Other comprehensive income	(5,692)							(20,810)		15,118
Total comprehensive income	160,711
Decrease in noncontrolling interests	(127,042)			(5,717)						(121,325)
Amounts related to stock incentive plans, net of forfeitures	19,178		637	25,555	(6,899)				(115)
Proceeds from issuance of common stock	93,105		1,505	91,600
Option compensation expense	79								79
Cash dividends paid:
Common stock	(305,770)						(305,770)
Preferred Stock	(16,352)						(16,352)
Balances at end of period at Mar. 31, 2016	14,999,794	1,006,250	356,953	16,589,738	(51,271)	3,891,093	(7,168,178)	(109,053)	4,062	480,200
Balances at beginning of period at Dec. 31, 2016	15,281,472	1,006,250	363,071	16,999,691	(54,741)	4,803,575	(8,144,981)	(169,531)	3,059	475,079
Comprehensive income:
Net income (loss)	338,567					336,787				1,780
Other comprehensive income	(4,856)							(7,669)		2,813
Total comprehensive income	333,711
Increase in noncontrolling interests				932
Decrease in noncontrolling interests	(4,680)									(5,612)
Amounts related to stock incentive plans, net of forfeitures	(1,931)		336	6,903	(7,565)				(1,605)
Proceeds from issuance of common stock	118,984		1,780	117,204
Redemption of preferred stock	(287,509)	(287,500)		9,760		(9,769)
Option compensation expense	10								10
Cash dividends paid:
Common stock	(315,415)						(315,415)
Preferred Stock	(14,379)						(14,379)
Balances at end of period at Mar. 31, 2017	$ 15,110,263	$ 718,750	$ 365,187	$ 17,134,490	$ (62,306)	$ 5,130,593	$ (8,474,775)	$ (177,200)	$ 1,464	$ 474,060

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Operating activities
Net income (loss)		$ 337,610	$ 165,474
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization		228,276	228,696
Other amortization expenses		3,361	1,118
Asset Impairment Charges		11,031	14,314
Stock-based compensation expense		4,906	8,186
Loss (gain) on derivatives, net		1,224	0
Loss (gain) on extinguishment of debt, net		31,356	(24)
Income from unconsolidated entities		23,106	3,820
Rental income in excess of cash received		(18,141)	(29,669)
Amortization related to above (below) market leases, net		8	230
Net loss (gain) on sales of properties		(244,092)	0
Distributions by unconsolidated entities		474	174
Increase (decrease) in accrued expenses and other liabilities		19,478	(13,526)
Decrease (increase) in receivables and other assets		(13,071)	1,816
Net cash provided from (used in) operating activities		385,526	380,609
Investing activities
Cash disbursed for acquisitions		(102,356)	(171,482)
Cash disbursed for capital improvements to existing properties		(42,115)	(35,025)
Cash disbursed for construction in progress		(69,334)	(66,739)
Capitalized interest		(4,129)	(3,037)
Investment in real estate loans receivable		(25,375)	(27,251)
Other investments, net of payments		48,311	(30,773)
Principal collected on real estate loans receivable		8,792	93,774
Contributions to unconsolidated entities		(13,073)	(12,784)
Distributions by unconsolidated entities		24,161	11,747
Proceeds from (payments on) derivatives investing		8,218	0
Decrease (increase) in restricted cash		145,065	(394)
Proceeds from sales of real property		1,087,074	0
Net cash provided from (used in) investing activities		1,065,239	(241,964)
Financing activities
Net increase (decrease) under unsecured lines of credit arrangements		(123,000)	(190,000)
Proceeds from issuance of senior unsecured notes		0	688,560
Payments to extinguish senior unsecured notes		0	(400,000)
Secured debt issued		12,536	75,136
Payments on secured debt		(822,438)	(130,343)
Net proceeds from the issuance of common stock		119,651	93,433
Redemption of preferred stock		(287,500)	0
Decrease (increase) in deferred loan costs		(36,674)	(1,217)
Contributions by noncontrolling interests	[1]	2,667	126,142
Distributions to noncontrolling interests	[1]	(20,014)	(76,222)
Acquisitions of noncontrolling interests		(38)	0
Cash distributions to stockholders		(329,794)	(322,122)
Other financing activities		(8,022)	(7,294)
Net cash provided from (used in) financing activities		(1,492,626)	(143,927)
Effect of foreign currency translation on cash and cash equivalents		2,843	323
Increase (decrease) in cash and cash equivalents		(39,018)	(4,959)
Cash and cash equivalents at beginning of period		419,378	360,908
Cash and cash equivalents at end of period		380,360	355,949
Supplemental cash flow information:
Interest paid		109,438	134,872
Income taxes paid		$ 3,349	$ 2,431

[1] (1) Includes amounts attributable to redeemable noncontrolling interests.

XML

Business

3 Months Ended

Mar. 31, 2017

Business [Abstract]

Business

1. Business

Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housingoperators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. Founded in 1970, we were the first real estate investment trust to invest exclusively in health care facilities.

XML

Accounting Policies and Related Matters

3 Months Ended

Mar. 31, 2017

Accounting Policies and Related Matters [Abstract]

Accounting Policies and Related Matters

2. Accounting Policies and Related Matters

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily an indication of the results that may be expected for the year ending December 31, 2017. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.

New Accounting Standards

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted beginning after December 15, 2016. A reporting entity may apply the new standard using either a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or a full retrospective approach. We are currently evaluating the impact that the adoption of the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the new standard. A significant source of our revenue is generated through leasing arrangements, which are specifically excluded from the new standard. We expect that the new standard will affect our accounting policies related to non-lease revenue, including certain fees in our RIDEA joint ventures, common area maintenance in our outpatient medical properties and real estate sales. Under ASU 2014-09, revenue recognition for real estate sales is mainly based on the transfer of control versus current guidance of continuing involvement. We expect that the new guidance will result in more transactions qualifying as sales of real estate and being recognized at an earlier date than under the current guidance.

In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which will require entities to measure their investments at fair value and recognize any changes in fair value in net income unless the investments qualify for the new practicability exception. The practicability exception will be available for equity investments that do not have readily determinable fair values. ASU 2016-01 is effective for fiscal years and interim periods within those years, beginning after December 15, 2017. We are currently evaluating the impact that the standard will have on our consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” which requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term. It will also require disclosures designed to give financial statement users information regarding amount, timing, and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. We are currently evaluating the impact of this standard on our consolidated financial statements. We believe that the adoption of this standard will likely have a material impact to our consolidated balance sheet for the recognition of certain operating leases as right-of-use assets and lease liabilities. We are in the process of analyzing our lease portfolio and evaluating systems to comply with the standard’s retrospective adoption requirements.

In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting”. ASU 2016-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted. We adopted ASU 2016-09 on January 1, 2017. The standard allows companies to make a policy election as to whether they will include an estimate of awards expected to be forfeited or whether they will account for forfeitures as they occur. We have elected to account for forfeitures as they occur. This election had an immaterial impact on our consolidated financial statements. The standard also requires an employer to classify as a financing activity in the statement of cash flow the cash paid to a tax authority when shares are withheld to satisfy the employer’s statutory income tax withholding obligation. This standard is required to be applied on a retrospective basis and resulted in an increase in net cash provided by operating activities and a decrease in net cash used in financing activities of $6,897,000 for the three months ended March 31, 2016. Upon adoption, no other provisions of ASU 2016-09 had an effect on our unaudited consolidated financial statements or related footnote disclosures.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments”. This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018. We are currently evaluating the impact that the standard will have on our consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, “Clarifying the Definition of a Business”. This standard changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. ASU 2017-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted. A reporting entity must apply ASU 2017-01 using a prospective approach. We adopted ASU 2017-01 on January 1, 2017 and as a result, have classified our real estate acquisitions completed during the three months ended March 31, 2017 as asset acquisitions rather than business combinations due to the fact that substantially all of the fair value of the gross assets acquired were concentrated in a single asset or group of similar identifiable assets. We have recorded identifiable assets acquired, liabilities assumed and any noncontrolling interests associated with any asset acquisitions at cost on a relative fair value basis and have capitalized transaction costs incurred.

XML

Real Property Acquisitions and Development

3 Months Ended

Mar. 31, 2017

Real Property Acquisitions and Development [Abstract]

Real Property Acquisitions and Development

3. Real Property Acquisitions and Development

The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their relative fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Effective January 1, 2017, with our adoption of ASU 2017-01, transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in “Other Expenses” on our Consolidated Statements of Comprehensive Income. Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. See Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for information regarding our foreign currency policies.

Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,017		$	15,331
Buildings and improvements				37,241			114,235
Acquired lease intangibles				-			1,623
	Total assets acquired			41,258			131,189
Accrued expenses and other liabilities				-			(809)
	Total liabilities assumed			-			(809)
Non-cash acquisition related activity(1)				-			(28,621)
	Cash disbursed for acquisitions			41,258			101,759
Construction in progress additions				46,754			43,835
Less:	Capitalized interest			(2,028)			(1,684)
	Foreign currency translation			(164)			(583)
Cash disbursed for construction in progress				44,562			41,568
Capital improvements to existing properties				10,495			7,438
	Total cash invested in real property, net of cash acquired		$	96,315		$	150,765
(1) Includes $25,691,000 related to the acquisition of assets previously financed as real estate loans receivable and $2,871,000 related to the acquisition of assets previously financed as an investment in an unconsolidated entity.

Seniors Housing Operating Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,304		$	3,440
Building and improvements				44,075			48,218
Acquired lease intangibles				1,741			1,942
Receivables and other assets				74			36
	Total assets acquired(1)			50,194			53,636
Accrued expenses and other liabilities				(2,755)			(11)
	Total liabilities assumed			(2,755)			(11)
Noncontrolling interests				(647)			(549)
Non-cash acquisition related activity(2)				(14,148)			-
	Cash disbursed for acquisitions			32,644			53,076
Construction in progress additions				8,062			4,033
Less:	Capitalized interest			(1,707)			(565)
	Foreign currency translation			691			(1,107)
Cash disbursed for construction in progress				7,046			2,361
Capital improvements to existing properties				24,254			16,808
	Total cash invested in real property, net of cash acquired		$	63,944		$	72,245
(1) Excludes $400,000 and $113,000 of cash acquired during the three months ended March 31, 2017 and 2016, respectively.
(2) Includes $6,349,000 related to the acquisition of assets previously financed as real estate loans receivable and $7,799,000 previously financed as an investment in an unconsolidated entity.

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	2,895	$	-
Buildings and improvements				23,310		17,637
Acquired lease intangibles				3,496		-
Receivables and other assets				3		-
	Total assets acquired			29,704		17,637
Accrued expenses and other liabilities				(1,250)		(990)
	Total liabilities assumed			(1,250)		(990)
	Cash disbursed for acquisitions			28,454		16,647
Construction in progress additions				14,921		28,934
Less:	Capitalized interest			(717)		(788)
	Accruals(1)			3,522		(5,336)
Cash disbursed for construction in progress				17,726		22,810
Capital improvements to existing properties				7,366		10,779
	Total cash invested in real property		$	53,546	$	50,236
(1) Represents the change in non-cash consideration accruals for amounts to be paid in periods other than the period in which the construction projects converted to operations.

Construction Activity

The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

			Three Months Ended
			March 31, 2017			March 31, 2016
	Development projects:
		Triple-net		$	157,460		$	-
		Seniors housing operating			3,634			-
		Outpatient medical			25,910			35,363
	Total development projects				187,004			35,363
Total construction in progress conversions				$	187,004		$	35,363

XML

Real Estate Intangibles

3 Months Ended

Mar. 31, 2017

Real Estate Intangibles [Abstract]

Real Estate Intangibles

4. Real Estate Intangibles

     The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

		March 31, 2017		December 31, 2016
Assets:
	In place lease intangibles	$	1,267,280	$	1,252,143
	Above market tenant leases		63,184		61,700
	Below market ground leases		62,224		61,628
	Lease commissions		28,589		27,413
	Gross historical cost		1,421,277		1,402,884
	Accumulated amortization		(1,010,364)		(966,714)
	Net book value	$	410,913	$	436,170
	Weighted-average amortization period in years		14.4		13.7
Liabilities:
	Below market tenant leases	$	90,745	$	89,468
	Above market ground leases		8,107		8,107
	Gross historical cost		98,852		97,575
	Accumulated amortization		(54,354)		(52,134)
	Net book value	$	44,498	$	45,441
	Weighted-average amortization period in years		15.1		15.2

The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended
	March 31,
	2017		2016
Rental income related to above/below market tenant leases, net	$	304	$	81
Property operating expenses related to above/below market ground leases, net		(312)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(39,302)		(34,454)

     The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

		Assets		Liabilities
2017	$	105,454	$	4,959
2018		77,561		6,106
2019		37,948		5,685
2020		24,169		5,208
2021		20,191		4,720
Thereafter		145,590		17,820
Total	$	410,913	$	44,498

XML

Dispositions, Assets Held for Sale and Discontinued Operations

3 Months Ended

Mar. 31, 2017

Disclosure Dispositions, Assets Held for Sale and Discontinued Operations [Abstract]

Dispositions, Assets Held for Sale and Discontinued Operations

5. Dispositions, Assets Held for Sale and Discontinued Operations

We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (e.g., property type, operator or geography). During the three months ended March 31, 2017 and 2016, we recorded impairment charges on certain held-for-sale seniors housing operating and outpatient medical properties as the fair values less estimated costs to sell exceeded our carrying values. The following is a summary of our real property disposition activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2017			March 31, 2016
Real estate dispositions:
	Triple-net		$	808,204		$	-
	Seniors housing operating			13,845			-
	Total dispositions			822,049			-
Gain (loss) on real estate dispositions, net				244,092			-
	Net other assets/liabilities disposed			20,933			-
Proceeds from real estate dispositions			$	1,087,074		$	-

Dispositions and Assets Held for Sale

Pursuant to our adoption of ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”, operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2017		2016
Revenues:
	Rental income	$	16,734	$	5,477
Expenses:
	Interest expense		1,301		851
	Property operating expenses		1,855		1,362
	Provision for depreciation		245		820
	Total expenses		3,401		3,033
Income (loss) from real estate dispositions, net		$	13,333	$	2,444

XML

Real Estate Loans Receivable

3 Months Ended

Mar. 31, 2017

Real Estate Loans Receivable [Abstract]

Real Estate Loans Receivable

Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for discussion of our accounting policies for real estate loans receivable and related interest income.

The following is a summary of our real estate loan activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2017						March 31, 2016
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	7,828	$	-	$	7,828	$	8,013	$	-	$	8,013
	Draws on existing loans		17,547		-		17,547		19,206		32		19,238
	Net cash advances on real estate loans		25,375		-		25,375		27,219		32		27,251
Receipts on real estate loans receivable:
	Loan payoffs		14,474		60,500		74,974		104,068		12,290		116,358
	Principal payments on loans		667		-		667		3,107		-		3,107
	Sub-total		15,141		60,500		75,641		107,175		12,290		119,465
	Less: Non-cash activity(1)(2)		(6,349)		(60,500)		(66,849)		(25,691)		-		(25,691)
	Net cash receipts on real estate loans		8,792		-		8,792		81,484		12,290		93,774
Net cash advances (receipts) on real estate loans			16,583		-		16,583		(54,265)		(12,258)		(66,523)
Change in balance due to foreign currency translation			1,718		-		1,718		(1,987)		-		(1,987)
Net change in real estate loans receivable		$	11,952	$	(60,500)	$	(48,548)	$	(81,943)	$	(12,258)	$	(94,201)
(1) Triple-net represents acquisitions of assets previously financed as real estate loans. Please see Note 3 for additional information.
(2) Outpatient medical represents a deed in lieu of foreclosure on a previously financed first mortgage property.

In 2016, we restructured two existing real estate loans in the triple-net segment with Genesis Healthcare. The two existing loans, with a combined principal balance of $317,000,000, were scheduled to mature in 2017 and 2018. These loans were restructured into four separate loans effective October 1, 2016. Each loan has a five-year term, a 10% interest rate and 25 basis point annual escalator. In 2016, we recorded a loan loss charge in the amount of $6,935,000 on one of the loans as the present value of expected future cash flows was less than the carrying value of the loan. We expect to collect all principal amounts due under the loans and, due to the passage of time, at March 31, 2017, the allowance for loan losses related to these loans is $6,196,000. At March 31, 2017, we had no real estate loans with outstanding balances on non-accrual status and recorded no provision for loan losses during the three months ended March 31, 2017.

		Three Months Ended
	March 31, 2017		March 31, 2016
Balance of impaired loans at end of period	$	317,049	$	-
Allowance for loan losses		6,196		-
Balance of impaired loans not reserved	$	310,853	$	-
Average impaired loans for the period	$	340,920	$	-
Interest recognized on impaired loans(1)		8,243		-
(1) Represents interest recognized in period since loans were identified as impaired.

XML

Investments in Unconsolidated Entities

3 Months Ended

Mar. 31, 2017

Investments In Unconsolidated Entities [Abstract]

Investments in Unconsolidated Entities

7. Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands):

	Percentage Ownership(1)	March 31, 2017		December 31, 2016
Triple-net	10% to 49%	$	23,108	$	27,005
Seniors housing operating	10% to 50%		360,260		407,172
Outpatient medical	43%		32,742		22,961
Total		$	416,110	$	457,138
(1) Excludes ownership of in-substance real estate.

At March 31, 2017, the aggregate unamortized basis difference of our joint venture investments of $211,268,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the entity. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.

XML

Credit Concentration

3 Months Ended

Mar. 31, 2017

Customer Concentration [Abstract]

Credit Concentration

8. Credit Concentration

We use net operating income from continuing operations (“NOICO”) as our credit concentration metric. See Note 17 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the three months ended March 31, 2017, excluding our share of NOICO in unconsolidated entities (dollars in thousands):

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOICO		NOICO(2)
	Genesis Healthcare	86	$	49,048	9%
	Sunrise Senior Living(3)	153		74,893	14%
	Brookdale Senior Living	137		38,372	7%
	Revera(3)	98		37,802	7%
	Benchmark Senior Living	48		22,614	4%
	Remaining portfolio	755		329,400	59%
	Totals	1,277	$	552,129	100%
(1) Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.
(2) NOICO with our top five relationships comprised 45% of total NOICO for the year ending December 31, 2016.
(3) Revera owns a controlling interest in Sunrise Senior Living.

XML

Borrowings Under Credit Facilities and Related Items

3 Months Ended

Mar. 31, 2017

Borrowings Under Credit Facilities and Related Items [Abstract]

Borrowings Under Credit Facilities and Related Items

9. Borrowings Under Credit Facilities and Related Items

At March 31, 2017, we had a primary unsecured credit facility with a consortium of 29 banks that includes a $3,000,000,000 unsecured revolving credit facility, a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at March 31, 2017). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate (1.88% atMarch 31, 2017). The applicable margin is based on certain of our debt ratings and was 0.90% at March 31, 2017. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on certain of our debt ratings and was 0.15% atMarch 31, 2017. The term credit facilities mature on May 13, 2021. The revolving credit facility is scheduled to mature on May 13, 2020 and can be extended for two successive terms of six months each at our option.

The following information relates to aggregate borrowings under the primary unsecured revolving credit facility for the periods presented (dollars in thousands):

		Three Months Ended March 31,
		2017		2016
Balance outstanding at quarter end(1)		$	522,000	$	645,000
Maximum amount outstanding at any month end		$	1,010,000	$	945,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	796,356	$	671,044
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.81%		1.29%
(1) As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Senior Unsecured Notes and Secured Debt

3 Months Ended

Mar. 31, 2017

Senior Unsecured Notes and Secured Debt [Abstract]

Senior Unsecured Notes and Secured Debt

10. Senior Unsecured Notes and Secured Debt

We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.At March 31, 2017, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2017	$	-	$	284,879	$	284,879
2018		450,000		421,751		871,751
2019		605,000		499,895		1,104,895
2020(4)		675,208		149,888		825,096
2021(5,6)		1,137,674		228,993		1,366,667
Thereafter(7,8,9,10)		5,416,385		1,080,071		6,496,456
Totals	$	8,284,267	$	2,665,477	$	10,949,744
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.6% to 6.5%.
(3) Annual interest rates range from 1.32% to 7.93%. Carrying value of the properties securing the debt totaled $4,947,646,000 at March 31, 2017.
(4) In November 2015, one of our wholly-owned subsidiaries issued and we guaranteed $300,000,000 of Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $225,208,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017).
(5) On May 13, 2016, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $187,674,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017). The loan matures on May 13, 2021 and bears interest at the Canadian Dealer Offered Rate plus 95 basis points (1.84% at March 31, 2017).
(6) On May 13, 2016, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on May 13, 2021 and bears interest at LIBOR plus 95 basis points (1.83% at March 31, 2017).
(7) On November 20, 2013, we completed the sale of £550,000,000 (approximately $689,535,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.8% senior unsecured notes due 2028.
(8) On November 25, 2014, we completed the sale of £500,000,000 (approximately $626,850,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.5% senior unsecured notes due 2034.
(9) In May 2015, we issued $750,000,000 of 4.0% senior unsecured notes due 2025. In October 2015, we issued an additional $500,000,000 of these notes under a re-opening of the offer.
(10) In March 2016, we issued $700,000,000 of 4.25% senior unsecured notes due 2026.

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Three Months Ended
	March 31, 2017			March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	8,260,038	4.245%	$	8,645,758	4.237%
Debt issued		-	0.000%		700,000	4.250%
Debt extinguished		-	0.000%		(400,000)	3.625%
Foreign currency		24,229	4.391%		(11,665)	3.943%
Ending balance	$	8,284,267	4.262%	$	8,934,093	4.266%

The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands):

	Three Months Ended
		March 31, 2017		March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	3,465,066	4.094%	$	3,478,207	4.440%
Debt issued		12,536	2.340%		75,136	3.060%
Debt extinguished		(806,189)	5.580%		(111,701)	4.450%
Principal payments		(16,249)	4.469%		(18,642)	4.539%
Foreign currency		10,313	3.262%		65,488	3.669%
Ending balance	$	2,665,477	3.744%	$	3,488,488	4.400%

Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintaincertain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2017, we were in compliance with all of the covenants under our debt agreements.

XML

Derivative Instruments

3 Months Ended

Mar. 31, 2017

Summary of Derivative Instruments [Abstract]

Derivative Instruments

11. Derivative Instruments

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to manage the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. In addition, non-U.S. investments expose us to the potential losses associated with adverse changes in foreign currency to U.S. Dollar exchange rates. We may elect to manage this risk through the use of forward contracts and issuing debt in foreign currencies.

Interest Rate Swap Contracts and Foreign Currency Forward Contracts Designated as Cash Flow Hedges

For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”), and reclassified into earnings in the same period or periods, during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings. Approximately $3,395,000 of gains, which are included in accumulated other comprehensive income (“AOCI”), are expected to be reclassified into earnings in the next 12 months.

Foreign Currency Hedges

For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI. During the threemonths ended March 31, 2017and 2016, we settled certain net investment hedges generating cash proceeds of $8,218,000 and $0, respectively.  The balance of the cumulative translation adjustment will be reclassified to earnings when the hedged investment is sold or substantially liquidated.

The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands):

		March 31, 2017		December 31, 2016
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	875,000	$	900,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars	$	-	$	57,000
Denominated in Canadian Dollars	$	72,000	$	54,000
Denominated in Pounds Sterling	£	69,000	£	48,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	37,000	$	37,000

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended
		March 31,
	Location		2017		2016
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense	$	-	$	(483)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,457		(1,327)
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		(44,341)		(2,739)

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2017

Commitments and Contingencies [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

At March 31, 2017, we had 14 outstanding letter of credit obligations totaling $169,961,000 and expiring between 2017 and 2024. At March 31, 2017, we had outstanding construction in progress of $390,180,000 and were committed to providing additional funds of approximately $466,031,000 to complete construction. At March 31, 2017, we had contingent purchase obligations totaling $17,058,000. These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property. 

     We evaluate our leases for operating versus capital lease treatment in accordance with ASC Topic 840 “Leases.”  A lease is classified as a capital lease if it provides for transfer of ownership of the leased asset at the end of the lease term, contains a bargain purchase option, has a lease term greater than 75% of the economic life of the leased asset, or if the net present value of the future minimum lease payments are in excess of 90% of the fair value of the leased asset. Certain leases contain bargain purchase options and have been classified as capital leases. At March 31, 2017, we had operating lease obligations of $1,092,169,000 relating to certain ground leases and company office space and capital lease obligations of $93,697,000 relating primarily to certain investment properties. Regarding ground leases, we have sublease agreements with certain of our operators that require the operators to reimburse us for our monthly operating lease obligations. At March 31, 2017, aggregate future minimum rentals to be received under these noncancelable subleases totaled $73,840,000.

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2017

Stockholders' Equity [Abstract]

Stockholders' Equity

13. Stockholders’ Equity

     The following is a summary of our stockholders’ equity capital accounts as of the dates indicated:

	March 31, 2017	December 31, 2016
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	14,375,000	25,875,000
Outstanding shares	14,375,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	365,651,576	363,576,924
Outstanding shares	364,563,653	362,602,173

Preferred Stock. The following is a summary of our preferred stock activity during the periods indicated:

	Three Months Ended
	March 31, 2017		March 31, 2016
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	25,875,000	6.500%
Shares redeemed	(11,500,000)	6.500%	-	0.000%
Ending balance	14,375,000	6.500%	25,875,000	6.500%

During the three months ended March 31, 2017, we recognized a charge of $9,769,000 in connection with the redemption of the Series J preferred stock.

Common Stock. The following is a summary of our common stock issuances during the three months ended March 31, 2017 and 2016 (dollars in thousands, except per share amounts):

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2016 Dividend reinvestment plan issuances	1,058,085	$	60.00	$	63,484	$	63,484
2016 Option exercises	9,864		21.29		210		210
2016 Equity shelf program issuances	443,096		67.12		30,192		29,739
2016 Stock incentive plans, net of forfeitures	484,005				-		-
2016 Totals	1,995,050			$	93,886	$	93,433
2017 Dividend reinvestment plan issuances	1,284,719	$	68.33	$	87,985	$	87,784
2017 Option exercises	156,675		52.71		8,258		8,258
2017 Equity shelf program issuances	338,486		69.75		23,776		23,609
2017 Stock incentive plans, net of forfeitures	181,600				-		-
2017 Totals	1,961,480			$	120,019	$	119,651

Dividends. The increase in dividends is primarily attributable to increases in our common shares outstanding as described above and an increase in common dividends per share. The following is a summary of our dividend payments (in thousands, except per share amounts):

	Three Months Ended
	March 31, 2017				March 31, 2016
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8700	$	315,415	$	0.8600	$	305,770
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.2347		2,699		0.4064		4,672
Totals			$	329,794			$	322,122

Accumulated Other Comprehensive Income. The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2016	$	(173,496)	$	5,120	$	(1,153)	$	(2)	$	(169,531)
Other comprehensive income before reclassification adjustments		2,900		(10,569)		-		-		(7,669)
Net current-period other comprehensive income		2,900		(10,569)		-		-		(7,669)
Balance at March 31, 2017	$	(170,596)	$	(5,449)	$	(1,153)	$	(2)	$	(177,200)
Balance at December 31, 2015	$	(85,484)	$	-	$	(1,343)	$	(1,416)	$	(88,243)
Other comprehensive income before reclassification adjustments		(13,746)		(7,549)		2		-		(21,293)
Reclassification amount to net income		-		-		-		483 (1)		483
Net current-period other comprehensive income		(13,746)		(7,549)		2		483		(20,810)
Balance at March 31, 2016	$	(99,230)	$	(7,549)	$	(1,341)	$	(933)	$	(109,053)
(1) Please see Note 11 for additional information.

XML

Stock Incentive Plans

3 Months Ended

Mar. 31, 2017

Stock Incentive Plans [Abstract]

Stock Incentive Plans

14. Stock Incentive Plans

Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $4,906,000for the three months ended March 31, 2017and $8,186,000 for the same period in 2016.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share

15. Earnings Per Share

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

		Three Months Ended
		March 31,
		2017		2016
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	312,639	$	148,969
Denominator for basic earnings per
	share - weighted average shares		362,534		355,076
Effect of dilutive securities:
	Employee stock options		70		101
	Non-vested restricted shares		397		253
	Redeemable shares		1,651		621
Dilutive potential common shares			2,118		975
Denominator for diluted earnings per
	share - adjusted weighted average shares		364,652		356,051
Basic earnings per share		$	0.86	$	0.42
Diluted earnings per share		$	0.86	$	0.42

The Series I Cumulative Convertible Perpetual Preferred Stock was not included in the calculations as the effect of conversions into common stock was anti-dilutive.

XML

Disclosure about Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2017

Disclosure About Fair Value of Financial Instruments [Abstract]

Disclosure about Fair Value of Financial Instruments

16. Disclosure about Fair Value of Financial Instruments

U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities. The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016 for additional information.The guidance describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.

Cash and Cash Equivalents — The carrying amount approximates fair value.

Available-for-sale Equity Investments — Available-for-sale equity investments are recorded at their fair value based on Level 1 publicly available trading prices.

Borrowings Under Primary Unsecured Credit Facility — The carrying amount of the primary unsecured credit facility approximates fair value because the borrowings are interest rate adjustable.

Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable.

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable.

Foreign Currency Forward Contracts — Foreign currency forward contracts are recorded in other assets or other liabilities on the balance sheet at fair market value. Fair market value is determined using Level 2 inputs by estimating the future value of the currency pair based on existing exchange rates, comprised of current spot and traded forward points, and calculating a present value of the net amount using a discount factor based on observable traded interest rates.

Redeemable OP Unitholder Interests — Our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances.

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

		March 31, 2017				December 31, 2016
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	430,607	$	465,548	$	485,735	$	521,773
	Other real estate loans receivable		143,473		149,151		136,893		138,050
	Available-for-sale equity investments		17,330		17,330		27,899		27,899
	Cash and cash equivalents		380,360		380,360		419,378		419,378
	Foreign currency forward contracts		110,439		110,439		135,561		135,561
Financial liabilities:
	Borrowings under unsecured credit facilities	$	522,000	$	522,000	$	645,000	$	645,000
	Senior unsecured notes		8,188,928		8,965,318		8,161,619		8,879,176
	Secured debt		2,669,787		2,728,171		3,477,699		3,558,378
	Foreign currency forward contracts		9,840		9,840		4,342		4,342
Redeemable OP unitholder interests		$	116,917	$	116,917	$	110,502	$	110,502

Items Measured at Fair Value on a Recurring Basis

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements as of March 31, 2017
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	17,330	$	17,330	$	-	$	-
Foreign currency forward contracts, net(2)		100,599		-		100,599		-
Redeemable OP unitholder interests		116,917		-		116,917		-
Totals	$	234,846	$	17,330	$	217,516	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 6 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value.We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of secured debt assumed in business combinations using current interest rates at which similar borrowings could be obtained on the transaction date.

XML

Segment Reporting

3 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Segment Reporting

17. Segment Reporting

We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: triple-net, seniors housing operating and outpatient medical. During the three months ended December 31, 2016, we reclassified interest expense on our foreign-denominated senior notes from the seniors housing operating segment to non-segment. Accordingly, the segment information provided in this Note has been reclassified to conform to the current presentation for all periods presented.

Our triple-net properties include long-term/post-acute care facilities, assisted living facilities, independent living/continuing care retirement communities, care homes (United Kingdom), independent support living facilities (Canada), care homes with nursing (United Kingdom) and combinations thereof. Under the triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our seniors housing operating properties include the seniors housing communities referenced above that are owned and/or operated through RIDEA structures (see Notes 3 and 18). Our outpatient medical properties are typically leased to multiple tenants and generally require a certain level of property management.

We evaluate performance based upon net operating income from continuing operations (“NOICO”) of each segment. We define NOICO as total revenues, including tenant reimbursements, less property operating expenses. We believe NOICO provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOICO to make decisions about resource allocations and to assess the property level performance of our properties.

Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOICO.The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. There are no intersegment sales or transfers.Summary information for the reportable segments (which excludes unconsolidated entities) is as follows(in thousands):

Three Months Ended March 31, 2017:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	227,290	$	-	$	139,851	$	-	$	367,141
Resident fees and services		-		670,337		-		-		670,337
Interest income		20,679		69		-		-		20,748
Other income		1,766		1,461		612		233		4,072
Total revenues		249,735		671,867		140,463		233		1,062,298
Property operating expenses		-		462,425		47,744		-		510,169
Net operating income from continuing operations		249,735		209,442		92,719		233		552,129
Interest expense		5,511		15,816		2,291		94,979		118,597
Loss (gain) on derivatives, net		1,224		-		-		-		1,224
Depreciation and amortization		59,608		119,737		48,931		-		228,276
General and administrative		-		-		-		31,101		31,101
Loss (gain) on extinguishment of debt, net		29,084		890		1,382		-		31,356
Impairment of assets		-		5,406		5,625		-		11,031
Other expenses		5,010		1,778		360		4,527		11,675
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		149,298		65,815		34,130		(130,374)		118,869
Income tax (expense) benefit		(800)		(1,087)		(335)		(23)		(2,245)
Income (loss) from unconsolidated entities		5,638		(29,191)(1)		447		-		(23,106)
Income (loss) from continuing operations		154,136		35,537		34,242		(130,397)		93,518
Gain (loss) on real estate dispositions, net		231,081		13,011		-		-		244,092
Net income (loss)	$	385,217	$	48,548	$	34,242	$	(130,397)	$	337,610
Total assets	$	9,906,585	$	12,646,321	$	4,947,544	$	266,827	$	27,767,277
(1) Primarily due to the recognition of goodwill and intangible asset impairments, as well as non-recurring income tax expense.

Three Months Ended March 31, 2016:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	283,825	$	-	$	131,838	$	-	$	415,663
Resident fees and services		-		602,149		-		-		602,149
Interest income		22,853		1,031		1,304		-		25,188
Other income		1,490		2,189		313		58		4,050
Total revenues		308,168		605,369		133,455		58		1,047,050
Property operating expenses		-		408,894		40,742		-		449,636
Net operating income from continuing operations		308,168		196,475		92,713		58		597,414
Interest expense		6,364		20,523		5,744		100,329		132,960
Depreciation and amortization		79,800		101,832		47,064		-		228,696
General and administrative		-		-		-		45,691		45,691
Transaction costs		2,852		3,933		1,423		-		8,208
Loss (gain) on extinguishment of debt, net		(24)		-		-		-		(24)
Impairment of assets		14,314		-		-		-		14,314
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		204,862		70,187		38,482		(145,962)		167,569
Income tax (expense) benefit		(317)		2,767		(228)		(497)		1,725
Income (loss) from unconsolidated entities		3,081		(6,935)		34		-		(3,820)
Income (loss) from continuing operations		207,626		66,019		38,288		(146,459)		165,474
Net income (loss)	$	207,626	$	66,019	$	38,288	$	(146,459)	$	165,474

Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands):

		Three Months Ended
		March 31, 2017			March 31, 2016
Revenues:		Amount	%		Amount	%
United States	$	858,668	80.9%	$	842,357	80.5%
United Kingdom		93,843	8.8%		100,555	9.6%
Canada		109,787	10.3%		104,138	9.9%
Total	$	1,062,298	100.0%	$	1,047,050	100.0%
		As of
		March 31, 2017			December 31, 2016
Assets:		Amount	%		Amount	%
United States	$	22,425,964	80.8%	$	23,572,459	81.7%
United Kingdom		2,835,782	10.2%		2,782,489	9.6%
Canada		2,505,531	9.0%		2,510,236	8.7%
Total	$	27,767,277	100.0%	$	28,865,184	100.0%

XML

Income Taxes and Distributions

3 Months Ended

Mar. 31, 2017

Income Taxes And Distributions [Abstract]

Income Taxes And Distributions

18. Income Taxes and Distributions

We elected to be taxed as a REIT commencing with our first taxable year.To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes.

Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.”  A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years.

     Income taxes reflected in the financial statements primarily represents U.S. federal and state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the three months ended March 31, 2017 and 2016, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and all of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service (“IRS”) for the year ended December 31, 2013 and subsequent years and by state taxing authorities for the year ended December 31, 2012 and subsequent years.  The company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada in May 2012, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom in August 2012 and by Luxembourg taxing authorities generally for periods subsequent to our establishment of certain Luxembourg-based subsidiaries during 2014.

XML

Variable Interest Entity Disclosure

3 Months Ended

Mar. 31, 2017

Variable Interest Entity Disclosure [Abstract]

Variable Interest Entity Disclosure [Text Block]

19. Variable Interest Entities

We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be variable interest entities (“VIE”). We have concluded that we are the primary beneficiary of these VIE’s based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such joint ventures have been consolidated, andthe table below summarizes the balance sheets of consolidated VIE’s in the aggregate (in thousands):

		March 31, 2017		December 31, 2016
Assets
	Net real property owned	$	980,570	$	989,596
	Cash and cash equivalents		7,390		10,501
	Receivables and other assets		16,530		12,102
	Total assets(1)	$	1,004,490	$	1,012,199
Liabilities and equity
	Secured debt	$	449,163	$	450,255
	Accrued expenses and other liabilities		13,880		13,803
	Redeemable noncontrolling interests		72,957		185,556
	Total equity		468,490		362,585
	Total liabilities and equity	$	1,004,490	$	1,012,199
(1) Note that assets of the consolidated variable interest entities can only be used to settle obligations relating to such variable interest entities. Liabilities of the consolidated variable interest entities represent claims against the specific assets of the variable interest entities.

XML

Accounting Policies and Related Matters (Policies)

3 Months Ended

Mar. 31, 2017

Accounting Policies and Related Matters (Policies) [Abstract]

Basis of Presentation

2. Accounting Policies and Related Matters

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily an indication of the results that may be expected for the year ending December 31, 2017. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.

New Accounting Standards

New Accounting Standards

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted beginning after December 15, 2016. A reporting entity may apply the new standard using either a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or a full retrospective approach. We are currently evaluating the impact that the adoption of the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the new standard. A significant source of our revenue is generated through leasing arrangements, which are specifically excluded from the new standard. We expect that the new standard will affect our accounting policies related to non-lease revenue, including certain fees in our RIDEA joint ventures, common area maintenance in our outpatient medical properties and real estate sales. Under ASU 2014-09, revenue recognition for real estate sales is mainly based on the transfer of control versus current guidance of continuing involvement. We expect that the new guidance will result in more transactions qualifying as sales of real estate and being recognized at an earlier date than under the current guidance.

In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which will require entities to measure their investments at fair value and recognize any changes in fair value in net income unless the investments qualify for the new practicability exception. The practicability exception will be available for equity investments that do not have readily determinable fair values. ASU 2016-01 is effective for fiscal years and interim periods within those years, beginning after December 15, 2017. We are currently evaluating the impact that the standard will have on our consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842),” which requires lessees to recognize assets and liabilities on their balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their income statements over the lease term. It will also require disclosures designed to give financial statement users information regarding amount, timing, and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. We are currently evaluating the impact of this standard on our consolidated financial statements. We believe that the adoption of this standard will likely have a material impact to our consolidated balance sheet for the recognition of certain operating leases as right-of-use assets and lease liabilities. We are in the process of analyzing our lease portfolio and evaluating systems to comply with the standard’s retrospective adoption requirements.

In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting”. ASU 2016-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted. We adopted ASU 2016-09 on January 1, 2017. The standard allows companies to make a policy election as to whether they will include an estimate of awards expected to be forfeited or whether they will account for forfeitures as they occur. We have elected to account for forfeitures as they occur. This election had an immaterial impact on our consolidated financial statements. The standard also requires an employer to classify as a financing activity in the statement of cash flow the cash paid to a tax authority when shares are withheld to satisfy the employer’s statutory income tax withholding obligation. This standard is required to be applied on a retrospective basis and resulted in an increase in net cash provided by operating activities and a decrease in net cash used in financing activities of $6,897,000 for the three months ended March 31, 2016. Upon adoption, no other provisions of ASU 2016-09 had an effect on our unaudited consolidated financial statements or related footnote disclosures.

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments”. This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018. We are currently evaluating the impact that the standard will have on our consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, “Clarifying the Definition of a Business”. This standard changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. ASU 2017-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is permitted. A reporting entity must apply ASU 2017-01 using a prospective approach. We adopted ASU 2017-01 on January 1, 2017 and as a result, have classified our real estate acquisitions completed during the three months ended March 31, 2017 as asset acquisitions rather than business combinations due to the fact that substantially all of the fair value of the gross assets acquired were concentrated in a single asset or group of similar identifiable assets. We have recorded identifiable assets acquired, liabilities assumed and any noncontrolling interests associated with any asset acquisitions at cost on a relative fair value basis and have capitalized transaction costs incurred.

XML

Real Property Acquisitions and Development (Tables)

3 Months Ended

Mar. 31, 2017

Real property acquisitions and development [Line Items]

Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities

Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,017		$	15,331
Buildings and improvements				37,241			114,235
Acquired lease intangibles				-			1,623
	Total assets acquired			41,258			131,189
Accrued expenses and other liabilities				-			(809)
	Total liabilities assumed			-			(809)
Non-cash acquisition related activity(1)				-			(28,621)
	Cash disbursed for acquisitions			41,258			101,759
Construction in progress additions				46,754			43,835
Less:	Capitalized interest			(2,028)			(1,684)
	Foreign currency translation			(164)			(583)
Cash disbursed for construction in progress				44,562			41,568
Capital improvements to existing properties				10,495			7,438
	Total cash invested in real property, net of cash acquired		$	96,315		$	150,765
(1) Includes $25,691,000 related to the acquisition of assets previously financed as real estate loans receivable and $2,871,000 related to the acquisition of assets previously financed as an investment in an unconsolidated entity.

Seniors Housing Operating Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	4,304		$	3,440
Building and improvements				44,075			48,218
Acquired lease intangibles				1,741			1,942
Receivables and other assets				74			36
	Total assets acquired(1)			50,194			53,636
Accrued expenses and other liabilities				(2,755)			(11)
	Total liabilities assumed			(2,755)			(11)
Noncontrolling interests				(647)			(549)
Non-cash acquisition related activity(2)				(14,148)			-
	Cash disbursed for acquisitions			32,644			53,076
Construction in progress additions				8,062			4,033
Less:	Capitalized interest			(1,707)			(565)
	Foreign currency translation			691			(1,107)
Cash disbursed for construction in progress				7,046			2,361
Capital improvements to existing properties				24,254			16,808
	Total cash invested in real property, net of cash acquired		$	63,944		$	72,245
(1) Excludes $400,000 and $113,000 of cash acquired during the three months ended March 31, 2017 and 2016, respectively.
(2) Includes $6,349,000 related to the acquisition of assets previously financed as real estate loans receivable and $7,799,000 previously financed as an investment in an unconsolidated entity.

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2017			March 31, 2016
Land and land improvements			$	2,895	$	-
Buildings and improvements				23,310		17,637
Acquired lease intangibles				3,496		-
Receivables and other assets				3		-
	Total assets acquired			29,704		17,637
Accrued expenses and other liabilities				(1,250)		(990)
	Total liabilities assumed			(1,250)		(990)
	Cash disbursed for acquisitions			28,454		16,647
Construction in progress additions				14,921		28,934
Less:	Capitalized interest			(717)		(788)
	Accruals(1)			3,522		(5,336)
Cash disbursed for construction in progress				17,726		22,810
Capital improvements to existing properties				7,366		10,779
	Total cash invested in real property		$	53,546	$	50,236
(1) Represents the change in non-cash consideration accruals for amounts to be paid in periods other than the period in which the construction projects converted to operations.

Summary of construction projects placed into service and generating revenues

			Three Months Ended
			March 31, 2017			March 31, 2016
	Development projects:
		Triple-net		$	157,460		$	-
		Seniors housing operating			3,634			-
		Outpatient medical			25,910			35,363
	Total development projects				187,004			35,363
Total construction in progress conversions				$	187,004		$	35,363

XML

Real Estate Intangibles (Tables)

3 Months Ended

Mar. 31, 2017

Real Estate Intangibles (Tables) [Abstract]

Summary of real estate intangibles excluding those classified as held for sale

		March 31, 2017		December 31, 2016
Assets:
	In place lease intangibles	$	1,267,280	$	1,252,143
	Above market tenant leases		63,184		61,700
	Below market ground leases		62,224		61,628
	Lease commissions		28,589		27,413
	Gross historical cost		1,421,277		1,402,884
	Accumulated amortization		(1,010,364)		(966,714)
	Net book value	$	410,913	$	436,170
	Weighted-average amortization period in years		14.4		13.7
Liabilities:
	Below market tenant leases	$	90,745	$	89,468
	Above market ground leases		8,107		8,107
	Gross historical cost		98,852		97,575
	Accumulated amortization		(54,354)		(52,134)
	Net book value	$	44,498	$	45,441
	Weighted-average amortization period in years		15.1		15.2

Schedule of Real Estate Intangible Amortization

	Three Months Ended
	March 31,
	2017		2016
Rental income related to above/below market tenant leases, net	$	304	$	81
Property operating expenses related to above/below market ground leases, net		(312)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(39,302)		(34,454)

Schedule of the future estimated aggregate amortization of intangible assets and liabilities

		Assets		Liabilities
2017	$	105,454	$	4,959
2018		77,561		6,106
2019		37,948		5,685
2020		24,169		5,208
2021		20,191		4,720
Thereafter		145,590		17,820
Total	$	410,913	$	44,498

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2017

Dispositions, Assets Held for Sale and Discontinued Operations (Tables) [Abstract]

Summary of real property disposition activity

		Three Months Ended
		March 31, 2017			March 31, 2016
Real estate dispositions:
	Triple-net		$	808,204		$	-
	Seniors housing operating			13,845			-
	Total dispositions			822,049			-
Gain (loss) on real estate dispositions, net				244,092			-
	Net other assets/liabilities disposed			20,933			-
Proceeds from real estate dispositions			$	1,087,074		$	-

Summary of disposed properties.

			Three Months Ended
			March 31,
		2017		2016
Revenues:
	Rental income	$	16,734	$	5,477
Expenses:
	Interest expense		1,301		851
	Property operating expenses		1,855		1,362
	Provision for depreciation		245		820
	Total expenses		3,401		3,033
Income (loss) from real estate dispositions, net		$	13,333	$	2,444

XML

Real Estate Loans Receivable (Tables)

3 Months Ended

Mar. 31, 2017

Real Estate Loans Receivable (Tables) [Abstract]

Summary of real estate loan activity

		Three Months Ended
		March 31, 2017						March 31, 2016
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	7,828	$	-	$	7,828	$	8,013	$	-	$	8,013
	Draws on existing loans		17,547		-		17,547		19,206		32		19,238
	Net cash advances on real estate loans		25,375		-		25,375		27,219		32		27,251
Receipts on real estate loans receivable:
	Loan payoffs		14,474		60,500		74,974		104,068		12,290		116,358
	Principal payments on loans		667		-		667		3,107		-		3,107
	Sub-total		15,141		60,500		75,641		107,175		12,290		119,465
	Less: Non-cash activity(1)(2)		(6,349)		(60,500)		(66,849)		(25,691)		-		(25,691)
	Net cash receipts on real estate loans		8,792		-		8,792		81,484		12,290		93,774
Net cash advances (receipts) on real estate loans			16,583		-		16,583		(54,265)		(12,258)		(66,523)
Change in balance due to foreign currency translation			1,718		-		1,718		(1,987)		-		(1,987)
Net change in real estate loans receivable		$	11,952	$	(60,500)	$	(48,548)	$	(81,943)	$	(12,258)	$	(94,201)
(1) Triple-net represents acquisitions of assets previously financed as real estate loans. Please see Note 3 for additional information.
(2) Outpatient medical represents a deed in lieu of foreclosure on a previously financed first mortgage property.

		Three Months Ended
	March 31, 2017		March 31, 2016
Balance of impaired loans at end of period	$	317,049	$	-
Allowance for loan losses		6,196		-
Balance of impaired loans not reserved	$	310,853	$	-
Average impaired loans for the period	$	340,920	$	-
Interest recognized on impaired loans(1)		8,243		-
(1) Represents interest recognized in period since loans were identified as impaired.

XML

Investments in Unconsolidated Entities (Tables)

3 Months Ended

Mar. 31, 2017

Investments In Unconsolidated Entities [Abstract]

Summary Of Investments In Unconsolidated Entities [Text Block]

	Percentage Ownership(1)	March 31, 2017		December 31, 2016
Triple-net	10% to 49%	$	23,108	$	27,005
Seniors housing operating	10% to 50%		360,260		407,172
Outpatient medical	43%		32,742		22,961
Total		$	416,110	$	457,138
(1) Excludes ownership of in-substance real estate.

XML

Credit Concentration (Tables)

3 Months Ended

Mar. 31, 2017

Customer Concentration (Tables) [Abstract]

Summary of credit concentration

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOICO		NOICO(2)
	Genesis Healthcare	86	$	49,048	9%
	Sunrise Senior Living(3)	153		74,893	14%
	Brookdale Senior Living	137		38,372	7%
	Revera(3)	98		37,802	7%
	Benchmark Senior Living	48		22,614	4%
	Remaining portfolio	755		329,400	59%
	Totals	1,277	$	552,129	100%
(1) Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.
(2) NOICO with our top five relationships comprised 45% of total NOICO for the year ending December 31, 2016.
(3) Revera owns a controlling interest in Sunrise Senior Living.

XML

Borrowings Under Credit Facilities and Related Items (Tables)

3 Months Ended

Mar. 31, 2017

Borrowings Under Credit Facilities and Related Items (Tables) [Abstract]

Aggregate borrowings under the unsecured line of credit arrangements

		Three Months Ended March 31,
		2017		2016
Balance outstanding at quarter end(1)		$	522,000	$	645,000
Maximum amount outstanding at any month end		$	1,010,000	$	945,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	796,356	$	671,044
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.81%		1.29%
(1) As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Senior Unsecured Notes and Secured Debt (Tables)

3 Months Ended

Mar. 31, 2017

Senior Unsecured Notes And Secured Debt (Tables) [Abstract]

Principal payments due on debt obligations

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2017	$	-	$	284,879	$	284,879
2018		450,000		421,751		871,751
2019		605,000		499,895		1,104,895
2020(4)		675,208		149,888		825,096
2021(5,6)		1,137,674		228,993		1,366,667
Thereafter(7,8,9,10)		5,416,385		1,080,071		6,496,456
Totals	$	8,284,267	$	2,665,477	$	10,949,744
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.6% to 6.5%.
(3) Annual interest rates range from 1.32% to 7.93%. Carrying value of the properties securing the debt totaled $4,947,646,000 at March 31, 2017.
(4) In November 2015, one of our wholly-owned subsidiaries issued and we guaranteed $300,000,000 of Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $225,208,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017).
(5) On May 13, 2016, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $187,674,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017). The loan matures on May 13, 2021 and bears interest at the Canadian Dealer Offered Rate plus 95 basis points (1.84% at March 31, 2017).
(6) On May 13, 2016, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on May 13, 2021 and bears interest at LIBOR plus 95 basis points (1.83% at March 31, 2017).
(7) On November 20, 2013, we completed the sale of £550,000,000 (approximately $689,535,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.8% senior unsecured notes due 2028.
(8) On November 25, 2014, we completed the sale of £500,000,000 (approximately $626,850,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.5% senior unsecured notes due 2034.
(9) In May 2015, we issued $750,000,000 of 4.0% senior unsecured notes due 2025. In October 2015, we issued an additional $500,000,000 of these notes under a re-opening of the offer.
(10) In March 2016, we issued $700,000,000 of 4.25% senior unsecured notes due 2026.

Summary of senior unsecured note activity

	Three Months Ended
	March 31, 2017			March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	8,260,038	4.245%	$	8,645,758	4.237%
Debt issued		-	0.000%		700,000	4.250%
Debt extinguished		-	0.000%		(400,000)	3.625%
Foreign currency		24,229	4.391%		(11,665)	3.943%
Ending balance	$	8,284,267	4.262%	$	8,934,093	4.266%

Secured debt principal activity

	Three Months Ended
		March 31, 2017		March 31, 2016
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	3,465,066	4.094%	$	3,478,207	4.440%
Debt issued		12,536	2.340%		75,136	3.060%
Debt extinguished		(806,189)	5.580%		(111,701)	4.450%
Principal payments		(16,249)	4.469%		(18,642)	4.539%
Foreign currency		10,313	3.262%		65,488	3.669%
Ending balance	$	2,665,477	3.744%	$	3,488,488	4.400%

XML

Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2017

Derivative Instruments (Tables) [Abstract]

Impact of derivative instruments on the statement of operations and OCI

		March 31, 2017		December 31, 2016
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	875,000	$	900,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars	$	-	$	57,000
Denominated in Canadian Dollars	$	72,000	$	54,000
Denominated in Pounds Sterling	£	69,000	£	48,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	37,000	$	37,000

		Three Months Ended
		March 31,
	Location		2017		2016
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense	$	-	$	(483)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,457		(1,327)
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		(44,341)		(2,739)

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2017

Stockholders' Equity (Tables) [Abstract]

Summary of stockholder's equity capital accounts

	March 31, 2017	December 31, 2016
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	14,375,000	25,875,000
Outstanding shares	14,375,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	365,651,576	363,576,924
Outstanding shares	364,563,653	362,602,173

Summary of preferred stock activity

	Three Months Ended
	March 31, 2017		March 31, 2016
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	25,875,000	6.500%
Shares redeemed	(11,500,000)	6.500%	-	0.000%
Ending balance	14,375,000	6.500%	25,875,000	6.500%

Summary of common stock issuances

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2016 Dividend reinvestment plan issuances	1,058,085	$	60.00	$	63,484	$	63,484
2016 Option exercises	9,864		21.29		210		210
2016 Equity shelf program issuances	443,096		67.12		30,192		29,739
2016 Stock incentive plans, net of forfeitures	484,005				-		-
2016 Totals	1,995,050			$	93,886	$	93,433
2017 Dividend reinvestment plan issuances	1,284,719	$	68.33	$	87,985	$	87,784
2017 Option exercises	156,675		52.71		8,258		8,258
2017 Equity shelf program issuances	338,486		69.75		23,776		23,609
2017 Stock incentive plans, net of forfeitures	181,600				-		-
2017 Totals	1,961,480			$	120,019	$	119,651

Summary of dividend payments

	Three Months Ended
	March 31, 2017				March 31, 2016
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8700	$	315,415	$	0.8600	$	305,770
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.2347		2,699		0.4064		4,672
Totals			$	329,794			$	322,122

Summary of accumulated other comprehensive income/(loss)

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2016	$	(173,496)	$	5,120	$	(1,153)	$	(2)	$	(169,531)
Other comprehensive income before reclassification adjustments		2,900		(10,569)		-		-		(7,669)
Net current-period other comprehensive income		2,900		(10,569)		-		-		(7,669)
Balance at March 31, 2017	$	(170,596)	$	(5,449)	$	(1,153)	$	(2)	$	(177,200)
Balance at December 31, 2015	$	(85,484)	$	-	$	(1,343)	$	(1,416)	$	(88,243)
Other comprehensive income before reclassification adjustments		(13,746)		(7,549)		2		-		(21,293)
Reclassification amount to net income		-		-		-		483 (1)		483
Net current-period other comprehensive income		(13,746)		(7,549)		2		483		(20,810)
Balance at March 31, 2016	$	(99,230)	$	(7,549)	$	(1,341)	$	(933)	$	(109,053)
(1) Please see Note 11 for additional information.

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2017

Earnings Per Share (Tables) [Abstract]

Computation of basic and diluted earnings per share

		Three Months Ended
		March 31,
		2017		2016
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	312,639	$	148,969
Denominator for basic earnings per
	share - weighted average shares		362,534		355,076
Effect of dilutive securities:
	Employee stock options		70		101
	Non-vested restricted shares		397		253
	Redeemable shares		1,651		621
Dilutive potential common shares			2,118		975
Denominator for diluted earnings per
	share - adjusted weighted average shares		364,652		356,051
Basic earnings per share		$	0.86	$	0.42
Diluted earnings per share		$	0.86	$	0.42

XML

Disclosure about Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2017

Disclosure about Fair Value of Financial Instruments (Tables) [Abstract]

Carrying amounts and estimated fair values of financial instruments

		March 31, 2017				December 31, 2016
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	430,607	$	465,548	$	485,735	$	521,773
	Other real estate loans receivable		143,473		149,151		136,893		138,050
	Available-for-sale equity investments		17,330		17,330		27,899		27,899
	Cash and cash equivalents		380,360		380,360		419,378		419,378
	Foreign currency forward contracts		110,439		110,439		135,561		135,561
Financial liabilities:
	Borrowings under unsecured credit facilities	$	522,000	$	522,000	$	645,000	$	645,000
	Senior unsecured notes		8,188,928		8,965,318		8,161,619		8,879,176
	Secured debt		2,669,787		2,728,171		3,477,699		3,558,378
	Foreign currency forward contracts		9,840		9,840		4,342		4,342
Redeemable OP unitholder interests		$	116,917	$	116,917	$	110,502	$	110,502

The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis

	Fair Value Measurements as of March 31, 2017
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	17,330	$	17,330	$	-	$	-
Foreign currency forward contracts, net(2)		100,599		-		100,599		-
Redeemable OP unitholder interests		116,917		-		116,917		-
Totals	$	234,846	$	17,330	$	217,516	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

XML

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2017

Segment Reporting (Tables) [Abstract]

Summary of information for reportable segments

Three Months Ended March 31, 2017:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	227,290	$	-	$	139,851	$	-	$	367,141
Resident fees and services		-		670,337		-		-		670,337
Interest income		20,679		69		-		-		20,748
Other income		1,766		1,461		612		233		4,072
Total revenues		249,735		671,867		140,463		233		1,062,298
Property operating expenses		-		462,425		47,744		-		510,169
Net operating income from continuing operations		249,735		209,442		92,719		233		552,129
Interest expense		5,511		15,816		2,291		94,979		118,597
Loss (gain) on derivatives, net		1,224		-		-		-		1,224
Depreciation and amortization		59,608		119,737		48,931		-		228,276
General and administrative		-		-		-		31,101		31,101
Loss (gain) on extinguishment of debt, net		29,084		890		1,382		-		31,356
Impairment of assets		-		5,406		5,625		-		11,031
Other expenses		5,010		1,778		360		4,527		11,675
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		149,298		65,815		34,130		(130,374)		118,869
Income tax (expense) benefit		(800)		(1,087)		(335)		(23)		(2,245)
Income (loss) from unconsolidated entities		5,638		(29,191)(1)		447		-		(23,106)
Income (loss) from continuing operations		154,136		35,537		34,242		(130,397)		93,518
Gain (loss) on real estate dispositions, net		231,081		13,011		-		-		244,092
Net income (loss)	$	385,217	$	48,548	$	34,242	$	(130,397)	$	337,610
Total assets	$	9,906,585	$	12,646,321	$	4,947,544	$	266,827	$	27,767,277
(1) Primarily due to the recognition of goodwill and intangible asset impairments, as well as non-recurring income tax expense.

Three Months Ended March 31, 2016:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	283,825	$	-	$	131,838	$	-	$	415,663
Resident fees and services		-		602,149		-		-		602,149
Interest income		22,853		1,031		1,304		-		25,188
Other income		1,490		2,189		313		58		4,050
Total revenues		308,168		605,369		133,455		58		1,047,050
Property operating expenses		-		408,894		40,742		-		449,636
Net operating income from continuing operations		308,168		196,475		92,713		58		597,414
Interest expense		6,364		20,523		5,744		100,329		132,960
Depreciation and amortization		79,800		101,832		47,064		-		228,696
General and administrative		-		-		-		45,691		45,691
Transaction costs		2,852		3,933		1,423		-		8,208
Loss (gain) on extinguishment of debt, net		(24)		-		-		-		(24)
Impairment of assets		14,314		-		-		-		14,314
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		204,862		70,187		38,482		(145,962)		167,569
Income tax (expense) benefit		(317)		2,767		(228)		(497)		1,725
Income (loss) from unconsolidated entities		3,081		(6,935)		34		-		(3,820)
Income (loss) from continuing operations		207,626		66,019		38,288		(146,459)		165,474
Net income (loss)	$	207,626	$	66,019	$	38,288	$	(146,459)	$	165,474

		Three Months Ended
		March 31, 2017			March 31, 2016
Revenues:		Amount	%		Amount	%
United States	$	858,668	80.9%	$	842,357	80.5%
United Kingdom		93,843	8.8%		100,555	9.6%
Canada		109,787	10.3%		104,138	9.9%
Total	$	1,062,298	100.0%	$	1,047,050	100.0%
		As of
		March 31, 2017			December 31, 2016
Assets:		Amount	%		Amount	%
United States	$	22,425,964	80.8%	$	23,572,459	81.7%
United Kingdom		2,835,782	10.2%		2,782,489	9.6%
Canada		2,505,531	9.0%		2,510,236	8.7%
Total	$	27,767,277	100.0%	$	28,865,184	100.0%

XML

Variable Interest Entity Disclosure (Tables)

3 Months Ended

Mar. 31, 2017

Variable Interest Entity Disclosure [Abstract]

Schedule of Variable Interest Entities [Table Text Block]

		March 31, 2017		December 31, 2016
Assets
	Net real property owned	$	980,570	$	989,596
	Cash and cash equivalents		7,390		10,501
	Receivables and other assets		16,530		12,102
	Total assets(1)	$	1,004,490	$	1,012,199
Liabilities and equity
	Secured debt	$	449,163	$	450,255
	Accrued expenses and other liabilities		13,880		13,803
	Redeemable noncontrolling interests		72,957		185,556
	Total equity		468,490		362,585
	Total liabilities and equity	$	1,004,490	$	1,012,199
(1) Note that assets of the consolidated variable interest entities can only be used to settle obligations relating to such variable interest entities. Liabilities of the consolidated variable interest entities represent claims against the specific assets of the variable interest entities.

XML

Accounting Policies and Related Matters (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($)
Accounting Policies and Related Matters [Abstract]
Payments Related to Tax Withholding for Share-based Compensation	$ 6,897

XML

Real Property Acquisitions and Development (Details 1) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Triple Net [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements		$ 4,017	$ 15,331
Buildings and improvements		37,241	114,235
Acquired lease intangibles		0	1,623
Total assets acquired		41,258	131,189
Accrued expenses and other liabilities		0	(809)
Total liabilities assumed		0	(809)
Non-cash acquisition related activity	[1]	0	(28,621)
Cash disbursed for acquisitions		41,258	101,759
Construction in progress additions		46,754	43,835
Less: Capitalized Interest		(2,028)	(1,684)
Less: Foreign currency translation		(164)	(583)
Cash disbursed for construction in progress		44,562	41,568
Capital improvements to existing properties		10,495	7,438
Total cash invested in real property		96,315	150,765
Non Cash Acquisition Financed As Real Estate Loan Receivable		25,691
Non cash acquisition financed as equity investments		2,871
Senior housing - operating [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements		4,304	3,440
Buildings and improvements		44,075	48,218
Acquired lease intangibles		1,741	1,942
Receivables and other assets		74	36
Total assets acquired	[2]	50,194	53,636
Accrued expenses and other liabilities		(2,755)	(11)
Total liabilities assumed		(2,755)	(11)
Noncontrolling interests		(647)	(549)
Non-cash acquisition related activity	[3]	(14,148)	0
Cash disbursed for acquisitions		32,644	53,076
Construction in progress additions		8,062	4,033
Less: Capitalized Interest		(1,707)	(565)
Less: Foreign currency translation		691	(1,107)
Cash disbursed for construction in progress		7,046	2,361
Capital improvements to existing properties		24,254	16,808
Total cash invested in real property		63,944	72,245
Cash Acquired from Acquisition		400	113
Non Cash Acquisition Financed As Real Estate Loan Receivable		6,349
Non cash acquisition financed as equity investments		7,799
Outpatient Medical [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements		2,895	0
Buildings and improvements		23,310	17,637
Acquired lease intangibles		3,496	0
Receivables and other assets		3	0
Total assets acquired		29,704	17,637
Accrued expenses and other liabilities		(1,250)	(990)
Total liabilities assumed		(1,250)	(990)
Cash disbursed for acquisitions		28,454	16,647
Construction in progress additions		14,921	28,934
Less: Capitalized Interest		(717)	(788)
Less: Accruals	[4]	3,522	(5,336)
Cash disbursed for construction in progress		17,726	22,810
Capital improvements to existing properties		7,366	10,779
Total cash invested in real property		$ 53,546	$ 50,236

[1] Includes $25,691,000 related to the acquisition of assets previously financed as real estate loans receivable and $2,871,000 related to the acquisition of assets previously financed as an investment in an unconsolidated entity.

[2] Excludes $400,000 and $113,000 of cash acquired during the three months ended March 31, 2017 and 2016, respectively.

[3] Includes $6,349,000 related to the acquisition of assets previously financed as real estate loans receivable and $7,799,000 previously financed as an investment in an unconsolidated entity.

[4] Represents the change in non-cash consideration accruals for amounts to be paid in periods other than the period in which the construction projects converted to operations.

XML

Real Property Acquisitions and Development (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Development projects:
Total development projects	$ 187,004	$ 35,363
Total construction in progress conversions	187,004	35,363
Triple Net [Member]
Development projects:
Total development projects	157,460	0
Seniors housing operating [Member]
Development projects:
Total development projects	3,634	0
Outpatient Medical [Member]
Development projects:
Total development projects	$ 25,910	$ 35,363

XML

Real Estate Intangibles (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Intangible Assets:
Gross historical cost	$ 1,421,277	$ 1,402,884
Accumulated amortization	1,010,364	966,714
Net book value	$ 410,913	$ 436,170
Weighted-average amortization period in years	14 years 5 months	13 years 8 months
Intangible Liabilities:
Gross historical cost	$ 98,852	$ 97,575
Accumulated amortization	54,354	52,134
Net book value	$ 44,498	$ 45,441
Weighted-average amortization period in years	15 years 1 month	15 years 2 months
In place lease intangibles [Member]
Intangible Assets:
Gross historical cost	$ 1,267,280	$ 1,252,143
Above market tenant leases [Member]
Intangible Assets:
Gross historical cost	63,184	61,700
Below market ground leases [Member]
Intangible Assets:
Gross historical cost	62,224	61,628
Lease commissions [Member]
Intangible Assets:
Gross historical cost	28,589	27,413
Below market tenant leases [Member]
Intangible Liabilities:
Gross historical cost	90,745	89,468
Above market ground leases [Member]
Intangible Liabilities:
Gross historical cost	$ 8,107	$ 8,107

XML

Real Estate Intangibles (Real Estate Intangible Maturity Schedule) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
Totals	$ 410,913	$ 436,170
Intangible Liability [Member]
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
2017	4,959
2018	6,106
2019	5,685
2020	5,208
2021	4,720
Thereafter	17,820
Totals	44,498
Intangible Asset [Member]
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
2017	105,454
2018	77,561
2019	37,948
2020	24,169
2021	20,191
Thereafter	145,590
Totals	$ 410,913

XML

Real Estate Intangibles (Details 1) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Real Estate Intangible Amortization [Abstract]
Rental income related to above/below market tenant leases, net	$ 304	$ 81
Property operating expenses related to above/below market ground leases, net	(312)	(311)
Depreciation and amortization related to in place lease intangibles and lease commissions	$ (39,302)	$ (34,454)

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Real property dispositions:
Total dispositions	$ 822,049	$ 0
Gain Loss On Sale Of Properties	244,092	0
Net other assets/liabilities disposed	20,933	0
Proceeds from sales of real property	1,087,074	0
Triple Net [Member]
Real property dispositions:
Total dispositions	808,204	0
Senior housing - operating [Member]
Real property dispositions:
Total dispositions	$ 13,845	$ 0

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues:
Rental income, disposed	$ 16,734	$ 5,477
Expenses:
Interest expense, disposed	1,301	851
Property operating expenses, disposed	1,855	1,362
Depreciation expense, disposed	245	820
Expenses, disposed	3,401	3,033
Income (loss) from disposed properties	$ 13,333	$ 2,444

XML

Real Estate Loans Receivable (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Advances on real estate loans receivable:
Investments in new loans		$ 7,828	$ 8,013
Draws on existing loans		17,547	19,238
Net cash advances on real estate loans		25,375	27,251
Receipts on real estate loans receivable:
Loan payoffs		74,974	116,358
Principal payments on loans		667	3,107
Sub-total		75,641	119,465
Less : Non-cash activity	[1],[2]	(66,849)	(25,691)
Total receipts on real estate loans		8,792	93,774
Net advances (receipts) on real estate loans		16,583	(66,523)
Change in balance due to foreign currency translation		1,718	(1,987)
Net change Real Estate Loans Receivable		(48,548)	(94,201)
Triple Net [Member]
Advances on real estate loans receivable:
Investments in new loans		7,828	8,013
Draws on existing loans		17,547	19,206
Net cash advances on real estate loans		25,375	27,219
Receipts on real estate loans receivable:
Loan payoffs		14,474	104,068
Principal payments on loans		667	3,107
Sub-total		15,141	107,175
Less : Non-cash activity	[1],[2]	(6,349)	(25,691)
Total receipts on real estate loans		8,792	81,484
Net advances (receipts) on real estate loans		16,583	(54,265)
Change in balance due to foreign currency translation		1,718	(1,987)
Net change Real Estate Loans Receivable		11,952	(81,943)
Outpatient Medical [Member]
Advances on real estate loans receivable:
Investments in new loans		0	0
Draws on existing loans		0	32
Net cash advances on real estate loans		0	32
Receipts on real estate loans receivable:
Loan payoffs		60,500	12,290
Principal payments on loans		0	0
Sub-total		60,500	12,290
Less : Non-cash activity	[1],[2]	(60,500)	0
Total receipts on real estate loans		0	12,290
Net advances (receipts) on real estate loans		0	(12,258)
Change in balance due to foreign currency translation		0	0
Net change Real Estate Loans Receivable		$ (60,500)	$ (12,258)

[1] Outpatient medical represents a deed in lieu of foreclosure on a previously financed first mortgage property.

[2] Triple-net represents acquisitions of assets previously financed as real estate loans. Please see Note 3 for additional information.

XML

Real Estate Loans Receivable (Details 1) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Summary of loan impairments
Balance of impaired loans at end of period		$ 317,049	$ 0
Allowance for loan losses		6,196	0
Balance of impaired loans not reserved		310,853	0
Average impaired loans for the period		340,920	0
Interest recognized on impaired loans	[1]	$ 8,243	$ 0

[1] Represents interest recognized in period since loans were identified as impaired.

XML

Real Estate Loans Receivable (Textuals) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016
Financing Receivable, Modifications [Line Items]
Allowance for loan losses	$ 6,196	$ 6,563	$ 0
Genesis Healthcare Loans [Member] | Triple Net [Member]
Financing Receivable, Modifications [Line Items]
Long-term Debt, Gross	$ 317,000
Provision For Loan And Lease Losses Real Estate Excluding Write Off		$ 6,935
Gensis Healthcare Loan Maturing In 2017 [Member] | Triple Net [Member]
Financing Receivable, Modifications [Line Items]
Maturity Date	Feb. 28, 2017
Gensis Healthcare Loan Maturing In 2018 [Member] | Triple Net [Member]
Financing Receivable, Modifications [Line Items]
Maturity Date	Sep. 30, 2018
Genesis Healthcare Four Restructured Loans [Member] | Triple Net [Member]
Financing Receivable, Modifications [Line Items]
Debt Instrument Restructured Loan Effective Date	Oct. 01, 2016
Debt Instrument, Term	5 years
Debt Instrument Interest Rate Stated Percentage	10.00%
Debt Instrument Basis Spread On Variable Rate1	0.25%

XML

Investments in Unconsolidated Entities (Summary of Investments in Unconsolidated Entities) (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities		$ 416,110	$ 457,138
Triple Net [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities		$ 23,108	$ 27,005
Triple Net [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	[1]	10.00%	10.00%
Triple Net [Member] | Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	[1]	49.00%	49.00%
Seniors Housing Facilities Operating [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities		$ 360,260	$ 407,172
Seniors Housing Facilities Operating [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	[1]	10.00%	10.00%
Seniors Housing Facilities Operating [Member] | Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	[1]	50.00%	50.00%
Outpatient Medical [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	[1]	43.00%	43.00%
Investments in unconsolidated entities		$ 32,742	$ 22,961

[1] Excludes ownership of in-substance real estate.

XML

Investments in Unconsolidated Entities (Details) $ in Thousands	Mar. 31, 2017 USD ($)
Schedule of Equity Method Investments [Line Items]
Unamortized Investment In Joint Venture Primarily Attributable To Real Estate And Related Intangible Assets	$ 211,268

XML

Credit Concentration (Details) $ in Thousands		3 Months Ended
		Mar. 31, 2017 USD ($) properties	Mar. 31, 2016 USD ($)	Dec. 31, 2016
Concentration by investment:
Number of properties in diversified portfolio | properties	[1]	1,277
Percent of NOI	[1],[2]	100.00%
Net Operating Income | $		$ 552,129	$ 597,414
Credit Concentration (Textual) [Abstract]
Percentage total investments with top five customers				45.00%
Genesis HealthCare [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1]	86
Genesis HealthCare [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2]	9.00%
Net Operating Income | $	[1]	$ 49,048
Sunrise Senior Living [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1],[3]	153
Sunrise Senior Living [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2],[3]	14.00%
Net Operating Income | $	[1],[3]	$ 74,893
Brookdale [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1]	137
Brookdale [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2]	7.00%
Net Operating Income | $	[1]	$ 38,372
Revera [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1],[3]	98
Revera [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2],[3]	7.00%
Net Operating Income | $	[1],[3]	$ 37,802
Benchmark Senior Living [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1]	48
Benchmark Senior Living [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2]	4.00%
Net Operating Income | $	[1]	$ 22,614
Remaining Portfolio [Member]
Concentration by investment:
Number of properties in diversified portfolio | properties	[1]	755
Remaining Portfolio [Member] | Net Operating Income [Member]
Concentration by investment:
Percent of NOI	[1],[2]	59.00%
Net Operating Income | $	[1]	$ 329,400

[1] Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.

[2] NOICO with our top five relationships comprised 45% of total NOICO for the year ending December 31, 2016.

[3] Revera owns a controlling interest in Sunrise Senior Living.

XML

Borrowings Under Credit Facilities and Related Items (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017		Mar. 31, 2016		Dec. 31, 2016
Aggregate borrowings under the unsecured line of credit arrangements
Balance outstanding at quarter end	$ 522,000	[1]	$ 645,000	[1]	$ 645,000
Maximum amount outstanding at any month end	1,010,000		945,000
Average amount outstanding (total of daily principal balances divided by days in period)	$ 796,356		$ 671,044
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)	1.81%		1.29%

[1] As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Borrowings Under Credit Facilities and Related Items (Details Textual) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($) properties
Line Of Credit Facility [Line Items]
Unsecured line of credit arrangement	$ 3,000,000
Number of banks in consortium | properties	29
Available to borrow in alternate currencies	$ 1,000,000
Annual facility fee for each bank based on commitment amount	0.15%
Term Loan Interest Rate Margin	0.90%
HCN Term Loan	$ 500,000
HCN Canadian Denomiated Term Loan	250,000
Accordion Feature [Member]
Line Of Credit Facility [Line Items]
HCN Term Loan	1,000,000
HCN Canadian Denomiated Term Loan	$ 250,000
Revolving Credit Facility [Member]
Line Of Credit Facility [Line Items]
Agent bank's prime rate of interest	1.88%
Maturity Date	May 13, 2020
Letter of credit that reduces the borrowing capacity	$ 32,456

XML

Senior Unsecured Notes and Secured Debt (Details) £ in Thousands, CAD in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2017 CAD	Mar. 31, 2017 GBP (£)	Mar. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Oct. 01, 2015 USD ($)
Principal payments due on debt obligations
2017				$ 284,879
2018				871,751
2019				1,104,895
2020	[1]			825,096
2021	[2],[3]			1,366,667
Thereafter	[4],[5],[6],[7]			6,496,456
Totals				10,949,744
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes				8,188,928	$ 8,161,619
Secured debt				2,669,787	$ 3,477,699
Senior Unsecured Notes [Member]
Principal payments due on debt obligations
2017	[8],[9]			0
2018	[8],[9]			450,000
2019	[8],[9]			605,000
2020	[1],[8],[9]			675,208
2021	[2],[3],[8],[9]			1,137,674
Thereafter	[4],[5],[6],[7],[8],[9]			5,416,385
Totals	[8],[9]			$ 8,284,267
Senior Unsecured Notes [Member] | Maximum [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		6.50%	6.50%	6.50%
Senior Unsecured Notes [Member] | Minimum [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		1.60%	1.60%	1.60%
Secured Debt [Member]
Principal payments due on debt obligations
2017	[8],[10]			$ 284,879
2018	[8],[10]			421,751
2019	[8],[10]			499,895
2020	[1],[8],[10]			149,888
2021	[2],[3],[8],[10]			228,993
Thereafter	[4],[5],[6],[7],[8],[10]			1,080,071
Totals	[8],[10]			2,665,477
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Carrying values of properties securing the debt				$ 4,947,646
Secured Debt [Member] | Maximum [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		7.93%	7.93%	7.93%
Secured Debt [Member] | Minimum [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		1.32%	1.32%	1.32%
3.35% senior unsecured note due 2020
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes issued amount		CAD 300,000		$ 225,208
Debt Instrument, Issuance Date		Nov. 01, 2015
Canadian Denominated Unsecured Term Loan [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes		CAD 250,000		187,674
Debt Instrument Basis Spread On Variable Rate1		1.84%
Debt Instrument, Issuance Date		May 13, 2016
Maturity Date		May 13, 2021
Canadian Denominated Unsecured Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Debt Instrument Basis Spread On Variable Rate1		0.95%
Unsecured term credit facility [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes				$ 500,000
Debt Instrument Basis Spread On Variable Rate1		1.83%
Debt Instrument, Issuance Date		May 13, 2016
Maturity Date		May 13, 2021
Unsecured term credit facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Debt Instrument Basis Spread On Variable Rate1		0.95%
UK Debt Due 2028 [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		4.80%	4.80%	4.80%
Senior unsecured notes issued amount			£ 550,000	$ 689,535
Debt Instrument, Issuance Date		Nov. 20, 2013
Maturity Date		Nov. 20, 2028
UK Debt Due 2034 [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Interest rate		4.50%	4.50%	4.50%
Senior unsecured notes issued amount			£ 500,000	$ 626,850
Debt Instrument, Issuance Date		Nov. 25, 2014
Maturity Date		Nov. 24, 2034
4.00% Senior Unsecured Notes Due 2025 [Member]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes issued amount				750,000
Debt Instrument, Issuance Date		May 01, 2015
Senior Unsecured Notes Additional Issued Amount						$ 500,000
4.25% Senior Unsecured Notes Due 2026
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Senior unsecured notes issued amount				$ 700,000
Debt Instrument, Issuance Date		Mar. 01, 2016
Maturity Date		Mar. 01, 2026

[1] In November 2015, one of our wholly-owned subsidiaries issued and we guaranteed $300,000,000 of Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $225,208,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017).

[2] On May 13, 2016, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $187,674,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2017). The loan matures on May 13, 2021 and bears interest at the Canadian Dealer Offered Rate plus 95 basis points (1.84% at March 31, 2017).

[3] On May 13, 2016, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on May 13, 2021 and bears interest at LIBOR plus 95 basis points (1.83% at March 31, 2017).

[4] In March 2016, we issued $700,000,000 of 4.25% senior unsecured notes due 2026.

[5] In May 2015, we issued $750,000,000 of 4.0% senior unsecured notes due 2025. In October 2015, we issued an additional $500,000,000 of these notes under a re-opening of the offer.

[6] On November 20, 2013, we completed the sale of £550,000,000 (approximately $689,535,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.8% senior unsecured notes due 2028.

[7] On November 25, 2014, we completed the sale of £500,000,000 (approximately $626,850,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2017) of 4.5% senior unsecured notes due 2034.

[8] Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the balance sheet.

[9] Annual interest rates range from 1.6% to 6.5%.

[10] Annual interest rates range from 1.32% to 7.93%. Carrying value of the properties securing the debt totaled $4,947,646,000 at March 31, 2017.

XML

Senior Unsecured Notes and Secured Debt (Details 1) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Unsecured note issuances
Senior unsecured debt issued	$ 0	$ 688,560
Senior unsecured debt redeemed	0	400,000
Excluding Fair Value Adjustments [Member]
Unsecured note issuances
Senior unsecured debt balance	8,284,267	8,934,093	$ 8,260,038	$ 8,645,758
Senior unsecured debt issued	0	700,000
Senior unsecured debt extinguished	0	(400,000)
Senior unsecured debt foreign currency	$ 24,229	$ (11,665)
Senior unsecured debt balance average rate	0.04262	0.04266	0.04245	0.04237
Senior unsecured debt issued average rate	0	0.0425
Senior unsecured debt extinguished average rate	0	0.03625
Senior unsecured debt foreign currency average rate	0.04391	0.03943

XML

Senior Unsecured Notes and Secured Debt (Details 2) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Secured debt principal activity
Secured debt issued	$ 12,536	$ 75,136
Secured debt extinguished	822,438	130,343
Excluding Fair Value Adjustments [Member]
Secured debt principal activity
Secured debt principal balance	2,665,477	3,488,488	$ 3,465,066	$ 3,478,207
Secured debt issued	12,536	75,136
Secured debt extinguished	(806,189)	(111,701)
Secured debt principal payments	10,313	65,488
Secured debt foreign currency	$ (16,249)	$ (18,642)
Secured debt principal balance average rate	0.03744	0.044	0.04094	0.0444
Secured debt principal issued average rate	0.0234	0.0306
Secured debt principal extinguished average rate	0.0558	0.0445
Secured debt principal payment average rate	0.03262	0.03669
Secured debt principal foreign currency average rate	0.04469	0.04539

XML

Derivative Instrument (Notional Table) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | USD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	$ 0	$ 57,000
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	72,000	54,000
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | GBP
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	69,000	48,000
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	875,000	900,000
Notional Amount Of Nonderivative Instruments	250,000	250,000
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | GBP
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	550,000	550,000
Notional Amount Of Nonderivative Instruments	1,050,000	1,050,000
Not Designated as Hedging Instrument [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	37,000	37,000
Not Designated as Hedging Instrument [Member] | GBP
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	$ 0	$ 0

XML

Derivative Instruments (Details 1) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Derivative [Line Items]
Derivative Gain Loss On Derivative Net	$ (1,224)	$ 0
Interest Rate Swap [Member]
Derivative [Line Items]
Gain (loss) on interest rate swaps recalssified from AOCI into income (effective portion)	0	(483)
Foreign Exchange Contract [Member]
Derivative [Line Items]
Gain (loss) on forward exchange contracts recognized in income.	2,457	(1,327)
Gain on Release of cumulative translation adjustment related to net investment hedge of an equity investment	$ (44,341)	$ (2,739)

XML

Derivative Instruments (Textual) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Derivative Instruments [Abstract]
Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months	$ 3,395
Derivative Cash Received On Hedge	$ 8,218	$ 0

XML

Commitments and Contingencies (Details Textual) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($) Number	Dec. 31, 2016 USD ($)
Commitments and Contingencies (Textual) [Abstract]
Number of outstanding letters of credit | Number	14
Letter of credit obligation	$ 169,961
Line Of Credit Facility [Line Items]
Outstanding construction financings for leased properties	390,180	$ 506,091
Additional financing to complete construction	466,031
Total contingent purchase obligations	$ 17,058
Minimum part of economic life of the leased asset to be classified as capital lease	75.00%
Minimum net present value of the future minimum lease payments to be classified as capital lease.	90.00%
Operating lease obligations relating to certain ground leases	$ 1,092,169
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals	73,840
Capital Leases, Future Minimum Payments Due	$ 93,697
Letter Of Credit Expiration Date Maximum	Dec. 31, 2024
Letter Of Credit Expiration Date Minimum	Jan. 01, 2017

XML

Stockholder's Equity (Details) - shares	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	14,375,000	25,875,000
Outstanding shares	14,375,000	25,875,000	25,875,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	365,651,576	363,576,924
Outstanding shares	364,563,653	362,602,173

XML

Stockholder's Equity (Details 1)	3 Months Ended
	Mar. 31, 2017 USD ($) $ / shares shares	Mar. 31, 2016 USD ($) $ / shares shares
Summary of common stock issuances
Equity shelf plan issuances, Shares Issued | shares	338,486	443,096
Equity shelf plan issuances, average price | $ / shares	69.75	67.12
Equity Shelf Plan Issuances Gross Proceeds	$ 23,776,000	$ 30,192,000
Equity Shelf Plan Issuances Net Proceeds	$ 23,609,000	$ 29,739,000
Dividend reinvestment plan issuances, Shares Issued | shares	1,284,719	1,058,085
Dividend reinvestment plan issuances, Average Price	68.33	60
Dividend reinvestment plan issuances, Net Proceeds	$ 87,784,000	$ 63,484,000
Dividend reinvestment plan issuances, Gross Proceeds	$ 87,985,000	$ 63,484,000
Option exercises, Shares | shares	156,675	9,864
Option exercises, Average Price	52.71	21.29
Option exercises, Gross Proceeds	$ 8,258,000	$ 210,000
Option exercises, Net Proceeds	$ 8,258,000	$ 210,000
Stock incentive plans, net of forfeitures, Shares Issued | shares	181,600	484,005
Issuance of Common Stock, Shares | shares	1,961,480	1,995,050
Gross Proceeds From Issuance of Common Stock	$ 120,019,000	$ 93,886,000
Net proceeds from the issuance of common stock	$ 119,651,000	$ 93,433,000

XML

Stockholder's Equity (Details 2) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges		$ (2)	$ (2)	$ (933)	$ (1,416)
Unrecognized losses on equity investments		(5,449)	5,120	(7,549)	0
Unrecognized gains (losses) on foreign currency translation		(170,596)	(173,496)	(99,230)	(85,484)
Unrecognized actuarial losses		(1,153)	(1,153)	(1,341)	(1,343)
Totals		(177,200)	$ (169,531)	(109,053)	$ (88,243)
Other comprehensive income before reclassification adjustments
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges		0		0
Unrecognized losses on equity investments		(10,569)		(7,549)
Unrecognized gains (losses) on foreign currency translation		2,900		(13,746)
Unrecognized actuarial losses		0		2
Totals		(7,669)		(21,293)
Reclassification amount to net income
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges	[1]			483
Unrecognized losses on equity investments				0
Unrecognized gains (losses) on foreign currency translation				0
Unrecognized actuarial losses				0
Totals				483
Net current period other comprehensive income
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges		0		483
Unrecognized losses on equity investments		(10,569)		(7,549)
Unrecognized gains (losses) on foreign currency translation		2,900		(13,746)
Unrecognized actuarial losses		0		2
Totals		$ (7,669)		$ (20,810)

[1] Please see Note 11 for additional information.

XML

Stockholder's Equity (Details 3) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015
Stockholders' Equity (Details) [Abstract]
Preferred Stock, Shares Outstanding	14,375,000	25,875,000	25,875,000	25,875,000
Preferred stock, shares redeemed	(11,500,000)	0
Preferred stock balance weighted average rate	6.50%	6.50%	6.50%	6.50%
Preferred stock balance redeemed weighted average rate	6.50%	0.00%
Preferred stock redemption charge	$ 9,769	$ 0

XML

Stockholder's Equity (Details 5) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Summary of dividend payments
Dividends declared and paid per common share	$ 0.87	$ 0.86
Common stock cash dividends	$ 315,415	$ 305,770
Total dividends paid	$ 329,794	$ 322,122
Series I Preferred Stock [Member]
Summary of dividend payments
Dividends declared and paid per preferred share	$ 0.8125	$ 0.8125
Preferred stock cash dividends	$ 11,680	$ 11,680
Series J Preferred Stock [Member]
Summary of dividend payments
Dividends declared and paid per preferred share	$ 0.2347	$ 0.4064
Preferred stock cash dividends	$ 2,699	$ 4,672

XML

Stock Incentive Plans (Details Textual) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Stock Incentive Plans [Line Items]
Number of common stock authorized for 2016 Long-Term Incentive Plan	10,000
Stock-based compensation expense	$ 4,906	$ 8,186
Maximum [Member]
Stock Incentive Plans [Line Items]
Vesting period	5 years
Minimum [Member]
Stock Incentive Plans [Line Items]
Vesting period	3 years
Employee Stock Option [Member] | Employee Stock Option [Member] | Officer [Member]
Stock Incentive Plans [Line Items]
Vesting period	10 years

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Computation of basic and diluted earnings per share
Numerator for basic and diluted earnings per share - net income (loss) attributable to common stockholders	$ 312,639	$ 148,969
Denominator for basic earnings per share - weighted average shares	362,534	355,076
Effect of dilutive securities:
Employee stock options	70	101
Non-vested restricted shares	397	253
Redeemable shares	1,651	621
Dilutive potential common shares	2,118	975
Denominator for diluted earnings per share - adjusted weighted average shares	364,652	356,051
Basic earnings per share	$ 0.86	$ 0.42
Diluted earnings per share	$ 0.86	$ 0.42

XML

Disclosure about Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2017		Dec. 31, 2016	Mar. 31, 2016		Dec. 31, 2015
Financial Assets:
Loans receivable, Carrying Amount	$ 574,080		$ 622,628
Loans receivable, Fair value	465,548		521,773
Available-for-sale equity investments, Carrying Amount	17,330		27,899
Available-for-sale equity investments, Fair Value	17,330	[1]	27,899
Cash and cash equivalents, Carrying Amount	380,360		419,378	$ 355,949		$ 360,908
Cash and cash equivalents, Fair Value	380,360		419,378
Foreign Currency Forward Contracts Carrying Value	110,439		135,561
Foreign Currency Forward Contracts Fair Value	110,439		135,561
Financial Liabilities:
Borrowings under primary unsecured credit facilities, Carrying Value	522,000	[2]	645,000	$ 645,000	[2]
Borrowings under primary unsecured credit facilities, Fair Value	522,000		645,000
Senior unsecured notes, Carrying Amount	8,188,928		8,161,619
Senior unsecured notes, Fair Value	8,965,318		8,879,176
Secured debt, Carrying Amount	2,669,787		3,477,699
Secured debt, Fair Value	2,728,171		3,558,378
Foreign Currency Forward Contracts Carrying Value	9,840		4,342
Foreign Currency Forward Contracts, Fair Value	9,840		4,342
Redeemable OP unitholder interests carrying value	116,917		110,502
Redeemable OP unitholder interests fair value	116,917		110,502
Mortgage Loans on Real Estate [Member]
Financial Assets:
Loans receivable, Carrying Amount	430,607		485,735
Loans receivable, Fair value	465,548		521,773
Other Real Estate Loans Receivable [Member]
Financial Assets:
Loans receivable, Carrying Amount	143,473		136,893
Loans receivable, Fair value	$ 149,151		$ 138,050

[1] Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.

[2] As of March 31, 2017, letters of credit in the aggregate amount of $32,456,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Disclosure about Fair Value of Financial Instruments (Details 1) - USD ($) $ in Thousands		Mar. 31, 2017		Dec. 31, 2016
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments		$ 17,330	[1]	$ 27,899
Foreign currency forward contracts	[2]	100,599
Redeemable OP unitholder interests		116,917
Totals		234,846
Level 1 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	[1]	17,330
Totals		17,330
Level 2 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Foreign currency forward contracts	[2]	100,599
Redeemable OP unitholder interests		116,917
Totals		$ 217,516

[1] Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.

[2] Please see Note 11 for additional information.

XML

Segment Reporting (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($)		Mar. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)
Summary of information for reportable segments
Rental income	$ 367,141		$ 415,663
Resident fees and services	670,337		602,149
Interest income	20,748		25,188
Other income	4,072		4,050
Total revenues	1,062,298		1,047,050
Property operating expenses	510,169		449,636
Net Operating Income from Continuing Operations	552,129		597,414
Interest expense	118,597		132,960
Loss (gain) on derivatives, net	1,224		0
Depreciation and amortization	228,276		228,696
General and administrative	31,101		45,691
Transaction costs	0		8,208
Loss (gain) on extinguishment of debt, net	31,356		(24)
Impairment of Asset	11,031		14,314
Other expenses	11,675		0
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	118,869		167,569
Income tax expense	(2,245)		1,725
(Loss) income from unconsolidated entities	(23,106)		(3,820)
Income (loss) from continuing operations	93,518		165,474
Gain (loss) on real estate dispositions, net	244,092		0
Net income	337,610		$ 165,474
Total assets	$ 27,767,277			$ 28,865,184
Percent Of Assets	1			1
Percent Of Revenues	1		1
United States
Summary of information for reportable segments
Total revenues	$ 858,668		$ 842,357
Total assets	$ 22,425,964			$ 23,572,459
Percent Of Assets	0.808			0.817
Percent Of Revenues	0.8093		0.805
United Kingdom
Summary of information for reportable segments
Total revenues	$ 93,843		$ 100,555
Total assets	$ 2,835,782			$ 2,782,489
Percent Of Assets	0.102			0.096
Percent Of Revenues	0.088		0.096
Canada
Summary of information for reportable segments
Total revenues	$ 109,787		$ 104,138
Total assets	$ 2,505,531			$ 2,510,236
Percent Of Assets	0.09			0.087
Percent Of Revenues	0.103		0.099
Triple Net [Member]
Summary of information for reportable segments
Rental income	$ 227,290		$ 283,825
Resident fees and services	0		0
Interest income	20,679		22,853
Other income	1,766		1,490
Total revenues	249,735		308,168
Property operating expenses	0		0
Net Operating Income from Continuing Operations	249,735		308,168
Interest expense	5,511		6,364
Loss (gain) on derivatives, net	1,224
Depreciation and amortization	59,608		79,800
General and administrative	0		0
Transaction costs			2,852
Loss (gain) on extinguishment of debt, net	29,084		(24)
Impairment of Asset	0		14,314
Other expenses	5,010
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	149,298		204,862
Income tax expense	(800)		(317)
(Loss) income from unconsolidated entities	5,638		3,081
Income (loss) from continuing operations	154,136		207,626
Gain (loss) on real estate dispositions, net	231,081		0
Net income	385,217		207,626
Total assets	9,906,585
Senior housing - operating [Member]
Summary of information for reportable segments
Rental income	0		0
Resident fees and services	670,337		602,149
Interest income	69		1,031
Other income	1,461		2,189
Total revenues	671,867		605,369
Property operating expenses	462,425		408,894
Net Operating Income from Continuing Operations	209,442		196,475
Interest expense	15,816		20,523
Loss (gain) on derivatives, net	0
Depreciation and amortization	119,737		101,832
General and administrative	0		0
Transaction costs			3,933
Loss (gain) on extinguishment of debt, net	890		0
Impairment of Asset	5,406		0
Other expenses	1,778
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	65,815		70,187
Income tax expense	(1,087)		2,767
(Loss) income from unconsolidated entities	(29,191)	[1]	(6,935)
Income (loss) from continuing operations	35,537		66,019
Gain (loss) on real estate dispositions, net	13,011		0
Net income	48,548		66,019
Total assets	12,646,321
Outpatient Medical [Member]
Summary of information for reportable segments
Rental income	139,851		131,838
Resident fees and services	0		0
Interest income	0		1,304
Other income	612		313
Total revenues	140,463		133,455
Property operating expenses	47,744		40,742
Net Operating Income from Continuing Operations	92,719		92,713
Interest expense	2,291		5,744
Loss (gain) on derivatives, net	0
Depreciation and amortization	48,931		47,064
General and administrative	0		0
Transaction costs			1,423
Loss (gain) on extinguishment of debt, net	1,382		0
Impairment of Asset	5,625		0
Other expenses	360
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	34,130		38,482
Income tax expense	(335)		(228)
(Loss) income from unconsolidated entities	447		34
Income (loss) from continuing operations	34,242		38,288
Gain (loss) on real estate dispositions, net	0		0
Net income	34,242		38,288
Total assets	4,947,544
Corporate, Non-Segment [Member]
Summary of information for reportable segments
Rental income	0		0
Resident fees and services	0		0
Interest income	0		0
Other income	233		58
Total revenues	233		58
Property operating expenses	0		0
Net Operating Income from Continuing Operations	233		58
Interest expense	94,979		100,329
Loss (gain) on derivatives, net	0
Depreciation and amortization	0		0
General and administrative	31,101		45,691
Transaction costs			0
Loss (gain) on extinguishment of debt, net	0		0
Impairment of Asset	0		0
Other expenses	4,527
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	(130,374)		(145,962)
Income tax expense	(23)		(497)
(Loss) income from unconsolidated entities	0		0
Income (loss) from continuing operations	(130,397)		(146,459)
Gain (loss) on real estate dispositions, net	0		0
Net income	(130,397)		$ (146,459)
Total assets	$ 266,827

[1] Primarily due to the recognition of goodwill and intangible asset impairments, as well as non-recurring income tax expense.

XML

Income Taxes and Distributions (Details)	3 Months Ended
	Mar. 31, 2017
Additional Income Taxes and Distributions (Textuals) [Abstract]
Percentage of Taxable income to be distributed to stockholders for federal tax purposes	90.00%
Percentage of capital gains excluded from taxable income distributed to shareholders	100.00%
Percentage of federal excise tax on real estate investment trusts that do not distribute income.	4.00%

XML

Variable Interest Entity Disclosure (Details) - Variable Interest Entity, Primary Beneficiary [Member] - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Variable Interest Entity [Line Items]
Total assets	[1]	$ 1,004,490	$ 1,012,199
Total equity		468,490	362,585
Total liabilities and equity		1,004,490	1,012,199
Net real property owned [Member]
Variable Interest Entity [Line Items]
Total assets		980,570	989,596
Cash and cash equivalents [Member]
Variable Interest Entity [Line Items]
Total assets		7,390	10,501
Receivables and other assets [Member]
Variable Interest Entity [Line Items]
Total assets		16,530	12,102
Secured Debt [Member]
Variable Interest Entity [Line Items]
Liabilities		449,163	450,255
Accrued expenses and other liabilities [Member]
Variable Interest Entity [Line Items]
Liabilities		13,880	13,803
Redeemable noncontrolling interests [Member]
Variable Interest Entity [Line Items]
Liabilities		$ 72,957	$ 185,556

[1] Note that assets of the consolidated variable interest entities can only be used to settle obligations relating to such variable interest entities. Liabilities of the consolidated variable interest entities represent claims against the specific assets of the variable interest entities.